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ABSTRACT 
Epigallocatechin gallate (EGCG), a major green tea polyphenol, has been widely studied 
and proposed as a functional food ingredient and nutraceutical for therapeutic use. 
However, EGCG is highly hydrophilic with poor solubility in lipophilic media which 
hinders its widespread application in foods and affects its absorption in vivo, resulting in 
limited uptake by the cells and bioavailability when ingested orally. Therefore, it is 
important to alter the hydrophilicity/lipophilicity balance (HLB) ofEGCG in order to take 
better advantage of its multifunctional properties. This work investigated structural 
modification of EGCG, more specifically esterification with fatty acids of different chain 
length and degree of unsaturation, as an approach to improving the lipophilicity while 
maintaining the maximum efficacy or even introducing novel bioactivities not found in 
the original EGCG. Additional perspectives may exist using the health beneficial omega-
3 polyunsaturated fatty acids (PUFA) as acyl donors. For this purpose, lipophilic ester 
derivatives of EGCG with butyric, stearic, eicosapentaenoic, docosapentaenoic, and 
docosahexaenoic acids were prepared, and their bioactivities evaluated, including 
antioxidant activities in different model systems, anti-inflammatory, antiviral and 
anticancer activities. The results indicated that lipophilization by esterification, especially 
with omega-3 PUF A, significantly improved the antioxidant and anti-inflammatory 
activity of EGCG. Moreover, the ester derivatives totally arrested colon cancer in mice, 
and exhibited an anti-HCV (hepatitis C virus) activity 1700-folds greater than that of the 
positive control embelin. These findings strongly suggest that the EGCG ester derivatives 
are of great potential as lipophilic alternatives of the water-soluble EGCG and may serve 
lll 
as novel functional ingredients for food, cosmetics, and nutraceutical!therapeutical 
applications and for use in medicine and natural health products. 
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CHAPTER 1 
Introduction and overview 
1 Phenolics 
1.1 Classification, chemistry and occurrence 
Phenolics are naturally occurring compounds widely distributed in the plant kingdom and 
important components of human daily diets. They are secondary metabolites synthesized 
by plants from phenylalanine and to a lesser extent tyrosine, both during normal 
development and in response to stress conditions (Harbome 1982; Beckman 2000). 
Phenolics comprise the largest group among the approximately 50,000 secondary plant 
metabolites (Grassmann et al. 2002). They are important constituents of plants with 
multiple functions from overall fitness regulation to plant defence mechanism against 
insects, pathogens and extreme environmental conditions. As dietary phytochemicals for 
humans, phenolics display a broad range of functional and biological activities, 
depending on their chemical structures. Phenolics vary in their structures from simple 
phenols to highly polymerized compounds and are characterized by an aromatic ring with 
one or more hydroxyl group substituents. The aromatic ring(s) may also bear other 
functional substituents such as esters, methyl ethers and glycosides, and thus contributing 
to the great diversity of their structures. There are more than 8000 phenolic compounds 
identified in fruits, vegetables, seeds and related products, which can be divided into 
several common categories based on their chemical structures. Phenolics are generally 
classified into simple phenols, phenolic acids, coumarins, stilbenes, flavonoids, lignans 
and their polymerized counterparts, such as tannins and lignins (Table 1-1 ). These groups 
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Table 1-1. Major classes of naturally occurring phenolic compounds. 
Classes 
Simple phenols 
Phenolic acids 
Hydroxybenzoic acids 
Hydroxycinnamic acids 
Coumarins 
Stilbenes 
Flavonoids 
Lignans 
Basic skeleton 
C6 
C6-C1 
C6-C3 
C6-C3 
C6-C2-C6 
C6-C3-C6 
C6-C4-C6 
1-2 
Examples 
Cresol 
p-Hydroxybenzoic acid 
Caffeic acid 
Scopolin 
Resveratrol 
Catechin 
Secoisolariciresinol 
can be further classified into many subcategories. Simple phenols include monophenols 
(e.g. cresol) and diphenols (e.g. hydroquinones). Phenolic acids are mostly either 
hydroxybenzoic acid (C6-C1) or hydroxycinnamic acid (C6-C3) derivatives with 
different number and location of hydroxy and/or methoxy substituents on the phenyl ring. 
Caffeic and ferulic acids are among the most common phenolic acids from dietary 
sources; the former is found abundantly in fruits and vegetables, most often as esters or 
other conjugates, and the latter is present in cereals, esterified to hemicelluloses in the cell 
wall (Scalbert et al. 2005). Phenolic acids are the major non-flavonoids and comprise 
approximately 30% of total dietary phenolics (Bravo 1998). Other non-flavonoid 
phenolics such as stilbenes and lignans are less commonly found in the diet. Stilbenes 
(C6-C2-C6) are present mostly as heartwood constituents of trees while in smaller 
amounts in the vegetative parts, and resveratrol is the most widespread stilbene in nature 
(Seigler 1998). Lignans (C6-C4-C6) are often found in seeds and nuts, and are most 
abundant in flax and sesame seeds. 
Flavonoids are ubiquitous in plants and account for about 60% of dietary polyphenols 
(Bravo 1998). Flavonoids exhibit multiple biological activities and have been implicated 
in the risk reduction of many chronic diseases and health conditions. The structures of 
flavonoids consist of two aromatic rings linked by three carbons in an oxygenated 
heterocycle with variable oxidation levels. The fused aromatic ring is referred to as A ring, 
the phenyl constituent as B ring, and the heterocyclic pyran as C ring. Flavonoids with 
this common characteristic diphenylpropane (C6-C3-C6) skeleton exhibit a broad 
variation in structural specificity, which differentiates them into several subclasses. More 
than 6500 different flavonoid structures have been described (Harbome and Williams 
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2000), among which 7 major groups are usually distinguished. These include flavones, 
flavanones, flavonols, flavanonols, flavanols, isoflavones, and anthocyanidins, varying in 
saturation and oxidation status of the C ring as well as the position of B and C ring 
linkage (Figure 1-1 ). Flavanones, characterized by a saturated C ring and a 4-keto group, 
are precursors to all flavonoid structures and are among the most prevalent naturally 
occurring flavonoids (Fowler and Koffas 2009). Flavonols, which contain 2, 3-double 
bonds, 4-keto and 3-hydroxyl groups in the C ring, and flavanols lacking the double 
bonds and keto groups are the most widespread in plants. More than 50% of plants 
contain quercetin, kaempferol and myricetin in their leaves and flowers (Kartsova and 
Alekseeva 2008). Isoflavones, differing from flavones in having their B ring attached at 
C-3 of the C ring, are rich in soybean and its fermented products, and have attracted 
special interest for their estrogen-like activity. Anthocyanidins with a pyrylium central C 
ring are aglycones of anthocyanin pigments in flowers, leaves, fruits and roots of many 
plants. 
In addition to the major groups, other flavonoids with slightly varied structures have also 
been identified. Among these are neoflavonoids, which have a C-4 linkage of the B and C 
rings, and some minor flavonoids such as chalcones, aurones and auronols (Marais et al. 
2006). Structural variations within the flavonoid subclasses may derive from substitution 
patterns, such as hydroxylation, methoxylation, 0-glycosylation, C-glycosylation and 
covalent addition of prenyl or alkyl groups (Aron and Kennedy 2008). Moreover, the 
primary substituents (e.g. hydroxyl, methoxyl and glycosyl groups) may themselves be 
subjected to substitution, such as additional glycosylation or acylation, yielding highly 
complex structures (Cheynier 2005). Flavonoids from natural sources often exist as gly-
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0 
flavone 
flavanonol 
+ 
0 
~ 
anthocyanidin 
0 0 
flavanone flavonol 
flavan-3-ol isoflavone 
Figure 1-1. Basic structures of major flavonoids. 
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cosides rather than in the free form, and the glycosyl groups are usually attached to the 
flavonoid core at the C-3 position of the C ring (Finotti and Di Majo 2003). In general, 
the leaves, flowers and fruits of plants contain mainly flavonoid glycosides, while the 
woody tissues contain aglycones and the seeds may contain both (Pan and Ho 2008). 
Some of the most common flavonoid aglycones from dietary sources include quercetin, a 
flavonol abundant in onion, apple and tea; catechins, a group of flavanols in tea and 
several fruits; cyanidin, an anthocyanidin in many red fruits (strawberry, raspberry, black 
currant, etc.); hesperetin, a flavanone in citrus fruits; daidzein, the main isoflavone in 
soybean, among others (Scalbert et al. 2005). 
Distribution of phenolics in plants is not uniform and vanes both qualitatively and 
quantitatively among plant species as well as tissues. Factors affecting phenolic profiles 
and contents in plants include plant species and cultivar, cultivation techniques employed, 
growing conditions and maturation stage, among others. Some phenolic compounds may 
show increased content under stress conditions such as UV radiation, air pollution, 
wounding, infection by pathogens and parasites, and exposure to extreme temperatures, 
etc. For example, the synthesis of stilbenes in grapes and isocoumarins in carrots can be 
stimulated by various plant injuries (Lafuente et al. 1989; Bavaresco et al. 1997). When 
consumed as dietary components for humans, phenolics in plant-derived food are also 
influenced by processing and storage conditions involved. For instance, peeling, chopping, 
boiling, microwaving and frying lead to loss of quercetin conjugates of up to 75%, as 
observed for onions; whereas cold-stored whole parsnips had a 33-fold increase in their 
furanocoumarin content (Makris and Rossiter 2001). 
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The phenolic distribution within the plants varies at the tissue, cellular and subcellular 
levels. Phenolics are generally present at higher levels in the outer layers of plants than in 
their inner parts (Prez-Ilzarbe et a!. 1992). At the cellular level, cell walls contain more 
insoluble phenolics, while soluble phenolics are mainly found in the cell vacuoles 
compartment (Wink 1997). This tissue and cellular distribution pattern of phenolics takes 
advantage of their specific characteristics and is believed to contribute to the mechanical 
strength, thermal stability and cell defence against stress and pathogens as well as 
regulation of growth and morphogenesis of the plant (Sca1bert 1993; Wallace and Fry 
1994). Phenolics in plants may act as phytoalexins, antifeedants, antioxidants, attractants 
for pollinators, and protective agents against UV, among others (Shahidi and Naczk 2004). 
Although phenolics are ubiquitous, individual compounds may vary and be restricted to 
specific families and species, thus contributing to the characteristic pigmentation and 
sensory properties of plant-derived foods. Phenolics may, at least partially, be responsible 
for the bitterness and astringency, color, odor, and oxidative stability of foods containing 
them (Naczk and Shahidi 2003). Phenolics are highly reactive compounds and substrates 
for various enzymes, including polyphenol oxidases, peroxidases, glycosidases and 
esterases. They undergo a number of chemical and enzymatic reactions during harvesting, 
processing and storage of the plant material, resulting in a complex mixture of products 
whose composition and concentration are still poorly understood (Cheynier 2005). The 
phenolics and their derived products contribute to major sensory characteristics of many 
plant foods and beverages, and more importantly are associated with numerous health 
benefits of consumption of fruits, vegetables, nuts and other plant-related foods. 
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1.2 Bioactivities and bioavailabilities 
Consumption of fruits and vegetables has been linked to a lower risk of many diseases, 
including inflammation, cardiovascular disease (CVD), cancer, diabetes and 
neurodegenerative diseases. Although most research has focused on their vitamins and 
other micronutrients, an association between health benefits of plant-rich diets and their 
bioactive phytochemicals is being established. The health promoting effects of fruits, 
vegetables and related products have recently been largely attributed to the presence of 
phenolics. Evidence from a large body of in vitro and in vivo studies has shown that 
phenolic compounds possess antioxidant, anti-inflammatory, antiatherogenic, 
anticarcinogenic, antidiabetic, anti-allergic, antimicrobial and antiviral activities, among 
others. The mechanisms of these biological activities of phenolics and their related health 
effects have been reviewed (Scalbert et al. 2005; Aron and Kennedy 2008). 
Phenolics are known as powerful antioxidants by inhibiting oxidative deterioration of 
foods and protecting against oxidative stress-mediated diseases. They may act as free 
radical scavengers, singlet oxygen quenchers, metal chelators, reducing agents and 
excellent synergists with other antioxidants, and thus inhibiting oxidation of biomolecules 
(e.g. membrane lipids, LDL-cholesterol, proteins and DNA) and suppressing related 
pathologies such as inflammation, atherosclerosis and carcinogenesis. These compounds 
are also able to modify physiological and pathological conditions independently from or 
in combination with antioxidant mechanisms (Biesalski 2007). Phenolics act as anti-
inflammatory agents by down-regulation of some inflammatory mediators at expression 
level and direct inhibition of the activity of the mediator enzymes (Shahidi and Zhong 
2009). The cholesterol--lowering effect and inhibition against LDL-cholesterol oxidation 
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contribute to the cardioprotective property of many plant polyphenols. The French 
paradox, an inverse relationship between red wine consumption and mortality rates from 
CVD and certain cancers, has been attributed to the polyphenols present in the skin of 
grapes, particularly resveratrol, which is also found in peanuts and mulberries (Boehm 
2000). Grape anthocyanidins were found to suppress the stomach mucosal injury induced 
by acidified ethanol, and their antiulcer property was believed to be due to both 
antioxidant activity and the ability to bind proteins (Saito et al. 1998). Phenolics have 
proven to possess anticancer activities and are considered as good candidates for food-
derived drugs. A study on the Zutphen elderly revealed that flavonoid intake from fruits 
and vegetables was inversely associated with all-cause cancer risk and cancer of the 
alimentary and respiratory tract (Hertog et al. 1994). Quercetin has shown vasoactive and 
gastroprotective effects, as well as inhibition against heterocyclic amines (HCA)-induced 
mutagenesis (Alarcon 1994; Kahraman et al. 2003). Proanthocyanidins A2 treatment 
effectively modulated expression of antioxidant enzymes and decreased UVB-induced 
skin tumors (Pan and Ho 2008). Isoflavones in soybean exhibit estrogenic activities and 
may protect against hormone-related cancer and CVD (Adlercreutz and Mazur 1997; 
Lichtenstein 1998). Consumption of soybean isoflavones reduced the incidence of breast, 
urinary tract and colon cancers, and provided protection against coronary heart diseases 
and osteoporosis (Brandi 1997). Genistein, the main bioactive isoflavone in soybean with 
anti-estrogenic activity has shown antitumor capabilities supported by many in vitro, 
cellular, animal model and clinical studies (Ravindranath et a!. 2004). Antimicrobial 
activities of phenolics have also been reported. Cranberry proanthocyanidins can 
competitively inhibit cellular adherence of uropathogenic strains of P-type E coli to 
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mucosal cells in the urinary tract (Howell 2002). Other bioactivities of phenolics include 
antiviral, anti-allergic, antidiabetic and analgesic properties, among others (Musci 1986; 
Nguyen et al. 1999; Julflkar Hossain et al. 2008). 
In addition to their health-promoting capability, some phenolics may exert antinutritional 
properties that are of great importance to both consumers and producers. Toxicity data on 
food phenolics, however, is still quite inadequate. Phenolics at high intake levels may act 
as prooxidants, mutagens, and inhibitors of key enzymes involved in hormone 
metabolism (Skibola and Smith 1999; Galati et al. 2002). Therefore, ingestion of 
excessively high levels of phenolics may overload the natural barriers or detoxification 
mechanisms, hence rendering a toxic effect and pose a serious health risk for humans. 
However, daily intake of phenolics from common food sources produces very low 
toxicities because of their low absorption, rapid metabolism and efficient defence 
mechanism in mammals. The average intake of dietary polyphenols is around 1 g/day, 
with individual phenolic intakes varying depending on the food pattern. For example, the 
consumption of flavonols has been estimated at 20-25 mg/day in the US (Biesalski 2007). 
The emerging bioactivity data on plant phenolics by various approaches have indicated 
that the activities established in in vitro experiments may not necessarily reflect their 
protective effectiveness in living organisms. This is due to the low bioavailability of 
ingested phenolics caused by both poor absorption and rapid elimination in the body. 
Information on absorption and metabolism of phenolics is still fragmentary and 
controversial. The structure-activity relationship obtained from cellular studies suggested 
that the amount of the phenolic compounds incorporated governs the dose-dependency 
(Nakayama et al. 2006). Cellular uptake differs greatly among individual phenolics, and 
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hence the abundance of a phenolic compound in our diet may not necessarily lead to a 
high concentration of the compound or its active metabolites in target tissues. Some 
phenolic compounds may be absorbed in sufficient amounts to render their biological 
effects. The presence and concentration of these phenolics and/or their metabolites in 
blood indicate their potential to cross the intestinal barrier and exert bioactivities in vivo 
(Hooper and Cassidy 2006). Absorption of a phenolic compound in the small intestine is 
influenced by such factors as its molecular size and structure, lipophilicity, solubility and 
pKa as well as gastric and intestinal transit time, membrane permeability and pH of the 
lumen (Higuchi et al. 1981 ). It is supposed that most phenolics are incorporated into the 
cells by passive transport since no specific transporter has been found in mammalian cells 
(Nakayama eta!. 2006). The rate of incorporation is related to the affinity of the phenolic 
compound for the cell membrane. Studies have been carried out on membrane affinities 
of different phenolics, including gallic and caffeic acid esters, curcuminoids, flavonols , 
and isoflavones, among others, and have concluded that the lipophilicity, rigidity and 
planer structure of the phenolic molecule have a key effect on its affinity for cell 
membrane and hence its cellular absorption (Murata eta!. 2002; Nakayama eta!. 2006). 
In addition to cellular incorporation, the metabolism, distribution and excretion are also 
important in determining the bioavailability of dietary phenolics. The phenolic 
metabolites present in blood resulting from digestive and hepatic activity often differ 
from the native compounds. The food-derived phenolic compounds in their ester, 
glycosides or polymer forms are either absorbed as such or are hydrolyzed by intestinal 
enzymes or the colonic microflora to release their aglycones. The phenolic aglycones 
undergo extensive metabolism in the small intestine and later in the liver and other organs. 
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Phenolics are conjugated by methylation, sulfation, glucuronidation or a combination 
resulting in decreased hydrophobicity, which facilitates their urinary and biliary excretion 
(Ramos 2007). Although the metabolism of phenolics has not yet been fully characterized, 
related studies have shown great variability in preferential pathways among individuals. 
Manach et al. (2004) reported the intermolecular conjugation of quercetin with albumin, 
which supports its slow elimination and hence extended its half-life. Moreover, 
flavonoids may go through an enterohepatic cycle, i.e. be secreted in bile to the 
duodenum and then reabsorded, thus evoking a longer half-life (Ramos 2007). The 
overall bioavailability of phenolics is the combined effects of cellular uptake, metabolism, 
distribution and elimination. Manach et al. (2005) summarized 97 studies of various 
classes of phenolics, whose bioavailabilities were presented in terms of maximal plasma 
concentration, time to reach the maximal plasma concentration, the area under the 
plasma-concentration-time curve, and the elimination half-life, etc. The intake of 50 mg 
of aglycone equivalents resulted in plasma concentration of total metabolites ranging 
from 0 to 4 J..Lmol/L, and the relative urinary excretion ranging from 0.3 to 43% of the 
ingested dose, depending on the phenolic species. Among the phenolic compounds 
studied, gallic acid and isoflavones were best absorbed, followed by catechins, flavanones 
and quercetin glucosides, but with different kinetics. Proanthocyanidins, galloylated tea 
catechins and anthocyanins were among the least absorbed phenolics. 
Dietary phenolics may also undergo biotransformation by gut microflora prior to their 
absorption. Although there are potentially thousands of different phenolic compounds in 
the diet, they are often transformed to a much smaller number of metabolites. This 
biotransformation may lead to modulation of the bioactivities of phenolics. It is therefore 
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suggested that health effects of dietary phenolics should be attributed to both their 
bioactive metabolites and modulation of the intestinal bacterial population. Research has 
been conducted to identify microorganisms involved and transformation pathways of 
particular phenolic groups. Gut microflora that could participate in metabolism of 
phenolics, particularly flavonoids, include Bacteroides, Clostridium, Eubacterium, 
Ruminococcus, Eggertheilla, Streptococcus, Lactobacillus, and Bifidobacterium genera 
(Kim et a!. 1998). Meanwhile, phenolics with antimicrobial activities may inhibit the 
growth of certain microorganisms in the gut. This 2-way phenolics-microflora interaction 
has been discussed in a recent review by Selma et a!. (2009). 
1.3 Sources, preparation and analysis 
Phenolics are present abundantly in a wide range of natural sources, especially in fruits, 
vegetables, legumes, cereals, nuts, herbs and spices, among others. Fruits such as apples, 
citrus, berries, grapes and pomegranates are rich sources of phenolics, especially 
flavonols (e.g. quercetin, kaempferol, myricetin and isorhamenetin), proanthocyanidins 
(e.g. procyanidins and prodelphinidins) and phenolic acids (mainly in esterified form, e.g. 
gallic, ferulic, sinapic, coumaric, caffeic and chlorogenic acids) . The total phenolic 
content in apple ranged from 1000 to 6000 mg/kg fresh weight (fw) in most varieties, and 
may be over 10,000 mg/kg fw in some cultivars (Sanoner et a!. 1999; Gorinstein et a!. 
2001). Blueberries contain substantial amounts of anthocyanins (127-1973.4 mg 
cyaniding 3-glucoside equivalents/kg fw), among which 3-glucosides, 3-galactosides and 
3-arabinosides of cyanidin, delphinidin, peonidin, petunidin, and malvidin were isolated 
and identified (Mazza and Miniati 1993). Cranberries are another excellent source of 
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anthocyanins, with the total contents ranging from 180 to 656 mg/kg fw in its fruits 
(Wang and Stretch 2001). High levels (lg/kg fw) of phenolic acids were also present in 
cranbenies (Zuo et al. 2002). Phenolics in citrus fruits include mainly cinnamic acid 
derivatives, coumarins and flavonoids. Flavanone glycosides such as naringin, 
neoeriocitrin and hesperidin comprise 50-80% of the total flavonoids in citrus fruits 
(Kanes et al. 1992). Polymethoxylated flavones in citrus peel are unique phenolic 
compounds found in citrus species (Ortuno et al. 2002). Stilbenes are the characteristic 
phenolics present in grape skins, leaves, seeds and stems in monomeric, oligomeric and 
polymeric forms. Resveratrol is the predominant stilbene located in grape skin as well as 
in wilting berries (Versari et a!. 2001 ). Pomegranates are rich in hydrolysable tannins, 
particularly the gallagyl type tannins (e.g. punicalagin), which are present in pomegranate 
juice at levels of 1500-1900 mg/L (Gil et al. 2000). In addition to the raw fruits 
mentioned above, the fermentation products from fruit material also display a variety of 
phenolic compounds, as observed for different types of wines and fruit vinegars (Shahidi 
et al. 2008). 
Vegetables provide a rich source of phenolic compounds. The content and composition of 
phenolics in various vegetable groups have been reviewed (Shahidi et al. 2010). Fruit 
vegetables such as peppers, eggplant, tomatoes, bitter melon, and pumpkin are reported to 
contain a wide anay of phenolic compounds, including protocatechuic, chlorogenic, 
coumaric and ferulic acids, and 0-glycosides of quercetin and luteolin, among others. 
Among bulb vegetables, onions are a rich source of flavonoids with quercetin being the 
most predominant one (2: 95% of the total flavonoids) (Galdon et al. 2008). Root (carrots, 
beets) and tuber (sweet potatoes, potatoes) vegetables contain chlorogenic and caffeic 
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acids as major phenolic acids and betalains contributing to the color of beets. Green leafy 
vegetables such as lettuce, spinach and kale have high levels of flavonoids. They are 
present in spinach leaves at 807-2241 mg/kg fw (Howard et al. 2002). Phenolics are also 
found in flowery (broccoli and artichoke) and stem (asparagus) vegetables at varying 
levels and compositions. 
Cereals, legumes, nuts and oilseeds are recognized as good sources of phenolics. The 
highest concentrations of phenolic acids and flavonoids are located in the aleurone layer 
in grains and seeds, and therefore removal of this layer in milling and pear ling processes 
leads to loss of phenolics. In beans, a higher level of phenolics was detected in the hulls 
(6.7-270 mg catechin equivalents/g extracts) than in whole seeds (4.9-93.6 mg/g extracts) 
(Madhujith and Shahidi 2005). Major phenolic acids present in bean hulls include vanillic, 
caffeic, p-coumaric, ferulic and sinapic acids. These phenolic acids were also found in 
wheat bran at higher levels than in its corresponding flour (Liyana-Pathirana and Shahidi 
2007). Anthocyanidins such as delphinidin, cyanidin and procyanidins B2, C 1, C2 and X 
were identified in red, brown and black bean hull extracts (Madhujith et al. 2004). 
Soybeans contain significant amounts of isoflavones (472-4200 mg/kg), which are of 
much interest because of their special health effects (Wang and Murphy 1994). The 
predominant phenolic compounds of oilseeds belong to the phenolic acid, coumarin, 
flavonoid, tannin and lignin groups of compounds. Flaxseed, for example, contains 350-
710 mg/kg of total flavonoids and 3 700 mg/kg of secoisolariciresinol, a major lignan of 
flaxseed (Oomah et al. 1996; Mazur et al. 1996). Unlike the phenolics in fruits and 
vegetables that are often in the free or soluble conjugate forms of glucosides, phenolic 
compounds in grains and oilseeds exist mostly in the insoluble bound form associated 
1-15 
with cell wall polyssacharides (Naczk and Shahidi 1989). Naczk and Shahidi (1989) 
reported that insoluble-bound phenolics contributed some 6-20% to the total phenolics in 
canola meal. More recent studies showed that both wheat and barley had large 
proportions of bound phenolics (60 and 75% of the total phenolics, respectively) 
(Liyanapathirana and Shahidi 2006; Madhujith and Shahidi 2009). It has been shown that 
colonic fermentation of such material, which survives gastrointestinal digestion, may lead 
to the release of some of the bound phenolics and hence exert their unique health benefits 
in the colon after absorption. 
Herbs and spices are loaded with high concentrations of phenolics, which are responsible 
for the medicinal properties of many herbs and their extracts. However, the compositional 
data on phenolics in herbs and spices are incomplete. Nakatani (2003) reported a number 
of phenolic compounds derived from herbs and spices. These include several phenolic 
diterpenes from rosemary and sage, phenolic carboxylic acids and glycosides from 
oregano and marjoram, ginerol-related compounds and diarylheptanoids from common 
ginger, biphenyls and flavonoids from thyme, phenolic amides from pepper and chilli 
peppers, carbazoles from curry leaves, lignans from Papua mace and polymethoxylated 
phenols from Alpinia. Zheng and Wang (2001) studied 27 culinary herbs and 12 
medicinal herbs for their phenolic compounds. The total phenolic content for the culinary 
herbs ranged from 260 to 17510 mg gallic acid equivalents (GAE)/kg fw. Among the 
identified phenolic compounds, rosmarinic acid was predominant in Salvia officina/is, 
Thymus vulgaris, Origanum x majoricum, and P. longiflora, whereas quercetin and 
kaempferol were the major aglycones in Ginkgo biloba leaves. Essential oils of many 
herbs and spices were demonstrated to contain considerable amounts of phenolics, which 
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are directly related to their plant origin (Theissedre and Waterhouse 2000). Essential oils 
of clove and Spain red thyme were among those with highest total phenolic contents 
(1567 and 972 mg/ml, respectively). Eugenol, thymol and vanillin were identified as the 
major phenolic compounds in these essential oils. Tea leaves and their beverages are rich 
sources of flavan-3-ols, or catechins, which are responsible for many health benefits 
associated with tea consumption. The simple catechins in fresh tea leaves undergo 
enzyme and/or microorganism-assisted fermentation during tea processing and are 
converted into more complex polymers. 
Upon recognition of the multiple bioactivities of phenolics, various plant extracts 
containing a broad array of phenolic compounds are commercially available and used in 
the food, cosmetic and pharmaceutical industries. A number of extraction methods have 
been employed for preparation of plant phenolic extracts in industry or laboratories. 
These include solvent, solid phase, supercritical fluid extraction and high-pressure liquid 
extraction, among others (Kartsova and Alekseeva 2008). In addition to extraction from 
natural plant sources, some high-value phenolic compounds are also prepared by 
chemical synthesis and plant cell cultures as well as biosynthesis by microorganisms. 
Production of phenolics, particularly flavanones, using microorganisms through 
heterologous protein expression has been discussed by Fowler and Koffas (2009). 
Separation of phenolics may be necessary when one or more specific compounds are of 
interest in various plants/food materials and biological fluids (e.g. urine, plasma, blood 
serum, saliva). Chromatography such as HPLC and TLC, and electrophoresis such as 
capillary zone electrophoresis and micellar electrokinetic chromatography are the main 
physicochemical methods for separation of phenolics (Kartsova and Alekseeva 2008). 
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2 Phenolics as antioxidants for food and health 
2.1 Lipid oxidation 
Oxidation is a major cause of quality deterioration of products and negatively affects the 
integrity of biological systems. It occurs in foods during harvesting, processing and 
storage, giving rise to the development of off-flavors, loss of essential fatty acids, fat-
soluble vitamins and other bioactives, and even formation of potentially toxic compounds, 
thus making the lipid or lipid-containing foods unsuitable for consumption. Lipids in 
living organisms may also undergo oxidation during normal aerobic metabolism or upon 
exposure to other oxidizing agents (Beckman and Ames 1998). Oxidation in vivo has 
destructive cellular effects and has been associated with pathophysiology of numerous 
diseases and health conditions including inflammation, atherosclerosis, cancer and aging, 
among others (Dalton et al. 1999; Davies 2000; Kruidenier and Verspaget 2002; Floyd 
and Hensley 2002). 
Lipids are susceptible to oxidation in the presence of catalytic systems such as light, heat, 
enzymes, metals, metalloproteins and microorganisms, leading to complex processes of 
autoxidation, photooxidation, thermal, and enzymatic oxidation, most of which involve 
free radicals and/or other reactive species as the intermediate (Vercellotti et al. 1992; 
Shahidi 2000). Autoxidation is the most common process among all and is defined as the 
spontaneous reaction of lipids with atmospheric oxygen through a chain reaction of free 
radicals. The process can be accelerated at higher temperatures as in thermal oxidation, 
with increased content of polar matters, foaming, color and viscosity, as observed in deep 
frying (Perkins 1992). Photooxidation involves excitation of a photosensitizer and energy 
transfer to lipid molecules or oxygen. Oxidation can also be catalyzed by certain enzymes 
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such as lipoxygenases. Unsaturated fatty acids are the major reactants affected by such 
reactions, whether they are present as free fatty acids, simple alkyl esters, acylglycerols or 
phospholipids. The polyunsaturated fatty acids (PUF A) in membrane phospholipids and 
cholesterol, especially low density lipoprotein (LDL)-cholesterol, are the major target 
substrates of oxidation in vivo, causing irreversible cellular and tissue damage. 
It has been widely accepted that lipid autoxidation occurs via a free radical chain 
mechanism that proceeds through three distinct stages of initiation, propagation, and 
termination, leading to a series of complex chemical changes (Shahidi and Zhong 2005). 
A simplified scheme explaining the mechanism of autoxidation is given in Figure 1-2. 
Unsaturated lipid molecules, in the presence of initiators such as heat, light/ionizing 
radiation and metal ions/metalloproteins, lose a hydrogen atom and produce free radicals. 
Lipid radicals subsequently react with oxygen to form peroxyl radicals, which act as the 
chain carriers of the rapid progressing reaction by attacking a new lipid molecule. This 
self-propagating and self-accelerating reaction may be repeated several thousand times 
until no hydrogen source is available or the chain is interrupted, for example, by 
antioxidants ( deMan 1999). Oxidation normally proceeds very slowly at the initial stage, 
until it reaches a sudden increase after an induction period. The initiation process is quite 
complex and not yet fully understood; however, it is believed to involve removing of a 
hydrogen atom from the lipid molecule. The loss of hydrogen atom takes place most 
readily at the carbon next to the double bond in the olefinic fatty acids, due to a lower C-
H bond energy. The bond energies for bisallylic, allylic and alkyl hydrogens are 75, 88 
and 101 kcal/mol, respectively, which explains why highly unsaturated fatty acids are 
more susceptible to oxidation than their saturated or less saturated counterparts (Erickson 
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Initiation: _ 
RtH initiat% R1• + H · 
and/or 
Propagation: 
R,oo· ~ R,· ...2.;. R,oo· ~ R; .. .... etc. 
R200H R300H 
l
oxidizing lreducing 
metals metals 
R to· + "OH R2oo· + H+ -oH + R3o · 
R.Hl lR,H lR,H I J 
I lR.H 
Rm" Rx" R " y H20 Rz" 
Termination: 
Roo· 
RO" Non-radical products (R-R, ROR, ROOR, etc.) 
Figure 1-2. Lipid autoxidation pathways. 
1-20 
---- ----- ---------------------------------
2002). The lipid free radicals generated during initiation and propagation are stabilized by 
radical resonance (as shown below), which also leads to shift of double bonds and cis-
trans isomerization. 
8 9 10 8 9 10 
-CH-CH=CH- ~<-~> -CH=CH-CH-
t 
8 9 10 
-CH-CH=CH-
1 
OOH 
• 
8 9 10 
-CH=CH-yH-
OOH 
Conjugated dienes and trienes are produced, due to the rearrangement of the methylene-
interrupted double bonds in PUF A, and are used as an index of oxidation (Shahidi and 
Zhong 2005). During propagation, lipid hydroperoxides are produced as primary products 
of oxidation. They are unstable and break down to a wide range of secondary oxidation 
products, including aldehydes, ketones, alcohols, hydrocarbons, volatile organic acids and 
epoxy compounds, among others, some of which have undesirable odors with very low 
threshold values. Meanwhile, alkoxyl (RO'), peroxyl (ROO'), hydroxyl ('OH) and new 
lipid radicals (R') are generated from decomposition of hydroperoxides, and further 
participate in the chain reaction of free radicals. In the termination stage of oxidation, 
radicals neutralize each other through radical-radical coupling or radical-radical 
disproportionation to form stable non-radical products, including a variety of polymeric 
products (Erickson 2002). 
Free radicals play a key role as important intermediates in the chain reaction of lipid 
oxidation. Free radicals are unstable, highly reactive and energized molecules with one or 
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more unpaired electron(s). They capture electrons from other compounds to gain stability. 
Examples of oxygen-derived free radicals include superoxide anion, hydroxyl, 
hydroperoxyl, peroxyl, and alkoxyl radicals, all of which are referred to as reactive 
oxygen species (ROS). Superoxide anion (02"), which is formed from the single-electron 
reduction of molecular oxygen through a variety of sources under both physiological and 
pathophysiological conditions, is a primary ROS. Approximately 2-5% oxygen consumed 
by a cell is reduced to oxygen radicals (Floyd and Hensley 2002). Superoxide anion can 
be neutralized by superoxide dismutase (SOD) to yield hydrogen peroxide; the latter is a 
known non-radical ROS and, although less reactive than superoxide anion, has a longer 
lifetime and a higher diffusibility and can cross biological membranes freely (Tylicki et al. 
2003). Moreover, it can react in Fenton reaction with reduced metal ions such as Fe2+ and 
Cu +to form hydroxyl radical (OH), which is considered as the most harmful ROS (Lubec 
1996). Other ROS include hydroxyalkenals, singlet oxygen and ozone, among others. 
Nitrogen dioxide and peroxynitrite anion formed from the interaction of nitric acid with 
superoxide anion are also strong oxidants, and together with nitric oxide (NO) are known 
as reactive nitrogen species (RNS). Singlet oxygen is generated photochemically from 
molecular oxygen and is usually involved in photooxidation processes. Table 1-2 
summarizes the reactive species involved in food and biological oxidation. Excessive 
ROS/RNS generated during oxidation may attack, in principle, all cellular and 
extracellular components, including cholesterol, proteins, enzymes, lipoproteins and DNA, 
leading to cell disruption and tissue damage. 
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Table 1-2. Major reactive species in food and biological systems. 
Free radicals 
Reactive oxygen species (ROS) 
Superoxide anion (02'l 
Hydroxyl (OH) 
Alkyl (R') 
Alkoxyl (RO') 
Peroxyl (ROO') 
Hydroperoxyl (HOO') 
Reactive nitrogen species (RNS) 
Nitric oxide (NO) 
Nitrogen dioxide (N02') 
Non-radicals 
Hydrogen peroxide (H20 2) 
Hydrochlorous acid (HOCl) 
Singlet oxygen eo2) 
Ozone (03) 
Hydroxyalkenals 
Peroxynitrite (ONOO") 
Alkyl peroxynitrite (LOONO) 
Dinitrogen trioxide (N20 3) 
Nitrous acid (HN02) 
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2.2 Phenolics as antioxidants 
Antioxidants have been used by food manufacturers world-wide for stabilizing food lipids 
and thus preventing quality deterioration and increasing shelf-life of the products. In the 
health-related areas antioxidants are used for health promotion due to their ability to 
protect the body against oxidative damage. Antioxidants are substances that when present 
at low concentrations compared to that of an oxidizable substrate markedly delay or 
prevent its oxidation. Antioxidants that fit in this definition include free radical 
scavengers, singlet oxygen quenchers, inactivators of peroxides and other ROS, metal ion 
chelators, quenchers of secondary oxidation products, and inhibitors of pro-oxidative 
enzymes, among others (Shahidi and Zhong 2007). Antioxidants may exert their 
inhibitory effect against oxidation via different mechanisms and with varied activities. 
They may be broadly classified based on their mode of action into primary antioxidants 
which break the chain reaction of oxidation by scavenging free radical intermediates, and 
secondary antioxidants which prevent or retard oxidation by deactivation of oxidation 
initiators/accelerators or regeneration of primary antioxidants. 
Phenolics are the major group of primary antioxidants, and their antioxidant activity 
arises from their unique structures, which render a superior electron donating capability 
over many other compounds due to the stable resonance hybrids of the phenyl ring. 
Phenolic compounds are able to neutralize free radicals by donating a hydrogen atom, as 
shown below. 
R" + AH 
ROO" + AH 
RO" + AH 
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RH + A" 
ROOH + A" 
ROH + A" 
The resultant phenolic radicals are stabilized by delocalization of the unpaired electron 
around the phenol ring to form stable resonance hybrids (Reische et al. 2002). These 
radicals have low reactivity and generally do not initiate formation of new radicals, thus 
breaking the chain-reaction of free radical propagation (Nawar 1996). Moreover, the 
phenolic radicals so formed can further scavenge free radicals by participating in the 
termination of oxidation. 
ROO' + A' 
RO' + A' 
A ' + A' 
ROOA 
ROA 
AA 
Therefore, phenolic antioxidants can trap two lipid radicals by donating a hydrogen atom 
to one radical and receiving an electron from another radical to form stable non-radical 
products (Young and Woodside 1999). 
Phenolic compounds may also act as secondary antioxidants that prevent or retard 
oxidation by suppressing the oxidation promoters, including metal ions, singlet oxygen, 
pro-oxidative enzymes and other oxidants. Phenolics, as reducing agents, are capable of 
reducing lipid peroxides and related oxidants through redox reactions, and are also 
referred to as oxygen scavengers. Metal ions as catalysts of oxidation reaction by 
producing free radicals through electron transfer (as shown below) may be chelated by 
some polyphenols. 
M (n+I)+ + RH 
M Cn+I)+ + ROOH -----7 
M n+ + ROOH --~ 
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M n+ + H + + R' 
M n+ + H + + ROO' 
M Cn+I)+ +- OH + RO' 
Polyphenol metal chelators can decrease the prooxidant effect of metal ions by forming a 
thermodynamically stable complex and reducing their redox potentials (Reische et al. 
2002). Some phenolic compounds are also able to quench singlet oxygen by a mixture of 
physical and chemical processes, as reported for some 2,4,6-trisubstituted phenolic 
compounds (Gorman et al. 1984). Some other phenolic antioxidants catalyze 
decomposition of hydroperoxides into non-radical species, or absorb UV radiation thus 
protecting lipids from UV -induced photooxidation. Phenolic compounds may exert their 
antioxidant activity by one or a combination of different mechanisms. The operative or 
dominant mechanism in a particular situation determines to a great extent the kinetics and 
hence the activity of the antioxidant (Antolovich et al. 2002). 
The effectiveness of phenolics as antioxidants is influenced by numerous factors, 
including their chemical structures, concentration, temperature, type of oxidation 
substrate and physical state of the system as well as presence of prooxidants and 
synergists (Yanishlieva-Maslarova 2001). The structural feature of the phenolic 
compounds determine their reactivity towards free radicals and other ROS and hence their 
antioxidant activity. The antioxidant efficiency of phenolics varies with their 
concentration, necessitating the use of optimal concentrations in order to achieve the 
greatest efficiency. It is important to note that, like many other antioxidants, phenolics 
may exhibit prooxidant effects at higher concentrations (Koskas et al. 1984; Cillard and 
Cillard 1986). Activity of antioxidant substances may be affected by the system 
environment. For example, the activity of antioxidants in bulk oils is different from that 
of oil-in-water emulsions (Porter 1993). A major proportion of naturally occurring 
phenolic antioxidants are water-soluble and renders their antioxidant activity mainly in 
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aqueous environments or water compartments in body tissues. Tocopherols or vitamin E, 
however, are among the very few fat-soluble phenolic antioxidants, and are vital for 
oxidative stability of lipids in food as well as biological systems. 
There has been growing interest in antioxidant effectiveness of phenolics. Individual 
phenolic compounds have been isolated and assessed as potential food additives, 
nutraceuticals and functional food ingredients. Moreover, various plant extracts 
containing a broad array of phenolic compounds have been extensively investigated for 
their composition, antioxidant efficiency and potential role in the food, cosmetic and 
pharmaceutical industries. In addition to naturally occurring phenolics, synthetic 
antioxidants bearing phenol structure have been used for different purposes, and these 
include several common synthetic antioxidants used by the food industry, namely 
butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), propyl gallate (PG) 
and tert-butylhydroquinone (TBHQ). However, use of synthetic antioxidants 1s now 
limited owmg to the growmg concern over their potential carcinogenic effects 
(Wattenberg 1986; Sherwin 1990). 
3 Epigallocatechin gallate (EGCG) 
3.1 Tea and tea po1yphenols 
Tea, a product made from leaf and bud of the plant Camellia sinensis, is the second most 
popular beverage world wide after water and a major source of dietary flavonoids 
(Rietveld and Wiseman 2003). Not only consumed as a daily routine drink, it also confers 
great health beneficial effects to human, and therefore is also considered as functional 
food and therapeutic aid in many diseases. Tea consumption has been linked to reduced 
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risk of numerous chronic diseases. A large body of in vitro and animal model studies has 
reported that tea or tea extracts may prevent cancer development, reduce cholesterol 
levels, decrease the risk of stroke and heart attack, protect neurodegenerative diseases and 
improve dental health, among others (Pham-Huy et al. 2008). Although mixed results 
from epidemiological and clinical studies have been reported on tea consumption and 
human health, they were thought to arise, at least in part, from socioeconomic and 
lifestyle factors which have been ignored as well as methodology flaws, and at present, 
tea consumption is recommended (Cabrera et a!. 2006). 
There are generally three types of tea in the market depending on the manufacturing 
process: non-fermented green tea (polyphenol oxidase inactivated by drying and 
steaming), semi-fermented oolong tea (fresh leaves subjected to a partial fermentation), 
and fermented black or red teas (leaves undergoing a post-harvest fermentation involving 
polyphenol oxidase catalyzed oxidation or microorganism assisted fermentation) (Wilson 
1999; McKay and Blumberg 2002). Among the 2.5 million tonnes of dried tea products 
manufactured every year, approximately 76-78% are black tea (mainly in Europe, North 
America and North Africa), 20-22% green tea (mainly in China, Japan and Korea), and 
2% oolong tea (popular in China and Taiwan) (Mitscher and Dolby 1998; Wu and Wei 
2002). In addition to the three main tea types, white tea produced from very young leaves 
and buds of the tea plant by an unfermented processing method, has recently been 
introduced to the market as the most precious Chinese tea. 
Although tea consumption has a history of more than 2000 years, scientific research on its 
chemical composition has only been underway for about three decades. Non-fermented 
green tea has been reported to contain by dry weight 15-20% proteins, 1-4% amino acids 
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and 5-7% carbohydrates, 26% fiber, 7% lipids, 30% phenolic compounds, and other 
minor components including xanthic bases (e.g. caffeine and theophylline), pigments (e.g. 
chlorophyll and carotenoids), and trace elements (e.g. fluoride, calcium, magnesium, 
chromium, zinc, copper, aluminum, selenium, etc.) (Cabrera et al. 2006). More than 300 
components have been found in the essential oil of green tea, which include aldehydes, 
alcohols, esters and hydrocarbons (Cabrera et a/. 2006; Pham-Huy eta/. 2008). Green tea 
also contains vitamins B, C and E, which are destroyed in black tea during the 
fermentation processing. The major components with functional properties are xanthic 
bases acting upon central nervous system, essential oils facilitating digestion, and 
polyphenols possessing antioxidant and other bioactivities (Cabrera eta!. 2006). 
Polyphenols, particularly flavonoids, are important constituents of tea. Among all 
polyphenols in tea, catechins (flavan-3-ols) have been considered the major active 
compounds responsible for the functional properties of tea. Catechins (Figure 1-3), 
namely (-)-epigallocatechin gallate (EGCG, 59% of the total catechins ), (-)-
epigallocatechin (EGC, 19%), (-)-epicatechin gallate (ECG, 13.6%) and (-)-epicatechin 
(EC, 6.4%), are the predominant flavonoids present in green tea (McKay and Blumberg 
2002). 
These catechins contribute to the characteristic bitter and astringent taste of tea. Catechin 
content in tea varies with climate, season, geographical location, horticultural practices, 
variety and age of the plant as well as processing and type of the products (e.g. blended, 
decaffeinated, instant, etc). Black tea has a lesser amount of simple catechins than green 
tea. The catechins in fresh tea leaves, during black tea preparation, are partially converted 
in situ by polyphenol oxidase to polymerized quinones such as theaflavins and thearubi-
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Figure 1-3. Chemical structures ofthe major catechins in green tea. 
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gins (USDA 2003). Manufactured bottled tea drinks also contain epimers of the catechins 
such as (+)-C, (-)-CG, (-)-GC, (-)-GCG, which are produced during the sterilization step 
(Murakami et al. 2006). In addition to catechins, other phenolic compounds are also 
found in tea as minor components, including gallic acid, chlorogenic acid, caffeic acid 
and flavonols such as kaempferol, myricetin and quercetin (USDA 2003). 
There has been strong evidence showing that green tea polyphenols (GTP) may play a 
protective role in the risk and pathogenesis of several chronic diseases, especially 
cardiovascular disease and cancer. GTP have been reported to have cholesterol lowering, 
insulin activity enhancing, immunomodulatory, antioxidant, anti-atherogenic, 
anticarcinogenic, antimicrobial and antiviral effects, among others (Cabrera et al. 2006). 
GTP are powerful antioxidants in vitro and in vivo with multifunctional mechanisms. 
Meanwhile, they are able to enhance the actions of many antioxidant enzymes such as 
glutathione reductase, glutathione-S-transferase, and superoxide dismutase in the liver, 
thus alleviating the oxidative stress and accelerating neutralization and elimination of 
toxic compounds (Sang et al. 2005). GTP also exhibit a cardioprotective effect by 
reducing blood pressure and cholesterol levels, and inhibiting LDL-cholesterol oxidation 
and atherosclerosis (Arts 2008). Consistent findings have revealed the anti-cancer effect 
of GTP, which is attributed to their antimutagenic, anticarcinogenic and antiangiogenic 
activities (Pharn-Huy et al. 2008). However, the exact site of action and mechanisms of 
cancer preventive activity of GTP are not yet clearly understood. It is believed that their 
effectiveness in inducing cell cycle arrest and apoptosis are the most significant (Yang et 
al. 2006). Protection against neurodegenerative diseases such as Parkinson's and 
Alzheimer's diseases by GTP have also been documented (Weinreb et al. 2004). On the 
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other hand, anti-nutritional effects of GTP are noted, in particular, in reducing the 
digestibility of carbohydrates, proteins and lipids, whose digestive enzymes (e.g. a-
amylase, pepsin, trypsin and lipase) are inhibited by the polyphenols (Arts 2008). Health 
effects of tea and tea polyphenols have been reviewed (Cabrera et al. 2006; Pham-Huy et 
al. 2008; Arts 2008; Sajilata et al. 2008; Ho et al. 2009). 
3.2 Epigallocatechin gallate (EGCG) as an antioxidant 
EGCG is the most predominant catechin in tea, and major component responsible for 
health effects related to tea consumption. A cup of green tea (2.5 g of leaves in 200 ml of 
water) may contain 90 mg ofEGCG (Wu and Wei 2002). Its level in black tea (1.58%) is 
lower than in green tea (7.36%) due to the formation of polymerized catechins (Cabrera et 
al. 2006). EGCG displays a wide variety of functional and biological properties, and has 
attracted much attention as a potential functional food ingredient and pharmaceutical 
agent. 
Like many other polyphenols, catechins in tea exhibit antioxidant activity. The 
antioxidant potential of catechins is dictated by their chemical structures and different 
mechanisms may apply depending on the reaction environment. EGCG has been shown 
to possess the highest antioxidant potency among all catechins (Guo et al. 1996). The 
antioxidant activity of EGCG is thought to arise from its structural features, including the 
trihydroxy (3 ',4' ,5 '-OH) substitution on the B-ring which allows electron delocalization 
and confer high reactivity to quench free radicals, the gallate moiety which accounts for 
increased redox potential and phospholipids/water partition coefficient, and the 5,7-
dihydroxylated A-ring which is thought to promote the antioxidant function of EGCG 
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(Caturla et al. 2003; Wan et al. 2009). EGCG has been reported to be 25-100 times more 
potent than the typical antioxidants a-tocopherol and ascorbic acid (Mitscher and Dolby 
1998). In vitro chemical assays have shown the effectiveness of EGCG in scavenging 2,2-
diphenyl-1-picrylhydrazyl (DPPH) radical, reducing ferric ion to ferrous ion and 
chelating metal ions (Zhu et al. 2001; Sun and Ho 2001; Xu et al. 2004; Chan et al. 2007). 
In food model systems, EGCG inhibited the bleaching of ~-carotene/linoleate 
(Amarowicz and Shahidi 1995) and photosensitized oxidation of conjugated linoleic acid 
in an oil-in-water emulsion system (Liu and Yang 2008). EGCG was able to protect 
highly unsaturated marine oils from oxidation to an extent similar to or better than that of 
BHA, BHT and TBHQ (Wanasundra and Shahidi 1996). EGCG also played a protective 
role in controlling oxidation of meat lipids. Formation of thiobarbituric acid reactive 
substances (TBARS) in pork (Shahidi and Alexander 1998) and headspace propanal in 
fish meat (He and Shahidi 1997) model systems was inhibited by EGCG to a greater 
extent than that by a-tocopherol. Antioxidant activity of EGCG varies in different model 
systems, and it is believed that the activity depends largely on the substrate system under 
investigation (Wanasundara and Shahidi 1996; He and Shahidi 1997). 
EGCG exhibits antioxidant efficiency in biological systems. Many researchers have 
demonstrated that EGCG suppresses oxidation in biological systems and subcellular 
fractions such as microsome, low-density lipoprotein (LDL) and DNA by scavenging free 
radicals, including hydroxyl, peroxyl, and superoxide anion radicals as well as nitric 
oxide in living organisms (Kondo et al. 1999). EGCG serves as an effective antioxidant in 
human blood plasma, retarding lipid oxidation and depletion of endogenous lipid soluble 
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antioxidants such as a-tocopherol and P-carotene (Lotito and Fraga 2000). EGCG can 
also protect lipids against oxidation in the liver, serum and brain (Skrzydlewska et al. 
2005). In addition, EGCG may act indirectly as antioxidant through its effects on content 
and activity of certain enzymes. Rats orally receiving green tea extracts containing EGCG 
showed higher levels of antioxidant enzymes such as glutathione peroxidase and 
reductase, superoxide dismutase and catalase in the brain (Skrzydlewska et al. 2005). 
Moreover, EGCG inhibits redox enzymes (monooxygenase, cyclooxygenase, 
lipoxygenase, xanthine oxidase, NADH oxidase) and therefore suppress the production of 
ROSin vivo (Halliwell and Gutteridge 1989; Korkina and Afanas'ev 1997). EGCG is also 
capable of protecting erythrocyte membrane-bound ATPases against oxidative stress 
(Saffari and Sadrzadeh 2004). 
3.3 Other properties of EGCG 
EGCG has been known to possess promising anticancer potential, which is thought to be 
attributed to its antioxidant activity, induction of phase II enzymes, inhibition against 
tumor necrosis factor (TNF)-a expression and release, inhibition against cell proliferation, 
and induction of apoptosis, among others (Pham-Huy et al. 2008). EGCG readily reacts 
with ROS and creates differential oxidative environments in normal and cancerous cells. 
It has been reported that EGCG treatment resulted in decreased oxidative stress in normal 
epithelial and salivary gland cells while the oxidative stress was increased in oral-
carcinoma cells (Yamamoto et al. 2003). EGCG may exert prooxidant property, which is 
apoptosis inducing, and hence an antiproliferative effect on cancerous cells (Azam et al. 
1-34 
2004). EGCG can directly bind to target molecules involved in cancer development, such 
as selected protein kinases, matrix metalloproteinases and DNA methyltransferases, and 
thus inhibiting their action (Yang et a!. 2006). Effects of EGCG on DNA synthesis may 
also contribute to its anticarcinogenic activity. EGCG has been shown to accelerate the in 
vitro degradation of 2-hydroxyamino-6-methyldipyrido [1 , 2-a, 3 ' ,2' -d] imidazole, a 
heterocyclic amine that induces single strand DNA breaks (Arimoto-Kobayashi et a!. 
2003). EGCG exhibited strong inhibition against DNA synthesis in HTC rat hepatoma 
cells and DS 19 mouse erythroleukemia cells (Lea et a!. 1993). EGCG has been found to 
decrease telomerase activity, which plays an important role in tumorigenesis, and thus 
shortening the life span of cancerous cells, as observed in monoblastoid U937 leukemia 
cells and HT29 colon adenocarcinoma cells (Naasani et a!. 2003). EGCG imparts a 
growth inhibitory effect on cancer cells and has been shown in vitro to inhibit cell 
proliferation and stimulate apoptosis of various cancer cells, including prostate, 
lymphoma, colon and lung cancer cell lines (Pham-Huy et a!. 2008). EGCG may affect 
the molecular mechanisms involved in angiogenesis, extracellular matrix degradation, 
regulation of cell death, and multi-drug resistance (Demeule eta!. 2002). EGCG is also 
considered to be a topical protective agent against some types of radiation (e.g. UV 
radiation), one of the factors accounting for skin disease, photoaging and cancer 
development (Elmets et a!. 2001 ). A significant dose-dependent inhibitory effect of 
topically applied EGCG against photocarcinogenesis has been demonstrated in mice 
(Gensler eta!. 1996). 
EGCG has been suggested to improve lipid metabolism and play a protective role against 
metabolic syndrome. EGCG interferes with the micellar solubilization of cholesterol in 
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the digestive tract, thus lowering the intestinal absorption of cholesterol (Ikeda 2008). 
EGCG can reduce body fat accumulation by suppressmg postprandial 
hype1iriacylglycerolemia and delaying intestinal absorption of triacylglycerols (Ideka 
2008). Visceral fat deposition can also be reduced by EGCG through inhibition of fatty 
acid synthase (Wang and Tian 2001). Another underlying mechanism for antiobesity 
effect of EGCG is through acting upon AMPc levels by enhancing the energy expenditure 
(Juhel et al. 2000). EGCG is also the major active compound in green tea that can 
increase insulin activity and contribute to prevention of diabetes (Anderson and Polansky 
2002). 
Immunomodulatory effects of EGCG have been reported. EGCG exerts a cytoprotective 
effect on macrophages subjected to asbestos-induced damage, and the effect has been 
associated with its antiradical activity against superoxide anion radical (Potapovich and 
Kostyuk 2003). EGCG suppressed the intracellular growth of L. monocytogenes in 
macrophages, by inhibiting its escaping from the phagosome into cytosolic space (Kohda 
et al. 2008). EGCG has been shown to possess anti-inflammatory activity, the mechanism 
of which includes an ability to scavenge NO and the peroxynitrite anion, to reduce the 
activity of NO synthase, and to down-regulate gene expression of pro-inflammatory 
mediators (Paquay et al. 2000). Other physiological properties and potential health 
benefits of EGCG include antiviral, such as anti-HIV (Kawai et al. 2003; Williamson et 
al., 2006), and anti-carcinogenic activities (Hamilton-Miller 2001) as well as prevention 
of neurodegenerative diseases such as Alzheimer's disease (Weinreb et a/. 2009) and 
chronic liver diseases such as liver fibrosis (Sakata et al. 2004; Bayer et al. 2004), among 
others. 
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3.4 Bioavailability and structure modification of EGCG 
Bioavailability after oral administration, i.e. the rate of absorption through the 
gastrointestinal tract, metabolism and elimination from the body, has always been an 
issue for EGCG and other flavonoids. Low oral bioavailability has been observed for tea 
catechins, possibly due to their bi-directional movement through intestinal epithelial cells 
(Vaidyanathan and Walle 2003). Moreover, the extensive phase II metabolism during the 
1 51-pass metabolism could lead to serious pre-systemic elimination after oral 
administration and may contribute to their overall low bioavailability (Zhang et al. 2004). 
EGCG and other tea catechins, after intestinal absorption, are metabolized and converted 
to conjugated forms (glucuronides and sulfates) predominantly in the liver, and some are 
methylated by catechol-0-methyltransferase (Riemersma et al. 2001). The conjugation in 
the intestinal epithelial cells and hepatocytes enhance the hydrophilicity of catechins and 
hence facilitate their elimination through urine and bile. However, a large portion of 
EGCG is present in the free form in the human plasma and has a longer half-life (3.9 h) in 
plasma after ingestion compared to EGC (1. 7 h), which is mostly in the conjugated forms 
(Van Arnelsvoort et al. 2001 ). Breakdown of EGCG by acid hydrolysis mainly occurs in 
the stomach and by microflora in the gut (Singh et al. 2008). EGCG is distributed in body 
tissues in different storage patterns; for instance, EGCG levels in rats given green tea 
polyphenols are higher in the esophagus and large intestine than other organs, possibly 
owing to poor systematic absorption of EGCG (Cabrera et al. 2006). Studies in rats 
indicated that EGCG is mainly excreted through the bile, while EGC and EC are excreted 
through urine and bile (Cabrera et al. 2006). In order to explore the potential of EGCG as 
a health promoting agent, more pharmacokinetic details for its bioavailability are required. 
1-37 
Lipophilicity is an important factor affecting the efficacy of phenolic compounds as 
additives in various food systems, and plays a key role in their bioavailability and hence 
health effect in living organisms. EGCG has a four-ring structure with 8 hydroxyl groups, 
and is therefore highly hydrophilic. Like many other natural antioxidants, EGCG is more 
soluble in aqueous media and exerts its bioactivities or health effects mainly in aqueous 
environments or water compartments in body tissues. The hydrophilic nature of EGCG 
may pose a restriction to its effectiveness in protecting lipophilic systems, such as fats 
and oils, lipid-based foods or cosmetic formulas and emulsions as well as biological 
environments. Moreover, poor lipophilicity is associated with the limited absorption of 
EGCG into the cells through lipid membranes and fast elimination from the body, and 
therefore compromised bioactivities under physiological conditions. Modification on the 
molecular structure of EGCG provides a potential means to alter its physico-chemical 
properties and improve its effectiveness as a bioactive agent in more diverse systems. 
Many naturally-occurring phenolics have been structurally modified for improved 
lipophilicity and hence expanded applications in more hydrophobic environments (Lue et 
a!. 2005; Sabally et a!. 2005; Lee et a!. 2006; Giraldo et a!. 2007). The water-soluble 
phenolic compounds are converted by chemical or enzymatic means to their 
corresponding alkyl esters or ethers. The esters or ethers so prepared with enhanced 
lipophilicity may show improved liposome incorporation, which offers an advantage of 
these derivatives in drug delivery and bioavailability in the body over their parent 
phenolic compounds. 
Structural modification of EGCG via esterification with aliphatic molecules such as long 
chain fatty acids can be a useful tool to improve its lipophilicity. Additional advantages 
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can be expected when long-chain omega-3 polyunsaturated fatty acids (PUFA) are 
selected as the acyl donor. Long-chain omega-3 PUF A originating from marine sources 
have been demonstrated to have cardioprotective, immune-enhancing and mental health 
promoting effects, among other health benefits (Shahidi and Miraliakbari 2004, 2005). 
Combination of EGCG and omega-3 PUF A in one molecule not only leads to enhanced 
lipophilicity of EGCG, but ~lso takes advantage of the health beneficial effects of omega-
3 PUF A. This thesis reports investigations about lipophilization of the water-soluble 
EGCG by esterification with fatty acids and evaluation of the derivatives so-produced as 
EGCG alternatives for their bioactivities, including antioxidant, anti-inflammatory, 
antiviral, and anti-cancer effects. 
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CHAPTER2 
Lipophilized epigaJiocatechin gallate (EGCG) derivatives as novel antioxidants 
Introduction 
Tea, a product made from leaves and buds of the plant Camellia sinensis, is the second 
most popular beverage worldwide, after water, and a major source of dietary polyphenols 
that are known to render a myriad of health benefits (Rietveld and Wiseman 2003). There 
has been strong evidence demonstrating that green tea polyphenols (GTP) play a 
protective role in the risk and pathogenesis of several chronic ailments, especially 
cardiovascular disease and cancer (Stensvold et al. 1992; Hamilton-Miller 2001). The dry 
leaves of tea contain approximately 30% (by weight) of polyphenols, majority of which 
are catechins (flavan-3-ols) (Graham 1992; McKay and Blumberg 2002). 
Epigallocatechin gallate (EGCG) is the predominant catechin in green tea (7.36%), but 
less abundant (1.58%) in black tea due to the formation of polymerized catechins 
(Cabrera et al. 2006). EGCG has a four-ring structure with 8 hydroxyl groups (Figure 1-3, 
Chapter 1 ), and is therefore highly hydrophilic. It renders its functional properties or 
health effects mainly in aqueous environments or water compartments in body tissues. In 
humans, EGCG may have limited bioavailability due to its physical and chemical 
characteristics, which dictate its rate of absorption through the gastrointestinal tract, 
metabolism and elimination from the body. 
EGCG is known as a powerful antioxidant, possessing the highest antioxidant potency 
among all tea catechins (Guo et al. 1996). EGCG has been reported to inhibit oxidation in 
various food model systems, including pork, fish, and highly unsaturated marine oils 
2-1 
(W anasundara and Shahidi 1996; He and Shahidi 1997; Shahidi and Alexander 1998). It 
also plays a protective role against oxidative stress in biological environments. A number 
of researchers have reported that EGCG effectively suppresses lipid oxidation in 
biological systems and subcellular fractions such as microsome and low-density 
lipoprotein (LDL) (Kondo et a!. 1999). EGCG retards lipid oxidation and depletion of 
endogenous lipid soluble antioxidants such as a-tocopherol and ~-carotene in the human 
blood plasma (Lotito and Fraga 2000). The antioxidant potential of EGCG arises from its 
polyphenolic structure and may vary depending on the reaction environment (e.g. 
temperature, pH, lipophilicity, type of oxidants, presence of synergist/antagonist, etc.) 
involved. 
EGCG, like many other natural antioxidants, shows good solubility in aqueous media. 
The hydrophilic nature of EGCG may restrict its effectiveness in protecting lipophilic 
systems, such as fats, oils, and lipid-based food or cosmetic formulas and emulsions as 
well as biological environments. EGCG can be structurally modified in order to improve 
its lipophilicity and hence expand its application in the food, medicinal and cosmetic 
industries. Structure modification of EGCG via esterification with aliphatic molecules 
such as long chain fatty acids can serve as a useful tool in altering its physical properties 
such as solubility and miscibility and hence its antioxidant activity and bioavailability. 
Additional advantages or synergism can be expected when long chain omega-3 
polyunsaturated fatty acids (PUF A) are selected as acyl donors; long chain PUF A such as 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been shown to 
render a broad range of health benefits, including cardioprotective, immuno-enhancing 
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and anti-cancer effects, among others (Shahidi and Miraliakbari 2004, 2005). In this 
chapter, the preparation of lipophilic derivatives of EGCG (compounds 1, 2 and 3) and 
evaluation of their antioxidant activity in vitro are presented. 
Materials and methods 
Materials. EGCG was supplied by Dr. Yu Shao of GlaxoSmithKline Consumer 
Healthcare (Parsippany, NJ, USA). Stearoyl chloride was purchased from Nu-chek Prep 
Inc. (Elysian, MN, USA). EPA was obtained from Fuso Pharmaceutical Industries, Ltd. 
(Osaka, Japan) and DHASCO (DHA single cell oil) from Martek Bioscience Corporation 
(Columbia, MD, USA). Trolox was purchased from Acros Organics (Fair Lawn, NJ, 
USA). Other chemicals were purchased from Sigma-Aldrich Canada Ltd. (Oakville, ON). 
All solvents used were obtained from Fisher Scientific Ltd. (Ottawa, ON). The solvents 
employed were HPLC or reagent grade. 
Preparation of crude EGCG derivatives. Long-chain fatty acids, namely EPA and 
DHA, used for acylation were prepared from EPA ethyl ester and DHA single cell oil 
(DHASCO, containing 40% DHA), respectively. EPA was obtained following 
saponification and DHA was prepared by saponification followed by a urea complexation 
process as described by Wanasundara and Shahidi (1999). Briefly, the KOH-catalyzed 
saponification was carried out in 95% ethanol at 62±2°C under reflux. The unsaponifiable 
matters were removed with hexane and the pH of the aqueous phase was adjusted to 1.0 
with HCl. Free fatty acids were then extracted into hexane and the solvent was removed 
using a rotary evaporator. For urea complexation, the free fatty acids were mixed with a 
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urea solution (20% in 95 % ethanol) and allowed to stand for 24 hours at 4°C for urea-
fatty acid adduct crystallization. The mixture was then filtered to obtain the non-urea 
complex fraction, whose pH was subsequently adjusted to 4-5 with HCl. DHA was 
extracted into hexane and the solvent was removed by evaporation. The purity of the fatty 
acids (EPA and DHA) so-obtained was confirmed by GC-MS. EPA and DHA were then 
converted to their corresponding acyl chlorides by reacting with thionyl chloride. Stearoyl 
chloride was a commercial product and used as such. Esterification of EGCG was carried 
out with acyl chlorides (stearoyl, eicosapentaenoyl, and docosahexaenoyl chloride) at a 
mole ratio of 1:1. Acyl chloride was added dropwise to EGCG dissolved in ethyl acetate. 
The reaction was carried out in the presence of pyridine which removed the released HCl 
from the medium. The mixture was then heated in an oil bath at 50°C under a nitrogen 
blanket with constant stirring. The reaction mixture upon completion of the esterification 
was cooled to ambient temperature and filtered. The filtrate was then washed 3 times with 
distilled water (60°C), and the ethyl acetate layer was collected and passed through a cone 
of anhydrous sodium sulfate. The dry powder of crude products containing a mixture of 
EGCG esters (at different degrees of substitution) was obtained by evaporating the 
solvent. 
Purification and identification of EGCG derivatives. The composition of reaction 
mixture was determined by reversed phase HPLC-MS, using an Agilent 1100 HPLC unit 
(Agilent Technologies, Palo Alto, CA, USA) with a UV -diode array detector (UV -DAD). 
Separation was achieved on a C-18 column (Agilent) by gradient elution with 
methanol/water mobile phase (95:5- 100:0 from 0 to 30 min) and fractions were detected 
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at 280 run. LC flow was further analyzed on-line by the MS detector system (LC-MSD-
Trap-SL, Agilent) with APCI (atmospheric pressure chemical ionization) at positive 
mode for identification of each fraction. 
In order to obtain individual EGCG derivatives for subsequent structure elucidation and 
bioactivity evaluation, the crude products of EGCG esters were purified by flash column 
chromatography. EGCG esters were eluted on a silica column with a gradient of 
hexane/ethyl acetate/formic acid (90: 10:2 - 50:50:2, v/v/v). Fractions corresponding to 
each band were collected and solvents removed using a rotary evaporator. The identity of 
each fraction was confirmed by HPLC-MS as described above. The predominant fractions 
of EGCG esters with stearic acid (SA), EPA and DHA (referred to as compounds 1, 2 and 
3, respectively) were analyzed for their specific structures and evaluated for their 
antioxidant activity in vitro. 
The 1H and 13C NMR analyses were carried out for purified EGCG esters (compounds 1, 
2 and 3) in order to identify their molecular structures, i.e. the location of fatty acid 
incorporation in the EGCG molecule. The 1H and 13C spectra were recorded on a Bruker 
A vance 500 MHz NMR spectrometer (Bruker Biospin Co. Billerica, MA, USA) operating 
at 500.13 and 125.77 MHz, respectively. The samples were dissolved in dimethyl 
sulfoxide (DMSO)-d6 containing TMS as internal standard. Signal processing and 
interpretation were performed with the softwares Topspin 1.3 (Bruker Biospin Co.) and 
MestRe Nova (Mestrelab Research SL, Santiago De Compostela, Spain) and structure 
elucidation was accomplished by comparing the chemical shifts of EGCG derivatives 
with that of the EGCG parent molecule. 
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Determination of liphophilicity. Lipohilicity of the identified EGCG derivatives was 
determined as octanol-water partition coefficient (P) by a shake flask method. Briefly, a 
flask containing a mixture of octane! (1 00 ml) and deionized water (1 00 ml) was shaken 
in a shaking waterbath at room temperature (22°C) for 24 hours. The content was then 
allowed to stand for 24 hours for separation into two phases. Test compounds (0.2 )lmol) 
were dissolved in 5 ml of the upper phase (pre-saturated octanol), and the absorbance (Ao) 
was read at 280 nm. A blank with no sample was prepared. Five millilitres of the bottom 
phase (pre-saturated water) were added afterwards, and the mixtures were vortexed for 1 
min and allowed to stand for 24 hours for separation. Absorbance (Ax) of the upper phase 
in the vials was measured and octanol-water partition coefficient (P) calculated using the 
following equation: P = log Axi(Ao-Ax), where blank-corrected absorbance was used. 
Antioxidant activity. Antioxidant activity of the lipophilic EGCG derivatives was 
evaluated as DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging capacity using 
EGCG as the reference. DPPH scavenging capacity of test compounds was determined by 
EPR (electron paramagnetic resonance) according to Madhujith and Shahidi (2006) with 
slight modifications. Trolox standards (50-300 )lM) and test compounds (25 )lM) were 
dissolved in ethanol, to which 2 ml of ethanolic DPPH solution (0.18mM) were added. 
Contents were mixed well and injected to the sample cavity of a Bruker e-scan EPR 
spectrometer (Bruker Biospin Co.) through capillary tubing. The spectrum was recorded 
after 1 min on a Bruker e-scan food analyzer (Bruker Biospin Co.). The operating 
parameters for EPR were as follows: 1.86 G modulation amplitude, 2.621 s sweep time, 8 
scans, 100.000 G sweep width, 3495 G center field, 5.12 ms time constant, 9.795 GHz 
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microwave frequency, and 86 kHz modulation frequency. Reduction of DPPH radical 
concentration in the presence of test compounds was monitored by change in the 
corresponding signal intensity. DPPH radical scavenging capacity (%) was calculated 
using the following equation: 
% scavenging = 100 x (1- signal intensity samprJ signal intensity control) 
where, control contained no test compounds or trolox. A standard curve was constructed 
and DPPH scavenging capacities for test compounds were expressed as trolox equivalents 
(TE). 
Statistical Analysis and Data Interpretation. One-way analysis of variance (ANOV A) 
with pairwise comparisons (Tukey's HSD) was performed at a P < 0.05 level using 
Sigmastat for Windows version 2.0 (Jandel Corp., San Rafael, CA) to determine the 
significant differences. 
Results and discussion 
Synthesis of EGCG derivatives. Several strategies for improving the functional and 
biological properties of EGCG through structural modification have been investigated. 
For example, introduction of alkoxyl groups and peracylation have been shown to 
increase lipid membrane permeability and chemical/metabolic stability of EGCG, thereby 
improving bioactivities under physiological conditions (Tanaka et al. 1998; Lam et al. 
2004). In this study, we intended to enhance the lipophilicity of the water-soluble EGCG 
while maintaining its antioxidant activity. This was achieved by partial esterification and 
incorporation of long chain saturated or polyunsaturated fatty acids. To the best of our 
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knowledge, incorporation of the health-beneficial omega-3 PUF A to EGCG, which may 
provide additional perspectives to food and health applications, was carried out for the 
first time. 
The more lipophilic derivatives of EGCG were prepared via reaction with various 
acylating agents, namely the acyl chloride of SA, EPA and DHA. The yield of the crude 
products containing a series of EGCG polyesters (tetra ester and higher) was 56.9, 42.7 
and 30.7% for SA, EPA and DHA esters, respectively. Long-chain PUFA showed lower 
rates of incorporation, possibly because of their non-linear (bent) structure that renders 
steric hindrance for the acylation reaction. Saturated fatty acids such as SA are known to 
allow facile packing and close intermolecular interactions. Esterification by chemical 
means, with less selectivity and specificity, has been reported to result in higher degrees 
of substitution (DS) in the products than those catalysed by enzymes. For example, 
polyesters of sucrose with fatty acids (DS 4-8) were prepared using acylating agents such 
as acyl chloride or aryl esters (Rizzi and Taylor 1978), while lipases were effective for the 
regioselective synthesis of mono- and diesters of sucrose (DS 1-2) (Ferret et a!. 2005). 
The electrophilic acyl group may react with different number of hydroxyl groups located 
in different JJOSitions depending on the nature of the electrophile, the reaction conditions 
and catalysts employed (Ballesteros et a!. 2007). A mixture of EGCG-monopalmitate 
regioisomers (yield lower than 23%) was prepared by a chemical method in 
tetrahydrofuran (THF) at ooc using triethylamine as the catalyst (Mori et al. 2008). In the 
current study, polyesters ofEGCG with high DS (2:4) were formed during acylation under 
the conditions employed. It was noticed that the composition of the reaction mixture 
varied depending on the ratio of the starting materials (EGCG/fatty acid), and esters with 
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higher DS (7 -8) were produced at lower ratios of EGCG/fatty acid ( <1) (data not shown). 
As the degree of substitution increases, the lipophilicity increases while hydrolysis by 
lipolytic enzymes decreases due to steric hindrance (Akoh and Swanson 1990), hence 
higher membrane permeability and metabolic stability of the esters. The antioxidant 
activity of the derivatives so prepared would presumably be preserved since hydroxyl 
groups were only partially acylated. According to the results from HPLC-MS anaysis, 
esterification of EGCG with fatty acids (at 1:1 ratio) yielded predominantly tetraesters 
(DS 4) in all crude products of SA, EPA and DHA esters, but at different proportions 
(Table 2-1 ). Chain length of the fatty acids appeared to play a role in their incorporation 
into the EGCG molecule. Pentaesters were produced at a highest level in the EGCG-SA 
crude product (36.7%) followed by EGCG-EPA (18.9%) and EGCG-DHA (5.33%), 
whose fatty acids were less effective in approaching the acyl acceptor and packing in the 
synthesized molecules. 
Identification of EGCG derivatives. The crude products of EGCG esters were separated 
into different fractions by flash column chromatography, and the major products 
corresponding to tetraesters (named compounds 1, 2 and 3 for the stearate, 
eicosapentaenoate and docosahexaenoate, respectively) were collected and subjected to 
lipophilicity and antioxidant activity assessment tests. The three compounds were 
identified by HPLC-MS; their mass spectra are shown in Figure 2-1. 
For compound 1, the molecular ion peak detected showed a m/z at 1524.5, representing 
[Mt radical ion of the EGCG-tetrastearate (C94Hi s40Is), which might result from loss of 
a hydrogen atom from the [M+Ht or its migration to the fragments. The presence and 
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Table 2-1. Composition(%) EGCG-fatty acid polyesters in crude products*. 
EGCG-SA 
EGCG-EPA 
EGCG-DHA 
Tetraester 
63.3 ± 1.99 c 
81.1±0.59b 
94.7 ± 0.63 a 
Pentaester Hexaester 
36.7 ± 1.99 a tr 
18.9 ± 0.59 b tr 
5.33 ± 0.63 c tr 
*Reaction mixture also contained unreacted EGCG, which was not calculated as a component of crude 
products. 
EGCG-SA, EGCG-EPA, and EGCG-DHA are ester products of EGCG with SA, EPA and DHA, 
respectively. 
Values (mean± SD of three replicates) in the same column with different letters were significantly different 
at P < 0.05. 
tr: trace. 
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Figure 2-1. Mass spectra of EGCG derivatives (a: compound 1; b: compound 2; c: 
compound 3) 
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abundance of [M( in relation to [M+Ht in APCI-MS have been reported to be 
dependant on the mobile phase in the LC as well as the H atom affinity of the analyte 
(Breeman 1997). The peaks at rnlz 1258.0, 991 .6, 725.5 and 459.3 showed one or 
multiple mass loss of 266.5 from the molecular ion, representing the ions of [M-266.5t, 
[M-2x266.5t, [M-3x266.5t and [M-4x266.5t, respectively. These appeared to be the 
fragments with 1, 2, 3 or 4 acyl groups (mass 267.5 for stearoyl moiety and a hydrogen 
atom migrating to the fragment ions) dissociated from the molecular ion. The peaks 
located at rnlz 822.9, 555.9 and 289.7 corresponding to [M-2x266.5-169t, [M-3x266.5-
169t and [M-4x266.5-169t, respectively, originated from additional cleavage of the 
gallic acid group (mass 169). Based on the presence ofthe molecular ion and fragments in 
the mass spectrum, the identity of compound 1 was confirmed to be EGCG tetrastearate. 
Similarly, compound 2 showed a molecular ion peak at rnlz 1596.5 (mass of EGCG 
tetraeicosapentaenoate, C102H13o0 15). The peaks at rnlz 1596.5, 1312.4, 1028.0 and 743.3 
had a difference in mass of 284.5, indicating the cleavage of an eicosapentaenoyl group 
(mass 285.5 minus a migrating H). The peak at rnlz 455.8 ([M-4x285.5t) might be 
derived from loss of all 4 eicosapentaenoyl moieties in the molecular ion (m/z 1596.5) 
without adding 4 H atoms. Peaks at rnlz 859.2 and 573.8 indicated additional cleavage of 
the gallic acid group (mass 169) from the fragments rnlz 1028.0 and 743.3, respectively. 
All of the above provides support to identification of compound 2 as EGCG 
tetraeicosapentaenoate. 
Similar ionization and fragmentation patterns were found for MS of compound 3. 
Molecular ion at rnlz 1700.9 implied the presence of EGCG tetradocosahexaenoate 
(CIIoHI380 15, MW 1700.3), which was further confirmed by its fragments. Peaks at rnlz 
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1390.7 and 1080.1 correspond to the fragments with 1 and 2 docosahexaenoyl moieties 
(mass 311.6 minus a migrating H) cleaved off, respectively. The fragments from 
dissociation of 3 and 4 docosahexaenoyl groups were detected as Na-adducts at rn/z 792.2 
(769+23) and 481.6 (458+23), respectively. Further cleavage of the gallic acid moiety 
(mass 169) from the fragments rn/z 769, 1080 and 1390 gave rise to peaks at rn/z 600.4, 
911.2 and 1221.5, respectively. Thus, it could be concluded that compound 3 was EGeG 
tetradocasahexaenoate. 
Structure elucidation of EGCG derivatives. The purified EGeG derivatives 
(compounds 1, 2 and 3) were identified by MS as EGeG tetraesters (DS 4). However, 
their structures need to be determined since EGeG has 8 hydroxyl groups that are capable 
of acylation with fatty acids and hence the possibility of production of different 
regioisomers. Location of fatty acid incorporation in EGeG molecule was determined 
using 1H and De NMR by comparing the chemical shifts of the derivatives with their 
parent EGeG molecule. The chemical shifts detected for EGeG in both 1H and De NMR 
were very close to those reported in the literature (Valcic et al. 1999), while the spectra 
for the three derivatives displayed additional signals for corresponding alkyl groups in the 
expected range, i.e. 8 0.79-2.31 ppm for 1H and 8 15.01-34.25 ppm for De NMR (spectra 
not shown). Presence of alkyl protons and carbon provided evidence for incorporation of 
fatty acids in the EGeG molecule. 
When comparing the chemical shifts of protons in the derivatives with those in EGeG, a 
downfield shift was observed for all proton signals of EGeG (Table 2-2), which is in 
accordance with the findings of Islambekov et al. (1976), who demonstrated that acetyl-
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Table 2-2. 1H and 13C chemical shifts (o ppm) ofEGCG and its derivatives. * 
EGCG Com_Eound 1 Com_Eound 2 Com.Eound 3 
C/H _Eosition 13c IH 13c IH 13c IH 13c IH 
2 77.56 4.91 77.47 4.99 77.47 4.99 77.28 5.00 
3 69.09 5.32 69.29 5.38 69.06 5.36 69.24 5.37 
4 26.82 2.61 26.77 2.63 26.21 2.65 26.26 2.61 
2.88 2.91 2.91 2.89 
5 156.71 156.68 156.77 156.58 
6 95.41 5.78 95.40 5.79 95.45 5.79 95.46 5.79 
7 157.58 157.60 157.58 157.70 
8 96.60 5.88 96.67 5.89 96.67 5.90 96.76 5.90 
9 157.58 157.60 157.58 157.70 
10 98.47 98.44 98.44 98.35 
1' 129.71 129.61 129.52 129.65 
2' 106.57 6.36 106.53 6.45 106.53 6.45 106.60 6.45 
3' 146.47 150.72 150.72 151.05 
4' 133.45 131.97 130.25 132.73 
5' 146.47 150.72 150.72 151.05 
6' 106.57 6.36 106.53 6.45 106.53 6.45 106.60 6.45 
1" 120.39 120.40 120.40 120.32 
2" 109.76 6.77 109.52 6.81 109.76 6.82 109.84 6.82 
3" 146.72 151.26 151.25 151.05 
4" 139.64 137.04 137.05 137.23 
5" 146.72 151.26 151.25 151.05 
6" 109.76 6.77 106.52 6.81 109.76 6.82 109.84 6.82 
coo 166.29 166.28 166.26 166.36 
* Proton and carbon in alkyl chain of incorporated fatty acids were not listed. 
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ation of catechin led to a downfield displacement of all the proton signals. Since there is 
no proton attached to the carbon bearing the hydroxyl substituent in the aromatic rings of 
EGCG, large downfield shifts (6.8 1.0-1.2 ppm) normally observed for geminal protons 
were not detected. 
Chemical shifts of protons in all three derivatives followed the same trend. H-2' and H-6' 
showed a downfield shift of 6.8 0.09 in comparison with the parent EGCG molecule, 
indicating the occurrence of acylation in the Bring. Downfield shift of H-2, H-3, and H-4 
in the C ring decreased in the order of H-2 > H-3 > H-4, due to the increasing distance 
from the acylation site in the B ring. Acylation sites were tentatively assigned to the D 
ring as well based on the downfield shifts ofH-2" and H-6" (6.8 0.04-0.05 ppm), which 
appeared to be smaller than that of H-2' and H-6' in the B ring, possibly because of the 
ester bond in the gallic acid moiety. Only minor shifts were found for H-6 and H-8 in the 
A ring, suggesting that A ring was not the acylation site. Based on the 1H NMR results, a 
tentative conclusion can be reached that the fatty acids were incorporated in the B and D 
rings of the EGCG molecule. 
The specific positions of hydroxyl groups being acylated were further confirmed by 13C 
NMR. The general strategy established by Yoshimoto et al. (1980) was employed for 
structure elucidation of the EGCG derivatives. As described by Yoshimoto et al. (1980), 
acylation of a hydroxyl group of the substrate resulted in a downfield shift of the 0-
acylated carbon and an upfield shift of the neighbouring carbon. As presented in Table 2-
2, a large downfield shift (6.8 4.25-4.58 ppm) was found for C-3' and C-5 ', indicating 
these might be the positions of acylation. The remarkable upfield shift (6.8 0.72-3 .20 ppm) 
observed for C-4', the carbon adjacent to both C-3' and C-5 ', suggested the presence of a 
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free hydroxyl group at C-4' and also further confirmed acylation of C-3' and C-5'. The 
other neighbouring carbons (C-2' and C-6') of the acylation site did not show any upfield 
shift, possibly due to the steric confotmation of the fatty acids incorporated, which is 
believed to affect the 13C chemical shifts. It has been demonstrated that 13C chemical 
shifts may be determined by more complex stereochemical factors, while electronic 
influences dominate chemical shifts of 1H (Ranganathan and Balaram 1984). Similarly, 
the positions of acylation in the D ring were assigned to C-3" and C-5", based on the 
downfield shift of C-3" and C-5" and upfield shift of C-4". Absence of downfield or 
upfield shift for carbons in the A ring implied that hydroxyl groups in the A ring were not 
acylated, which is in agreement with the 1H NMR results. Thus, the structure 
characterization of the EGCG derivatives was conclusive based on the combined 1H and 
13C NMR, and compounds 1, 2 and 3 were identified as EGCG-3 ',5 ',3 ",5 "-0-
tetrastearate, EGCG-3 ',5 ',3' ',5' '-0-tetraeicosapentaenoate, and EGCG-3 ',5 ',3' ' ,5' '-0-
tetradocosahexaenoate, respectively, as shown in Figure 2-2. 
Lipophilicity of EGCG derivatives. EGCG is highly hydrophilic with a large polar 
molecular surface area, and is among those considered to be poorly absorbed in the body 
(Lambert et al. 2006). The hydrophilic nature of EGCG also poses a serious 
disadvantage/challenge for its use as a food preservative in stabilizing fats, oils and lipid-
based food systems. Therefore, structure modification of EGCG serves as a potential 
means to alter its physicochemical properties and hence improving its effectiveness as an 
antioxidant in more diverse systems. Many water soluble bioactives have structurally 
been modified for improved lipophilicity and hence expanded applications in more lipo-
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Figure 2-2. Structures of EGCG derivatives. 
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philic environments. These include a number of antioxidant phenolics such as ferulic, 
chlorogenic, cinnamic, sinapic, p-coumaric, and caffeic acids (Sabally eta!. 2005; Lee et 
al. 2006; Giraldo et al. 2007; Lue et al. 2005; Stevenson et al. 2007), which were 
esterified with various aliphatic alcohols, as well as ascorbic acid, tyrosol, protocatechuyl 
and vanillyl alcohol, esculin, rutin, naringin, genistein and daidzein (Stamatis et al. 1999; 
Aissa et al. 2007; Torres de Pinedo eta!. 2007; Ardhaoui et al. 2004; Kontogianni eta!. 
2001; Lewis et al. 1998), which were converted into their corresponding fatty acid esters. 
In addition, sterols including cholesterol, cholestanol, and sitosterol were esterified with 
long chain fatty acids for better water-holding properties of the resultant esters (Shimada 
et al. 1999). Many of these studies used saturated fatty alcohols or acids as alkyl chain 
donors to enhance the lipophilicity of the molecules of interest. In this work, we 
investigated the incorporation of a saturated fatty acid as well as two long-chain omega-3 
PUF A into the EGCG molecule. Long-chain omega-3 PUF A such as EPA and DHA are 
the major bioactive components in fish oils that are believed to render a myriad of health 
benefits, and are used as supplements, pharmaceutical substances, functional food 
ingredients and natural health products as well as cosmetics. Acylation of EGCG with 
these fatty acids will not only increase the lipophilicity ofEGCG, but also take advantage 
of the health promoting effects of long-chain omega-3 PUF A. Additional perspectives 
may also be expected such as synergism between the two moieties, namely EGCG and 
the omega-3 fatty acids. 
The EGCG derivatives prepared were evaluated for their lipophilicity in terms of octanol-
water partition coefficient (P). Higher P values indicate higher lipophilicity of the 
compound. As expected, acylation with fatty acids resulted in increased lipophilicity, as 
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ail three derivatives showed higher P than their parent molecule EGCG (Table 2-3). 
Compound 1 had the highest P among all, due to the presence of the highly lipophilic 
stearic acid side chain. Compounds 2 and 3 did not differ significantly in their 
lipophilicity. The lipophilicity of the test compounds was in agreement with their 
retention times observed in the reversed phase HPLC, which was in the order of 
compound 1 > 3 ~ 2 > EGCG. The enhanced lipophilicity of EGCG derivatives may lead 
to their improved incorporation into the lipid bilayers of cell membrane and hence better 
bioavailability in the body as well as greater potential in liposome-based drug delivery. 
Hashimoto et al. (1999) in a study on interaction of tea catechins with lipid bilayers 
reported that the incorporation rate was positively associated with the partition coefficient 
in octanol-water. 
Antioxidant activity. EGCG and other catechins are powerful antioxidants acting as free 
radical scavengers, reducing agents and metal chelators. In vitro assays have shown the 
antioxidant effectiveness of EGCG in scavenging DPPH radical, reducing ferric ion to 
ferrous ion and chelating metal ions (Zhu et al. 2001; Sun and Ho 2001; Xu et al. 2004; 
Chan et al. 2007). Studies on antioxidant mechanism of EGCG have suggested that 
EGCG may have multiple reaction pathways for exerting oxidation/antioxidation effects 
depending on the reaction environment. The hydroxyl groups at positions 3 and 5 on the 
A-ring were thought to be not so important in radical scavenging of EGCG (Nanjo et al. 
1996). However, a study on oxidation products ofEGCG and H20 2 demonstrated that A-
ring of EGCG might be a site for rendering antioxidant activity (Zhu et al. 2000). The 
trihydroxyphenyl B-ring was found to be the most active site of antioxidant action in 
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Table 2-3. Lipophilicity ofEGCG derivatives as octanol-water partition coefficient (P). 
Compounds EGCG Compound 1 Compound 2 
1.10 ± 0.06 b 
Compound 3 
1.03 ± 0.10 b p 0.48 ± 0.01 c 1.42 ± 0.02 a 
Values (mean ± SD of three replicates) with different letters were significantly different at P < 0.05. 
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DPPH-induced oxidation of EGCG (Zhu et a!. 2000, 2001). Nevertheless, the gallate 
moiety which accounts for increased phospholipids/water partition coefficient may lead to 
a higher antioxidant potential in vivo (Caturla et al. 2003). 
The EGCG derivatives in this study, as identified by MS and NMR, had 4 hydroxyl 
groups acylated with fatty acids, and the remaining hydroxyl groups on the aromatic rings 
of EGCG may contribute to the antioxidant property of the derivatives. However, the 
antioxidant efficacy of the derivatives may differ from that of EGCG, due to possible 
electronic and steric effects rendered by the fatty acid chains incorporated. Antioxidant 
activity of the modified EGCG was evaluated as scavenging capacity against DPPH 
radical, a stable hydrophobic radical frequently used in antioxidant assessment. Figure 2-
3 shows the EPR spectra of DPPH radical as affected by the test antioxidants. The 
presence of test compounds significantly decreased the resonance signal intensity, 
indicating the scavenging effect of EGCG and its derivatives against DPPH radical. When 
comparing their radical scavenging capacity, compound 1 showed the highest capacity as 
trolox equivalents, followed by compounds 3 and 2 (Figure 2-4). All derivatives 
displayed a higher scavenging activity against DPPH than EGCG itself. The trend for 
antioxidant activity among test compounds was in accordance with that of their octanol-
water coefficient. 
Lipophilicity has been found to play a role in antioxidant activity of flavonoids. The 
lipophilic derivatives of EGCG may have greater accessibility/affinity to the lipophilic 
DPPH radical than the hydrophilic EGCG. Moreover, acylation may have an effect on the 
hydrogen atom donation capability of EGCG by altering its electron density and 
distribution on the aromatic rings. Maintaining and even enhancing of the antioxidant act-
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ivity for EGCG derivatives suggests that these derivatives may be used as antioxidants or 
EGCG alternatives in more lipophilic environments. Further investigation on the 
antioxidant effectiveness of EGCG derivatives in different model systems is needed for 
exploring their full potential for application in the food and health industries. 
Conclusions 
Esterification of EGCG with long-chain saturated (SA) or polyunsaturated (EPA and 
DHA) fatty acids yielded mainly EGCG tetraesters. The specific structures of the 
synthesized EGCG derivatives were confirmed by 1H and 13C NMR as EGCG-
3 ',5 ',3 ",5 "-0-tetraester of the fatty acids involved. These derivatives had higher 
lipophilicity than EGCG itself. Antioxidant activity of all EGCG derivatives was superior 
to that of EGCG in terms of DPPH radical scavenging capacity, suggesting their potential 
use as antioxidants and EGCG alternatives in more lipophilic environments. Moreover, 
incorporation of long-chain omega-3 PUF A into the EGCG molecule may render 
additional health benefits or possible synergistic effects in vivo, which will be further 
investigated. 
2-24 
References 
1. Aissa, I., Bouaziz, M., Ghamgui, H., Kamoun, A., Miled, N., Sayadi, S. and Gargouri, 
Y. 1999. Optimization of lipase-catalyzed synthesis of acetylated tyro sol by response 
surface methodology. J Agric. Food Chem. 2007, 55, 10298-10305. 
2. Akoh, C.C. and Swanson, B.G. 1990. Absorbability and weight gain by mice fed 
methyl glucoside fatty acid polyesters: potential fat substitutes. J Nutr. Biochem. 2, 
652-655. 
3. Ardhaoui, M., Falcimaigne, A., Engasser, J.M., Oussou, P., Pauly, G. and Ghoul, M. 
2004. Enzymatic synthesis of new aromatic and aliphatic esters of flavonoids using 
Candida Antarctica lipase as biocatalyst. Biocatalysis Biotransformation 22, 253-259. 
4. Ballesteros, A., Plou, F.J., Alcalde, M., Ferrer, M., Garcia-Arellano, H. , Reyes-Duarte, 
D. and Ghazi, I. 2007. Enzymatic synthesis of sugar esters and oligosaccharides from 
renewable resources. In: Biocatalysts in the pharmaceutical and biotechnology 
industries. Patel, R. ed., CRC press, Taylor & Francis, Inc., Boca Raton, FL, pp463-
488. 
5. Breeman, R.B.van. 1997. Liquid chromatography/mass spectrometry of carotenoids. 
Pure Appl. Chem. 69,2061-2066. 
6. Cabrera, C. , Artacho, R. and Gimenez R. 2006. Beneficial effects of green tea- a 
review. JAm. Call. Nutr. 25, 79-99. 
7. Caturla, N., Vera-Samper, E., Villalain, J., Mateo, C.R. and Micol, V. 2003. The 
relationship between the antioxidant and the antibacterial properties of galloylated 
catechins and the structure of phospholipids model membranes. Free Radical Bioi. 
Med. 34, 648-662. 
8. Chan, E.W.C., Lim, Y.Y. and Chew, Y.L. 2007. Antioxidant activity of Camellia 
sinensis leaves and tea from a lowland plantation in Malaysia. Food Chern. 102, 1214-
1222. 
9. Ferret, M., Soliveri, J., Plou, F. J. , Lopez-Cortes, N. Reyes-Duarte, D., Christensen, M. 
Copa-Patino, J.L. And Ballesteros, A. 2005 . Synthesis of sugar esters in solvent 
mixtures by lipases from Thermomyces lanuginosus and Candida antarctica B, and 
their antimicrobial properties. Enzyme Microbial Techno!. 36, 391-398. 
10. Giraldo, L.J.L., Laguerre, M., Lecomte, J., Figueroa-Espinoza, M.C., Barouh, N., 
Barea, B. and Villeneuve, P. 2007. Lipase-catalyzed synthesis of chlorogenate fatty 
esters in solvent-free media. Enzyme Microbial Techno!. 41, 721-726. 
11. Graham, H.N. 1992. Green tea composition, consumption, and polyphenol chemistry. 
Prev. Med. 21, 334-350. 
2-25 
12. Guo, Q., Zhao, B, Li, M., Shen, S. and Xin, W. 1996. Studies on protective 
mechanisms of four components of green tea polyphenols against lipid peroxidation 
in synaptosome, Biochim. Biophys. Acta 1304, 210-222. 
13. Hamilton-Miller, J.M.T. 2001. Anti-carcinogenic properties of tea (Cameliia 
sinenesis). J Med. Microbial. 50, 299-302. 
14. Hashimoto, T., Kumazawa, S., Nanjo, F., Hara , Y. and Nakayama, T. 1999. 
Interaction of tea catechins with lipid bilayers investigated with liposome systems. 
Biosci. Biotechnol. Biochem. 63, 2252-2255. 
15. He, Y. and Shahidi, F. 1997. Antioxidant activity of green tea and its catechins in a 
fish meat model system. J Agric. Food Chern. 45, 4262-4266. 
16. Islamkov, S.Y., Karimdzhanov, A.K., Ismailov, A.I., Kamaev, F.G. and Sadykov, A.S. 
1976. PMR spectra of catechins and their derivatives. Translated from Khimiya 
Prirodnykh Soedinenii 1, 46-50. 
17. Kondo, K., Kurihara, M, Miyata, N., Suzuki, T. and Toyoda, M. 1999. Mechanistic 
studies of catechins as antioxidants against radical oxidation. Arch. Biochem. Biophys. 
362, 79-86. 
18. Kontogianni, A., Skouridou, V., Sereti, V., Stamatis, H., Kolisis, F.N. 2001. 
Regioselective acylation of flavonoids catalyzed by lipase in low toxicity media. Eur. 
J Lipid Sci. Techno!. 103, 655-660. 
19. Lam, W. H., Kazi, A., Kuhn, D. J., Chow, L. M. C., Chan, A. S. C., Dou, Q. P. and 
Chan, T.H. 2004. A potential prodrug for a green tea polyphenol proteasome inhibitor: 
evaluation of the peracetate ester of (- )-epigallocatechin gallate [(-)-EGCG]. Bioorg. 
Med. Chern. 12, 5587-5593. 
20. Lambert, J.D., Sang, S., Hong, J., Kwon, S.J., Lee, M.J., Ho, C.T. and Yang, C.S. 
2006. Peracetylation as a means of enhancing in vitro bioactivity and bioavailability 
of epigallocatechin-3-gallate. Drug Metabol. Disp. 34, 2111-2116. 
21. Lee, G.S., Widjaja, A. and Ju, Y.H. 2006. Enzymatic synthesis of cinnamic acid 
derivatives. Biotechnol. Lett. 28, 581-585. 
22. Lewis, P., WahaHi, K., Meng, Q.H., Adlercreutz, H. and Tikkanen, M.J. 1998. 
Synthesis of antioxidant isoflavone fatty acid esters. Natural antioxidants and 
anticarcinogens in nutrition, health and disease: Proceedings of the Second 
International Conference on Natural Antioxidants and Anticarcionogens in Nutrition, 
Health and Disease, Helsinki, Finland, 24-27 June, 
23. Lotito, S.B. and Fraga, C.G. 2000. Catechins delay lipid oxidation and a -tocopherol 
and P-carotene depletion following ascorbate depletion in human plasma. Proceedings 
of The Society for Experimental Biology and Medicine 225, 32. 
2-26 
24. Lue, B.M., Karboune, S., Yeboeah, F.K. and Kermasha, S. 2005. Lipase-catalyzed 
esterification of cinnamic acid and oleyl alcohol in organic solvent media. J Chern. 
Techno!. Biotechnol. 80, 462-468. 
25. Madhujith, T. and Shahidi, F. 2006. Optimization of the extraction of antioxidative 
constituents of six barley cultivars and their antioxidant properties. J Agric. Food 
Chern. 54, 8048-8057. 
26. McKay D.L. and Blumberg, J.B. 2002. The role of tea in human health: an update. J 
Am. Col!. Nutr. 21, 1-13. 
27. Mori, S., Miyake, S., Kobe, T., Nakaya, T., Fuller, S.D., Kato, N. and Kaihatsu, K. 
2008. Enhanced anti-influenza A virus activity of (-)-epigallocatechin-3-0-gallate 
fatty acid monoester derivatives: effect of alkyl chain length. Bioorg. Med. Chern. Lett. 
18, 4249-4252. 
28. Nanjo, F., Goto, K., Seto, R., Suzuki, M. Sakai, M. and Hara, Y. 1996. Scavenging 
effects of tea catechins and their derivatives on 1, 1-diphenyl-2-picrylhydrazyl radical. 
Free Radical Bioi. Med. 21, 895-902. 
29. Ranganathan, M. and Balaram, P. 1984. 13C NMR studies on trifluoroacetyl 
derivatives of 2-acetamido-2-deoxyhexoses. Organic Magnetic Resonance, 22, 717-
719. 
30. Rietveld, A. and Wiseman, S. 2003. Antioxidant effects of tea: evidence from human 
clinical trials. J Nutr. 133, 3275-3284. 
31. Rizzi, G.P. and Taylor, H.M. 1978. Synthesis of higher polyol fatty acid polyesters 
using high soap: polyol ratios. JAm. Oil Chern. Soc. 55, 398-401. 
32. Sabally, K., Karboune, S., Yeboah, F.K. and Kermasha, S. 2005. Lipase-catalyzed 
esterification of selected phenolic acids with linolenyl alcohols in organic solvent 
media. Applied Biochem. Biotechnol. 127, 17-27. 
33. Shahidi, F. and Alexander, D.M. 1998. Green tea catechins as inhibitors of oxidation 
of meat lipids. J Food Lipids 5, 125-133. 
34. Shahidi, F. and Miraliakbari, H. 2004. Omega-3 (n-3) fatty acids in health and disease: 
Part 1 -Cardiovascular disease and cancer. J Med. Food 7, 387-401. 
35. Shahidi, F. and Miraliakbari, H. 2005. Omega-3 fatty acids in health and disease: part 
2--health effects of omega-3 fatty acids in autoimmune diseases, mental health, and 
gene expression. J Med. Food 8, 133-148. 
36. Shimada, Y., Hirota, Y., Bada, T., Sugihara, A., Moriyama, S., Tominaga, Y. and 
Terai, T. 1999. Enzymatic syntesis of steryl esters of polyunsaturated fatty acids. J 
Am. Oil Chern. Soc. 76,713-716. 
2-27 
37. Stamatis, H., Sereti, V. And Kolisis, F.N. Studies on the enzymatic synthesis of 
lipophilic derivatives ofNatural antioxidants. JAm. Oil Chern. Soc. 76, 1505-1510. 
38. Stensvold, I., Tverdal, A., Solvoll, K. and Foss, O.P. 1992. Tea consumption: 
relationship to cholesterol, blood pressure, and coronary and total mortality. Prev. 
Med. 21, 546-663. 
39. Stevenson, D.E., Parkar, S.G., Zhang, J., Stanley, R.A., Jensen, D.J. and Cooney, J.M. 
2007. Combinatorial enzymic synthesis for functional testing of phenolic acid esters 
catalysed by Candida Antarctica lipase B (Novozym 435~. Enzyme Microbial 
Techno!. 40, 1078-1086. 
40. Sun, T. and Ho, C.T. 2001. Antiradical efficiency of tea components J Food Lipids 8, 
231-238. 
41. Tanaka, T., Kusano, R. and Kouno, I. 1998. Synthesis and antioxidant activity of 
novel amphipathic derivatives of tea polyphenol. Bioorg. Me d. Chern. Lett. 8, 1801-
1806. 
42. Torres de Pinedo, A., Penalver, P., Perez-Victoria, I., Rondon, D. and Morales, J.C. 
2007. Syntheis of new phenolic fatty acid esters and their evaluation as lipophilic 
antioxidants in an oil matrix. Food Chern. 105, 657-665. 
43. Valcic, S., Muders, A., Jacobsen, N.E., Liebler, D.C. and Timmermann, B.N. 1999. 
Antioxidant Chemistry of Green Tea Catechins. Identification of Products of the 
Reaction of (-)-Epigallocatechin Gallate with Peroxyl Radicals. Chern. Res. Toxicol. 
12, 382-386. 
44. Wanasundara, U. and Shahidi, F. 1996. Stabilization of seal blubber and menhaden 
oils with green tea catechins. J Am. Oil Chern. Soc. 73, 1183-1190. 
45. Wanasundara, U.N. and Shahidi, F. 1999. Concentration of omega-3 polyunsaturated 
fatty acids of seal blubber oil by urea complexation: optimization of reaction 
conditions. Food Chern. 65, 41-49. 
46. Xu, J.Z., Yeung, S.Y.V., Chang, Q., Huang, Y. and Chen, Z.Y. 2004. Comparison of 
antioxidant activity and bioavailability of tea epicatechins with their epimers. Br. J 
Nutr. 91, 873-881. 
47. Yoshimoto, K., ltatani, Y. and Tsuda, Y. 1980. 13C-Nuclear magnetic resonance 
spectra of 0-acylglucoses: additivity of shift parameters and its application to 
structure elucidations. Chern. Pharrn. Bull. 28, 2065-2074. 
48. Zhu, N., Sang, S., Huang, T.C., Bai, N., Yang, C.S. and Ho, C.T. 2000. Antioxidant 
chemistry of green tea catechins: oxidation products of (-)-epigallocatechin gallate 
and (-)-epigallocatechin with peroxidase. J Food Lipids 7, 275-282. 
2-28 
49. Zhu, N., Wang, M., Wei, G.J., Lin, J.K., Yang, C.S. and Ho, C.T. 2001. Identification 
of reaction products of (-)-epigallocatechin, (-)-epigallocatechin gallate and pyrogallol 
with 2,2-diphenyl-1-picrylhydrazyl radical. Food Chern. 73, 345-349. 
2-29 
CHAPTER3 
Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) 
derivatives in vitro 
Introduction 
Tea and tea products contain substantial amounts ofbioactive flavonoids and have proven 
to render a multiplicity of functional and physiological effects (Cabrera et al. 2006). 
Many of the health effects related to tea consumption have been attributed to its catechin 
(simple or condensed) content, which is also responsible for the characteristic color, 
flavor and aroma of tea. Among all catechins found in tea, epigallocatechin gallate 
(EGCG) is the most abundant (59% of the total catechins) (McKay and Blumberg 2002) 
and has been extensively studied as a potential health promoting agent. EGCG has a four 
ring structure with 8 hydroxyl groups, and is readily dissolved in aqueous phase while 
sparingly soluble in hydrophobic phase. The hydrophilic nature of EGCG restricts its 
bioefficiency in lipophilic environments due to limited solubility and hence hindered 
approaching to the sites of action. Moreover, the hydrophilicity also accounts for poor 
cellular absorption of EGCG in vivo and thus low bioavailability when ingested orally. In 
order to take better advantage of this multifunctional compound, the water-soluble EGCG 
was structurally modified by esterification with different fatty acids, including stearic 
(SA), eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids (Chapter 2). The 
tetraesters produced showed enhanced lipophilicity and improved radical scavenging 
capacity compared to EGCG. Lipophilization of EGCG through esterification may be 
useful for improving its bioefficiency in lipophilic media or even introducing novel 
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bioactivities due to the fatty acid moieties incorporated, especially when the health 
beneficial long-chain omega-3 polyunsaturated fatty acids (PUF A) are involved. This 
chapter aims to investigate the lipophilized EGCG derivatives as potential alternatives of 
EGCG in foods and natural health products. Four EGCG-fatty acid esters (Figure 3-1), 
namely EGCG-3',5',3",5"-0-tetrastearate (compound 1), EGCG-3',5',3",5"-0-
tetraeicosapentaenoate (compound 2), EGCG-3 ',5 ',3' ',5' '-0-tetradocosahexaenoate 
(compound 3), and peracylated EGCG-octabutyrate (compound 4) were evaluated for 
their selected bioactivities (antioxidant and antiviral activities) using in vitro chemical 
assays. 
EGCG IS known as a powerful antioxidant protecting against free radical-mediated 
oxidative changes both in food and in living organisms. EGCG acts as scavengers of 
many reactive oxygen/nitrogen species (ROS/RNS) such as superoxide radical anion, 
peroxyl and hydroxyl radicals, singlet oxygen, nitric oxide and peroxynitrite, among 
others, which are implicated in human pathogenesis including inflammation and 
carcinogenesis. EGCG can trap peroxyl radicals and thus break the chain reaction of free 
radicals and terminate lipid oxidation. An electron paramagnetic resonance (EPR) study 
on tea catechins indicated that EGCG trapped 6 superoxide anion or hydroxyl radicals, 
whereas epicatechin (EC) only trapped 2 free radicals (Yang et al. 1994). EGCG can also 
inhibit oxidation by chelating metal ions, such as Fe and Cu ions, which are catalysts of 
free radical generation. Antioxidant activity of EGCG depends on many factors, including 
metal-reducing potential, chelating behavior, pH, solubility characteristics, bioavailability, 
and stability in the environment (Luczaj and Skrzydlewska 2005), which are in turn deter-
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EGCG: 
Compound 1: 
Compound 2: 
Compound 3: 
Compound 4: 
0 
o-c 
II 
0 
R1 = R2 = H 
R1 = H, R2 = CO(CH2)16CH3 
R1 = H, R2 = CO(CH2)J(CH=CHCH2)sCH3 
R1 = H, R2 = CO(CH2h(CH=CHCH2)6CH3 
R1 = R2 = CO(CH2)2CH3 
Figure 3-1. Chemical structures of EGCG and its derivatives. 
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mined by the structural features of the molecule. Effect of structural modification of 
EGCG on its antioxidant activity is presented in this chapter. 
Antiviral activities of EGCG have also been reported. EGCG has been shown to inhibit 
via multiple mechanisms the maturation, replication, infectivity or function of numerous 
viruses, including adenovirus, coronavirus, influenza virus, rotavirus, herpes simplex 
virus (HSV), enterovirus (EV, e.g. coxsackievirus, poliovirus, hepatitis A virus), and 
human immunodeficiency virus (HIV) (Weber et al. 2003; Clark et al. 1998; Friedman 
2007; Ho et al. 2009; Nance et al. 2009), among others. Antiviral activities of EGCG are 
thought to be attributed to its ability to act as an antioxidant, to inhibit enzymes, to 
suppress viral RNA synthesis, to disrupt cell membranes, to bind to virulent proteins thus 
preventing their penetration into the receptor cells, and to trigger the host cell self-defense 
mechanisms (Friedman 2007). In this study, the antiviral potential of EGCG and its 
lipophilic derivatives was evaluated in vitro as inhibitory activity against NS3/4A 
protease, an important enzyme for the maturation of hepatitis C virus (HCV), and a-
glucosidase, the enzyme essential for HIV infectivity. 
Materials and methods 
Materials. EGCG was supplied by Dr. Yu Shao of GlaxoSmithKline Consumer 
Healthcare (Parsippany, NJ, USA). Butyroyl and stearoyl chlorides were purchased from 
Nu-chek Prep Inc. (Elysian, MN, USA). EPA and DHA were respectively prepared as 
described in chapter 2 from oils provided by Fuso Pharmaceutical Industries, Ltd. (Osaka, 
Japan) and Martek Bioscience Corporation (Columbia, MD, USA). Randomly methylated 
cyclodextrin (RMCD) was purchased from Cyclodextrin Technologies Inc. (High Springs, 
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FL, USA). Trolox was purchased from Acros Organics (Fair Lawn, NJ, USA). SensoLyte 
520 HCV Protease Assay Kit was purchased from AnaSpec (San Jose, CA, USA). Other 
chemicals and a-glucosidase (from Bacillus stearothermophilus) were purchased from 
Sigma-Aldrich Canada Ltd. (Oakville, ON). All solvents used were obtained from Fisher 
Scientific Ltd. (Ottawa, ON). The solvents employed were ofHPLC and reagent grade. 
Preparation of EGCG esters. EGCG esters were prepared as previously described in 
Chapter 2. Briefly, EGCG was acylated with different fatty acids, namely SA, EPA and 
DHA, through their corresponding acyl chlorides. Peracylated EGCG butyrate was 
prepared with excess of butyroyl chloride. The composition of the crude products 
containing a mixture of EGCG polyesters was determined by HPLC-MS and the 
predominant individual EGCG esters were isolated by flash column chromatography. The 
purified individual EGCG esters (compounds 1-4) were identified by HPLC-MS, 1H 
NMR and 13C NMR, and subjected to antioxidant and antiviral activity assessment by in 
vitro chemical assays. 
ORAC (Oxygen radical absorbance capacity). The ORAC assay for EGCG and its 
derivatives (compounds 1-3) was carried out using a Fluostar Optima plate reader (BMG 
Labtech, Durham, NC) equipped with an incubator and two injector pumps. A modified 
method for lipophilic antioxidants was followed, in which RMCD was used as water 
solubility enhancer, as described by Huang et al. (2002). Trolox standards (6.25-50 J.!M) 
and samples (0.25 J.!M) were dissolved in acetone/water (1/1) containing 7% RMCD. 
Fluorescein and AAPH [2,2'-azobis (2-aminopropane) dihydrochloride] were used as the 
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probe and radical generator, respectively. Trolox standard or test compound solutions (20 
fll, 7% RMCD used as a control) were added to each well of a 96-well black microplate, 
flo llowed by 200 fl l of fluorescein in phosphate buffer solution (0.11 f.LM). The plate was 
incubated at 3rC for 15 min and the machine was programmed to inject 75 fll of AAPH 
(17.2 mg/ml in buffer) into the wells. The conditions used were as follows: 0.3 s position 
delay, 8 s orbital shaking before each cycle with 4 mm width, 21 0 s cycle time, and 25 
cycles. Fluorescence was measured at an excitation wavelength of 485 nm and emission 
of 520 nm. A standard curve was plotted and ORAC values for test compounds were 
obtained as trolox equivalents (TE). 
Reducing power. The reducing power ofEGCG and its derivatives (compounds 1-3) was 
determined according to Oyaizu (1986). One millilitre of test compounds (1 mM in 95% 
ethanol) was mixed with 2.5 ml of phosphate buffer solution (PBS, 0.2 M, pH 6.6) and 
2.5 ml of a 1% solution of potassium ferricyanide K 3Fe(CN)6. The mixture was incubated 
at 50°C for 20 min. A portion of (2.5 rnl) of trichloroacetic acid (TCA, 1 0%) was added to 
the mixture, and the content was centrifuged at 770 x g for 10 min. An aliquot (2.5 ml) of 
the supernatant was transferred to a tube containing 2.5 ml of distilled water and 0.5 ml of 
ferric chloride FeCb (0.1 %). The content was mixed well and the absorbance was 
recorded at 700 nm. Higher absorbance of the reaction mixture indicates greater reducing 
power. Ascorbic acid (1-6 mM in 95% ethanol) was used as a standard. 
Metal chelation. The metal chelation capacity of EGCG and its derivatives (compounds 
1-3) was measured according to Decker and Welch (1990) with some modifications. 
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Ethanolic solutions of test compounds (0.2 ml, 1 mM) were mixed well with 1.74 ml of 
ethanol and 0.02 ml of ferrous chloride (FeCh, 2 mM). To the mixture, 0.04 ml of 
ferrozine (5 mM) was added, and the reaction mixture allowed to stand for 10 min for 
color development. The absorbance was then measured at 562 run. A blank without 
ferrozine was used for each compound, since the antioxidant-Fe2+ complex gives a color 
that might interfere with the absorbance reading. Metal chelation capacity was calculated 
using the following equation: 
%chelation = [1- (Abs.5ample-Abs.blank)/Abs.control] X 100 
where, control is in the absence of test compounds, while blank contained no ferrozine. 
HCV protease inhibitory activity. Inhibitory activity of EGCG and its derivatives 
(compounds 1-4) against HCV protease was evaluated as an indicator for their antiviral 
activity. The assay was conducted following a method described by Ma et al. (2009) 
using a SensoLyte 520 HCV Protease Assay Kit. An aliquot (2 J..Ll) of test compounds 
dissolved in dimethyl sulfoxide (DMSO) was added to each well of a 384-well black 
Assay plate, followed by addition of 8 J..Ll of HCV NS3/4A protease solution (0.5 J..Lg/ml). 
The reaction was initiated by adding 10 J..Ll of freshly diluted substrate (1 00 x dilution of a 
DMSO stocking solution). The mixture was incubated at room temperature for 30 min, 
and the fluorescence intensity was measured at 485 run for excitation and 535 run for 
emission by a TECAN GENios plate reader. Inhibitory activity of test compounds was 
calculated as inhibition percentage according to the following equation: 
% inhibition = 1 00 X (F control - F sample)/F control 
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where, Fcontrol and Fsample stand for the fluorescence value of control without test 
compounds and of those with added test compounds. All fluorescence values were 
conected with a substrate blank. Samples were assayed at different concentrations to plot 
a concentration versus inhibition percentage curve, and IC50 values were obtained from 
the curve for each sample. A known HCV protease inhibitor, embelin, was used as a 
reference. 
a-Glucosidase inhibitory activity. The a-glucosidase inhibitory activity of EGCG and 
its derivatives (compounds 1-4) was determined following the procedure described by Ma 
et al. (2008). To each well of a 96-well plate 40 J..Ll of 4-nitrophenyl a-D-glucopyranoside 
(2 mM, dissolved in 100 mM potassium phosphate buffer, pH 7.0) and 5 J..Ll of sample 
solution (in DMSO) were added. The reaction was initiated by adding 5 J..Ll of the enzyme 
solution (0.3 J..Lulml a-glucosidase from Bacillus stearothermophilus). The plate was 
incubated at 37 °C for 20 min, and the absorbance was measured before and after 
incubation at 405 nm with an InterMed ImmunoReader (Nippon InterMed K.K. Tokyo, 
Japan). The absorbance change (~A) was recorded and compared between control and 
samples. The inhibitory activity of test compounds against a-glucosidase was calculated 
as follow: 
%inhibition = 100 X (~Acontro l - ~Asample) I ~Acontrol 
where, ~Acontrol and ~Asample represent the absorbance change after incubation of the 
control (DMSO only) and samples, respectively. Acarbose was used as a reference 
inhibitor for a-glucosidase. 
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Statistical Analysis. One-way analysis of variance (ANOVA) with pairwise comparisons 
(Tukey's HSD) was performed at a P < 0.05 level using Sigmastat for Windows version 
2.0 (Jande! Corp., San Rafael, CA) to determine the significant differences. 
Results and discussion 
Radical scavenging capacity. EGCG derivatives (compounds 1-3) were effective in 
scavenging DPPH (1,1-diphenyl-2-picrylhydrazyl) radicals, as summarized in Chapter 2. 
The radical scavenging capacity of EGCG was significantly enhanced by incorporation of 
fatty acid side chains, which was attributed to the increased lipophilicity and hence 
greater accessibility/affinity of the derivatives to the lipophilic DPPH radical than the 
parent EGCG molecule. However, since DPPH radical is a stable artificial free radical 
that is not found in nature, the antioxidant activity estimated from DPPH scavenging may 
not necessarily reflect the real situation in food and biological systems, where radicals are 
generally unstable with very short life time. In order to have better understanding of their 
antiradical activity in biological environments, the EGCG derivatives were evaluated for 
their capability to scavenge peroxyl radicals, measured as oxygen radical absorbance 
capacity (ORAC). 
The ORAC assay utilizes a biologically relevant radical source and has been established 
as a standard method for assessing the activity of hydrophilic antioxidants. In this study, a 
modified ORAC method for lipophilic antioxidants proposed by Huang et al. (2002) was 
employed, which introduces acetone/water as the solvent and RMCD as a solubility 
enhancer. The results showed that the peroxyl radicals generated by AAPH were 
3-9 
scavenged by EGCG and its derivatives to a greater extent than by the reference 
antioxidant trolox, i.e. 15-85 folds more effective than trolox (Figure 3-2). 
The ORAC values of the derivatives were higher than that of EGCG, indicating their 
greater hydrogen atom donating capability under the test conditions. The decreased 
number of hydroxyl groups in EGCG derivatives did not appear to negatively affect the 
antioxidant activity. Wright et al. (2001) stated that the number of hydroxyl groups in 
EGCG is largely irrelevant to its antioxidant activity, and it is the strategic placing of such 
groups that does matter. The substituents on the phenol ring play an essential role in the 
efficacy of phenolic antioxidant via both electronic and steric effects. Electron donating 
groups at the ortho and para positions are able to lower the activation energy for 
hydrogen abstraction and thus enhancing the hydrogen donating capability of the 
antioxidant (Singh et al. 2005). In the EGCG derivatives, the 0-acylation replaced the 
strong electron donating hydroxyl group (a combination of inductive and resonance 
effects) with a weaker electron donating ester group, which would presumably lead to 
compromised hydrogen donating capability of the molecule. However, the substitution 
also hindered the formation of the moderately strong hydrogen bonding of the adjacent 
hydroxyl groups in the EGCG molecule. These intramolecular hydrogen bonds contribute 
to stabilization of the molecule and increased bond dissociation enthalpy (BDE) of the 0-
H bond, i.e. resistance of the hydrogen atom dissociation (Wright et al. 2001). Ortho-
substitution of EGCG might result in enhanced hydrogen atom donating capacity by 
reducing intramolecular hydrogen bonds and BDE. 
Sterically, the acylation might have altered the 3D conformation of EGCG, which might 
facilitate hydrogen atom donation, hence increasing its radical scavenging capacity. Con-
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Figure 3-2. ORAC values ofEGCG and its derivatives as trolox equivalents (compounds 
1, 2 and 3 are EGCG tetraesters of SA, EPA and DHA, respectively). 
3-11 
formation characteristics are important factors affecting activity of antioxidants. 
Hakamata eta!. (2006) reported that planar catechin (the catechol and chroman structure 
are constrained to be planar) showed a hydrogen transfer rate that was 5-fold faster than 
that of the native (+)-catechin. The scavenging activities of catechin against DPPH and 
AAPH radicals were increased by switching to the planar conformation. In this study, the 
acylation of hydroxyl groups on the phenyl ring might have led to planar formation or 
other steric changes that enhance the n-conjugation of the substituents with the phenol 
ring and hence the hydrogen donating capability. This, however, needs to be further 
investigated. In addition to the conformational attribute, the steric crowding caused by 
incorporation of high-molecular-weight bulky moieties might contribute to the greater 
hydrogen donating capability of the EGCG derivatives. Lucarini et al. (1996) have 
demonstrated that ortho-substituted phenols had lowered BDE due to the steric repulsion 
between the substituents and the hydroxyl group, especially when the substituents are 
bulky. 
In summary, the combined electronic and steric factors discussed above might explain the 
overall improved radical scavenging activity of the EGCG derivatives. Among the 
derivatives, compounds 2 and 3 containing PUF A side chains showed higher ORAC 
values than compound 1 which had a saturated alkyl side chain. The superior hydrogen 
atom donating capacity of compounds 2 and 3 may be due to the electron-rich double 
bonds in the PUF A that may alter the electron distribution on the phenol rings as well as 
the bent stmctures of the PUF A chains that may help form more sterically-favored 
conformations for facilitating the dissociation of hydrogen atoms. 
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Reducing power. In addition to hydrogen atom donation, antioxidants may also inhibit 
oxidation through single electron transfer. The antioxidant can deactivate a free radical or 
reduce an oxidant by donating an electron and forming an antioxidant radical cation, 
followed by rapid and reversible deprotonation (Wright et al. 2001 ). The antioxidant 
radical formed is then stabilized by electron delocalization (resonance), as in hydrogen 
atom donation mechanism. Although the net result of electron transfer is the same as the 
hydrogen atom transfer route, the capability of an antioxidant to donate an electron or a 
hydrogen atom may vary depending on both intrinsic and extrinsic factors. The ability of 
an antioxidant to act as an electron donor, or its reducing power, is determined by the 
ionization potential (IP) of the compound and strongly solvent-dependant (Wright et al. 
2001). 
The reducing power of EGCG and its derivatives was measured as Fe3+-Fe2+ 
transformation mediated by the test compounds and expressed as ascorbic acid 
equivalents. Ascorbic acid is a known reducing agent. The results showed that both 
EGCG and its derivatives (compounds 1-3) exhibited greater reducing power than 
ascorbic acid of 2-13 folds (Figure 3-3). EGCG had the highest reducing power among all. 
Acylation with long chain fatty acids led to dramatic decrease of reducing power, as 
found for compounds 1-3. This is not in agreement with their free radical scavenging 
capacity (Figure 3-2). The poor correlation may arise from different mechanisms as well 
as the test environments involved in the two assays. As already mentioned, the electron 
donating capability of antioxidants is dependent on the IP, which may be altered by 
structure modification. Substituents on the phenol ring may change not only the BDE, but 
also IP. The presence of electron-donating substituent groups can stabilize the phenoxy! 
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Figure 3-3. Reducing power of EGCG and its derivatives as ascorbic acid equivalents 
(compounds 1, 2 and 3 are EGCG tetraesters of SA, EPA and DHA, 
respectively). 
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radical cation and hence lowering the IP and enhancing the electron donating capability. 
Therefore, replacement of the strong electron-donating hydroxyl group with a weaker 
ester group results in increased IP and decreased reducing power of the antioxidant. As 
observed in this case, acylated EGCG with ester side chains showed lower reducing 
power than the original molecule. The opposite trend was observed for ORAC, although 
phenyl substitution influences the 0-H BDE in a similar way, possibly because the 
electronic effect of the substituents on hydrogen atom donation was counteracted by other 
factors, such as hydrogen bonding and steric changes. Moreover, the BDE of a phenolic 
antioxidant seems less sensitive to substitution than the IP. For example, BDE decreases 
by 1 kcallmol, while IP decreases by over 8 kcal/mol, when an aminophenol is 
methylated (Wright et al. 2001). 
Solubility also affects the effectiveness of antioxidants, especially their reducing power 
since electron transfer mechanism is strongly solvent dependent due to solvent 
stabilization of charged species (Wright et al. 2001). EGCG derivatives with enhanced 
lipophilicity (data shown in chapter 2) have poor solubility in aqueous media and hence 
compromised activity under the hydrophilic test environment. Moreover, they might have 
formed micelles in the assay solution with the B and D rings bearing long fatty acid side 
chains being buried in the hydrophobic core, leaving only A ring as the site available for 
antioxidant action. Similar changes in reducing power caused by acylation have been 
found for rutin esters (Lue eta!. 201 0). 
Metal chelation. Metals play important roles in health. For example, iron is essential in 
oxygen transport, respiration, and activity of many enzymes. However, transition metals 
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are extremely reactive and act as catalysts for lipid oxidation by generating free radicals. 
They can react with hydrogen or lipid peroxides and produce hydroxyl or peroxyl radicals, 
as in Fenton reaction. Iron or copper-induced LDL oxidation has been implicated in 
atherosclerosis and other cardiovascular diseases. Metal chelators such as many 
polyphenols can bind to metal ions and form a stable complex with reduced redox 
potential, thus suppressing the pro-oxidant effect of the metal ions. EGCG is a known 
metal chelator due to its vicinal trihydroxy structure, in which the oxygen atoms act as 
electron donors to form bonds with the electrophilic metal ions. 
In this study, chelation capacity of EGCG and its ester derivatives for ferrous ion was 
evaluated. All test compounds exhibited ferrous ion chelation activity, ranging from 8 to 
35% (Figure 3-4). The highest chelation activity was found for compound 2, followed by 
compound 3, indicating that the PUF A esters of EGCG were more potent metal chelators 
than the parent EGCG and its saturated ester. Compound 1 did not show any significant 
difference (P>0.05) from that of EGCG. Metal chelation capability has been related to 
geometric feature of the chelator-metal complex (e.g. ionic diameter, nng s1ze, 
conformation, etc.) (Hassan 1992), and can therefore be positively or negatively 
influenced by any structural modifications that may lead to geometric alterations of the 
complex. The greater metal chelation capability found for EGCG-PUF A esters is possibly 
due to steric changes resulting from the bent structure of the PUF A chain that favors the 
stability of the antioxidant-Fe2+ complex. 
HCV protease inhibitory activity. Hepatitis C virus (HCV) infection is a serious health 
threat globally. More than 170 million people worldwide are chronically infected with 
3-16 
40 
a 
b 
30 
c 
.Q 
ro 
Q3 20 
.r:. 
u 
~ 0 
10 
0 
EGCG 2 3 
Figure 3-4. Metal chelation capacity(%) ofEGCG and its derivatives (compounds 1, 2 
and 3 are EGCG tetraesters of SA, EPA and DHA, respectively). 
3-17 
-------------~----------------- ~-~ 
HCV (Qiu 2009). Chronic infection with HCV is associated with liver cirrhosis that often 
leads to hepatic failure and hepatocellular carcinoma (HCC) (Chen and Tan 2005). 
Current approved therapies using interferon and pegylated interferon in combination with 
ribavirin can achieve only limited virologic response rates in a significant patient 
population (e.g. those infected with HCV genotype 1) and have been shown to have side 
effects (Chen and Tan 2005), necessitating development of new antiviral drugs. The 
NS3/4A protease, one of the most thoroughly characterized HCV enzymes has become an 
important target for anti-HCV treatment. The viral NS3/4A protease mediates the 
cleavage of the HCV polyprotein to release the functional proteins that are essential for 
viral propagation. Inhibitors ofNS3/4A protease bind to the enzyme and inhibit activation 
of viral proteins, thus blocking HCV replication in infected host cells (Chen and Njoroge 
2009). 
The inhibitory effect of EGCG and its derivatives against HCV NS3/4A protease was 
examined using an in vitro assay and compared with embelin, a known HCV protease 
inhibitor. EGCG did not show any significant effect in inhibiting the protease, having a 
high IC50 value of >200 11M compared to that ofthe positive control embelin (10.19 11M), 
as shown in Table 3-1 . However, distinctive inhibition was observed for its ester 
derivatives and compounds 2 and 3 containing omega-3 PUF A displayed a protease 
inhibitory activity that was 1700-fold stronger than that of embelin. Although less 
effective than compounds 2 and 3, compound 1 inhibited the protease to approximately 
80-fold higher than embelin. The perbutyrated EGCG (compound 4) with all 8 hydroxyl 
groups occupied with short chain acyl moieties was not expected to possess any antioxid-
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Table 3-1. Inhibitory effect (IC50) ofEGCG and its derivatives against HCV protease*. 
Compounds 
ICso (J.!M) 
RSD% 
EGCG 
>200 
5.5 
1 
0.13 
1.8 
2 
0.006 
3.4 
3 
0.006 
3.0 
4 
0.98 
4.4 
Em be lin 
10.19 
9.0 
*Compounds 1, 2 and 3 are EGCG tetraesters of SA, EPA and DHA, respectively; compound 4 is EGCG-
octabutyrate. 
RSD: relative standard deviation. 
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ant activity due to absence of the functional OH groups. However, it exhibited a protease 
inhibitory activity 10-fold stronger than that of embelin. The remarkable improvement of 
EGCG derivatives in inhibiting HCV protease might arise from the changes in steric 
features and hydrophilic-lipophilic balance (HLB) of the molecules leading to the 
superior binding affinity to the enzyme. A study on antiviral activities of theaflavins by 
molecular modeling has revealed that steric and conformational effects govern the 
infectivity of the virus (Clark et al. 1998). In this study, the ester derivatives of EGCG 
with fatty acids, especially long chain PUF A with a bent chain structure, may be more 
sterically favored than EGCG in binding to the protease and thus inhibiting its function in 
virus replication. 
a-Glucosidase inhibitory activity. a-Glucosidases are important hydrolytic enzymes in 
carbohydrate digestion and vital for biosynthesis of viral envelope glycoproteins. 
Glycosylation of the viral envelope glycoproteins is essential for infectivity of HIV, and 
inhibition of a-glucosidase provides a promising strategy for developing novel anti-HIV 
drugs. Moreover, inhibition of a-glucosidase may also have a therapeutic effect against 
type II diabetes by interfering with digestion of carbohydrates and delaying glucose 
absorption. 
Catechin and its planar analogues have been investigated for a-glucosidase inhibitory 
activity (Hakamata et al. 2006). Only a weak inhibitory effect (ICso >500 f.!M) was found 
for (+)-catechin, while the lipophilic planar analogues (alkyl chains incorporated in a 
heterocycle ring) exhibited strong inhibition (IC5o = 0.7-47.5 f.!M) against a-glucosidase. 
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Another study on chlorogenic acid derivatives suggested that hydrophobic interactions 
were involved in a-glucosidase binding and inhibiting activity of these compounds (Ma et 
al. 2008). In this study, the ester derivatives of EGCG were determined for their a-
glucosidase inhibitory activity and compared with the parent EGCG molecule and a 
positive control acarbose, a known a-glucosidase inhibitor used to reduce postprandial 
hyperglycemia. Table 3-2 presents the IC50 values of all test compounds, among which 
acarbose was found to be the most potent inhibitor of a-glucosidase. EGCG showed the 
highest IC50 value (>200 f.!M) among all. The derivatives with enhanced lipophilicity had 
significantly improved effectiveness in inhibiting a-glucosidase. Compound 1 had the 
lowest IC50 value i.e. highest potency as a-glucosidase inhibitor among all derivatives, 
followed by compound 4. The less lipophilic derivatives, compounds 2 and 3, were less 
effective. The results suggest that the binding affinity of EGCG and its derivatives to a-
glucosidase may be dependent on a combined factor of hydrophobic interaction and steric 
features, since compound 1 showed a higher inhibitory activity than compound 4 while 
having lower hydrophobicity (according to the retention times in HPLC, data not shown). 
Conclusions 
Ester derivatives of EGCG with enhanced lipophilicities exhibited higher antioxidant 
activities than the parent EGCG in scavenging peroxyl radicals and chelation pro-oxidant 
metal ions, possibly due to a combined electronic and steric effects. However, reducing 
power of the derivatives was lower than EGCG, which may be explained by their poor 
solubility in the aqueous test medium or formation of micelle. The derivatives also show-
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Table 3-2. Inhibitory effect (IC5o) ofEGCG and its derivatives against a.-glucosidase·. 
Compounds 
ICso (!-lM) 
RSD% 
EGCG 
>200 
8.0 
1 
2.62 
1.9 
2 
15.66 
7.0 
3 
15.87 
2.7 
4 
6.87 
4.7 
Acarbose 
0.15 
5.3 
*Compounds 1, 2 and 3 are EGCG tetraesters of SA, EPA and DHA, respectively; compound 4 is EGCG-
octabutyrate. 
RSD: relative standard deviation. 
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ed excellent antiviral activities in inhibiting HCV protease and a-glucosidase, which were 
not significant for EGCG. The steric features and lipophilicity of the derivatives may be 
responsible for the increased binding affinity to the enzymes, leading to greater inhibition. 
These results suggest that lipophilic EGCG derivatives may be used as potential 
functional ingredients of food, cosmetics, drugs and natural health products for health 
promoting purposes. However, these findings are based on in vitro chemical assays, and 
more research on their bioactivities in real food and biological systems is needed for 
better understanding and utilization of these derivatives as functional compounds. 
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CHAPTER4 
Lipophilized epigallocatechin gallate (EGCG) derivatives and their antioxidant 
potential in food model systems 
Introduction 
Lipid oxidation is considered a major cause of quality deterioration affecting both the 
nutritional/sensory quality and safety of foods, especially lipid-based products, and has 
thus been a challenge for manufacturers and food scientists alike. Among the many 
strategies employed for controlling lipid oxidation, addition of antioxidants is the most 
effective, convenient and economical approach (Wanasundara and Shahidi 2005). 
Antioxidants in foods, naturally occurring as food components, produced from process-
induced chemical changes, or added as preservatives, can minimize rancidity, maintain 
nutritional quality, retard the formation of toxic oxidation products, and increase shelf-life 
of the food (Jadhav et al. 1996). Antioxidants are also used in the health-related areas due 
to their ability to protect the body against oxidative stress and its consequences. 
Substances with antioxidant potential are available from a variety of natural sources as or 
as synthetic chemicals. Polyphenols are the most abundant antioxidants in nature. The 
antioxidant activity of polyphenols arises from their unique structures, which render a 
superior hydrogen donating capability over many other compounds. Tea is a rich source 
of polyphenols, particularly flavonoids. The flavonoids, mainly catechins (flavan-3-ols), 
contribute to the characteristic bitter and astringent taste of tea, and are among the major 
active components responsible for the functional properties of tea and its extracts 
(Cabrera et al. 2006). 
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Epigallocatechin gallate (EGCG), the predominant catechin in tea, has been known as a 
powerful antioxidant. In vitro assays have shown the antioxidant effectiveness of EGCG 
in radical scavenging, reduction and metal chelation (Zhu et a!. 2001; Sun and Ho 2001; 
Xu et a!. 2004; Chan et a!. 2007). In food model systems, EGCG has been shown to 
protect highly unsaturated marine oils as well as fish and meat lipids against oxidation 
(Wanasundara and Shahidi 1996; He and Shahidi 1997; Shahidi and Alexander 1998). 
EGCG also inhibited the bleaching of P-carotene/linoleate (Amarowicz and Shahidi 1995) 
and photosensitized oxidation of conjugated linoleic acid in an oil-in-water emulsion 
system (Liu and Yang 2008). EGCG shows varied antioxidant activity in different model 
systems, and it is well documented that its activity depends largely on the substrate 
system under investigation (Wanasundara and Shahidi 1996; He and Shahidi 1997). 
EGCG, like many other phenolic antioxidants in nature, is soluble in water while 
sparingly soluble in more lipophilic media, which poses a restriction to its antioxidant 
effectiveness in lipophilic systems, such as fats, oils, lipid-based food or cosmetic 
formulas and emulsions as well as biological environments. In order to expand the 
application of EGCG as an antioxidant or other functional ingredient in more diverse 
systems, ester derivatives of EGCG with improved lipophilicity were synthesized 
(Chapter 2) and their antioxidant activity confirmed by various in vitro assays (Chapter 
3). In this chapter, the antioxidant efficacy of the lipophilic EGCG derivatives 
(compounds 1-3, Figure 2-2 in Chapter 2) in selected food model systems is presented as 
an indicator of their potential use in the food industry. 
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Materials and methods 
Materials. EGCG was supplied by Dr. Yu Shao of GlaxoSmithK.line Consumer 
Healthcare (Parsippany, NJ, USA). Stearoyl chloride and linolenic acid were pmchased 
from Nu-chek Prep Inc. (Elysian, MN, USA). Eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA) were prepared as described in chapter 2 from oils provided 
by Fuso Pharmaceutical Industries, Ltd. (Osaka, Japan) and Martek Bioscience 
Corporation (Columbia, MD, USA), respectively. Stripped com oil, BHA, P-carotene, 
Tween 40, TBA (thiobarbitmic acid), TMP (1,1,3,3-tetramethoxypropane), and TCA 
(trichloroacetic acid) were pmchased from Sigma-Aldrich Canada Ltd. (Oakville, ON). 
All solvents used were of HPLC grade quality and obtained from Fisher Scientific Ltd. 
(Ottawa, ON). Fresh lean ground pork was obtained from a local supermarket. 
Preparation and characterization of lipophilic EGCG derivatives. EGCG was 
acylated with stearic acid (SA), EPA or DHA by reacting with their correspondent acyl 
chlorides as described in Chapter 2. The composition of the crude products containing a 
mixtme of EGCG polyesters was determined by HPLC-MS and the predominant 
individual esters were isolated by flash column chromatography. The predominant ester 
products of EGCG with SA, EPA and DHA (referred to as compounds 1, 2 and 3, 
respectively), whose structmes were identified by HPLC-MS, 1H NMR and 13C NMR, 
were analyzed for their antioxidant potential in different food model systems. 
Antioxidant activity in bulk oil. Antioxidant activity of EGCG derivatives in bulk oil 
was measured as protection against lipid oxidation in a stripped com oil model system by 
4-3 
a well-established Rancimat method. EGCG or its derivatives dissolved in ethanol (1 
j.lmol/ml, 1 ml) was transferred into a reaction vessel, followed by evaporation of the 
solvent to dryness under a stream of nitrogen. To each vessel (an empty vessel was used 
as control) 3 g of stripped com oil (devoid of endogenous antioxidants) were added. The 
evaluation was carried out under accelerated oxidation in a Rancimat apparatus (Metrohm 
Model 7 4 3, Herisau, Switzerland) at 1 00°C with an air flow rate of 20 1/h. Lipid oxidation 
in the absence and presence of test compounds was monitored by changes in electrical 
conductivity, arising from the formation of volatile oxidation products. The induction 
periods (IP, time to reach a sudden increase in oxidation rate) were recorded. The longer 
the IP, the greater the oxidative stability of the oil and hence the higher was the 
antioxidant potential of the compounds involved. Antioxidant activity was interpreted as 
protection factor (PF), which was calculated as follow. 
PF = IP samp1JIP control 
where, IP sample and IP control represent induction periods for the oil with and without test 
compounds, respectively. 
Antioxidant activity in oil-in-water emulsion. Antioxidant activity of EGCG 
derivatives in an oil-in-water emulsion was determined by a modification of the ~­
carotene bleaching assay (Amarowicz and Shahidi 1995). The ability of test compounds 
to decrease oxidative loss of ~-carotene in a P-carotene/linoleic acid emulsion was 
evaluated as described below. P-Carotene (1 0 mg) was dissolved in chloroform (1 0 ml) 
and an aliquot (1.2 ml) of this solution was transferred into a round-bottom flask 
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containing linoleic acid ( 40 mg) and Tween 40 ( 400 mg). A blank without P-carotene was 
also prepared ( 40 mg of linoleic acid + 400 mg of Tween 40). After removal of 
chloroform under a nitrogen stream, 1 00 ml of oxygenated distilled water were added to 
the flask and the mixture was stirred vigorously. Aliquots ( 4.5 rnl) of the above emulsion 
were transferred into a series of tubes containing 0.5 ml of test compounds (1 mM in 
ethanol) or ethanol as control. A mixture of blank (without P-carotene) was prepared for 
each sample. The tubes were vortexed and the zero time absorbance was read 
immediately at 470 nm. The tubes are kept in a water bath at 50°C with gentle shaking, 
and measurement of absorbance was continued over a 105 -min period at intervals of 15 
min. Blank-corrected absorbance was obtained and plotted against time for kinetic curve 
of P-carotene bleaching. Antioxidant activity of test compounds in protecting P-
carotene/linoleic acid oxidation was calculated using the following equation. 
AA% = [1- (Ao-At)I(Ao0 -At0)] x 100 
where, Ao and At are corrected absorbance values for test samples measured at zero time 
and after incubation, respectively; while A0° and At0 are corrected absorbance values for 
control at zero time and after incubation, respectively. 
Antioxidant activity in muscle food. A pork model system was employed for assessing 
antioxidant effectiveness of EGCG derivatives. The meat model systems were prepared as 
described by Shahidi and Alexander (1998). Fresh ground pork (40g) was mixed with 
deionized water (1 0 g) in a Mason jar. Samples and reference antioxidant compound 
(BHA) dissolved in ethanol were added to meat at a level of 80 Jlmollkg (14, 37, 122, 128, 
and 136 ppm for BHA, EGCG, compounds 1, 2, and 3, respectively). A control without 
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any antioxidant was also prepared. The content was thoroughly mixed and cooked at 80°C 
in a thermostated water bath for 40 min with intermittent stirring. The cooked meat was 
cooled to room temperature and homogenized with a Polytron PT 3000 (Brinkmann 
Instruments, Rexdale, ON) homogenizer. The homogenate was then transferred into 
plastic bags and stored at 4 °C for 14 days. The meat samples were taken on day 0, 3, 5, 7, 
and 14 for measurement of oxidation in terms of TBARS (thiobarbituric acid reactive 
substances) formation. 
TBARS values were determined as described by Shahidi and Hong (1991). A series of 
TMP (1,1,3,3-tetramethoxypropane) standard solution at difference concentrations was 
mixed with thiobarbituric acid (TBA) in screw-capped tubes and heated in a boiling water 
bath for 45 min. After cooling on ice, the absorbance was recorded at 532 nm and a 
standard curve was constructed (absorbance versus concentration). For TABRS in the 
cooked meat model system, 2 g of meat were mixed with 5 ml of trichloroacetic acid 
(TCA, 10% w/v) in a centrifuge tube, followed by addition of 5 ml of TBA reagent. The 
mixture was centrifuged at 3000xg for 10 min and the supernatant was filtered. The 
filtrate was heated in a boiling water bath for 45 min and absorbance was measured at 532 
nm after cooling to room temperature. TBARS values in meat samples were obtained 
using the standard curve as !J.mol malonaldehyde equivalents/kg of meat. Antioxidant 
activity was calculated as percentage inhibition ofTBARS formation by test compounds. 
Statistical Analysis. One-way analysis of variance (ANOV A) with pairwise comparisons 
(Tukey's HSD) was performed at a P < 0.05 level using Sigmastat for Windows version 
2.0 (Jandel Corp., San Rafael, CA) to determine the significant differences. 
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Results and discussion 
Antioxidant activity in bulk oil. It is well known that the effectiveness of antioxidants is 
influenced by a number of factors, including their structural features, concentration, 
temperature, type of oxidation substrate and physical state of the system as well as 
presence of pro-oxidants and synergists (Yanishlieva-Maslarova 2001). The chemical 
structure of an antioxidant determines its reactivity towards free radicals and other 
reactive oxygen species (ROS) and hence its antioxidant activity. Antioxidant activity is 
also affected by the system environment. For example, the activity of antioxidants in bulk 
oils is different from that in oil-water emulsions (Porter 1993). In order to investigate the 
effect of structure modification on the antioxidant activity of EGCG, the lipophilized 
derivatives were evaluated for their antioxidant efficacy in different food model systems, 
namely a bulk oil, an emulsion and a muscle food model system. 
A stripped com oil devoid of endogenous antioxidants was employed for assessmg 
antioxidant efficiency of EGCG derivatives in bulk oil. The oil was heated and aerated as 
experienced during deep fat frying and lipid oxidation was accelerated with increased 
content of polar compounds, foaming, color and viscosity (Perkins 1992). Volatile flavor 
and odor components such as organic acids were formed and detected in the Rancimat 
method as an indicator of oxidation. The calculated PF of EGCG and its derivatives as 
affected by their molar concentrations (converted from ppm) is shown in Figure 4-1. 
EGCG showed a dose-dependent antioxidant activity in the oil (0.3-0.9 Jlmollg of oil) 
while antioxidant efficiency of its ester derivatives decreased with increasing 
concentration (0.2-0.4 J.lmol/g of oil). Compound 1 had the highest antioxidant activity 
among all derivatives tested, although the activity was higher at lower concentrations. 
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Figure 4-1. PF (protection factor) ofEGCG and its derivatives in stripped com oil at 
different concentrations (compounds 1, 2 and 3 are EGCG tetraesters of SA, 
EPA and DHA, respectively). 
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Compounds 2 and 3 acted as antioxidants (PF> 1) at the lowest concentration, and had no 
effect on oxidative stability of the oil (PF=1) when the concentration increased, while 
exerted a slightly pro-oxidative effect at the highest concentration (PF<1). The results 
suggest that these derivatives achieve their maximum efficacy in oil at relatively low 
concentrations compared to that of EGCG, and that higher dose leads to loss of 
antioxidant power or even prooxidative action. EGCG appears to require higher 
concentrations for exhibiting greater antioxidant efficacy, possibly due to its poor 
solubility in the oil. However, a high PF of 6.37 was observed for EGCG at a 
concentration of 0.87 ~-tmollg of oil, which may be explained by the interfacial 
phenomenon of hydrophilic antioxidants in bulk oil. The partially soluble hydrophilic 
antioxidants tend to be oriented in the air-oil interface where surface oxidation occurs, 
and therefore protects the system from oxidative changes (Frankel et al. 1994). The 
interfacial phenomenon also lends support to the antioxidant "polar paradox" that in food 
systems of low surface-to-volume ratio (e.g. bulk oils) polar antioxidants with high 
hydrophilic-lipophilic balance (HLB) are more effective than nonpolar lipophilic 
antioxidants (Porter 1993; Frankel et al. 1994 ). However, the hydrophilic antioxidant 
EGCG and its lipophilic derivatives at the same molar concentration (0.33 ~-tmol/g of oil) 
showed a different trend in their antioxidant activity in the stripped corn oil. Compound 1 
was more effective than EGCG in inhibiting oxidation. It is hypothesized that at this 
concentration the effect of solubility on antioxidant efficiency dominates over the effect 
of interfacial phenomenon and hence compound 1 with higher lipophilicity exerted 
greater antioxidant efficiency than EGCG. It is possible that the polar paradox theory only 
applies when the antioxidant under investigation reaches a critical concentration so that 
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interfacial phenomenon dominates over the solubility issue. More research is needed for 
confirmation of this hypothesis. With respect to compounds 2 and 3, which had slightly 
pro-oxidative activity, the long-chain PUF A side chains in the molecules might have 
compromised their oxidation inhibitory effect at this concentration by contributing to 
formation of lipid oxidation products, because they are highly susceptible to oxidation. 
In summary, the lipophilic EGCG ester derivatives with better fat-solubility showed 
antioxidant activity comparable to the parent EGCG molecule and may serve as potential 
candidates for possible application in bulk oil systems. Although EGCG at higher 
concentrations protected the oil from oxidation, better than its derivatives, the poor 
solubility remains a bottleneck since it would exist as a suspension in the oil and the 
appearance of oil products is one of the important parameters for quality judgment. 
Concentration of EGCG-PUF A esters added to oil should be closely monitored, since 
they may have compromised efficacy as antioxidants or may even exert a pro-oxidant 
activity at higher concentrations. 
Antioxidant activity in oil-in-water emulsion. Antioxidants are found to behave in 
different manners when used in different media. Hence, their efficacy in bulk oil may not 
necessarily reflect that in oil/water emulsions. Moreover, it has been recognized that high 
surface-to-volume ratio emulsions are the natural conditions, while low surface-to-
volume bulk lipid is more like an artifact that is less common in foods and biological 
systems. Therefore, it is important to also include information on effectiveness of an 
antioxidant in oil/water emulsions for a more comprehensive assessment of antioxidant 
activity. In this work, the antioxidant activity of EGCG and its lipophilic derivatives in 
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oil-in-water emulsion was determined using a ~-carotene/linoleic acid emulsion model 
system. Their antioxidant activity was detected by monitoring the bleaching of ~-carotene 
as affected by test compounds. The decoloration of the pigment ~-carotene is a free 
radical-mediated phenomenon resulting from oxidation of linoleic acid in the emulsion, 
which gives rise to formation of free radicals and hydroperoxides. The presence of 
antioxidants can minimize the loss of ~-carotene during the coupled oxidation of linoleic 
acid and ~-carotene in the emulsified aqueous system. 
The results indicate that EGCG and its derivatives inhibited bleaching of ~-carotene by 
7.90 - 32.1% over the 105 min incubation period (Table 4-1). Lower rates of absorbance 
decay were observed for emulsions containing test compounds compared to the control, 
as shown in Figure 4-2. When comparing the antioxidant activity of EGCG and its 
derivatives, compound 1 was the most effective in retaining ~-carotene in the first 45 min, 
followed by compound 3 and compound 2, while EGCG had the lowest effectiveness. 
The antioxidant activity oftest compounds was well correlated with their hydrophobicity, 
which is in the order of compound 1 > 3 ~ 2 > EGCG (measured as octanol-water 
partition coefficient). Similar correlation was found for naturally occurring tea catechins, 
which demonstrated antioxidant activity in a ~-carotene/linoleic acid model system 
following the order of ECG > EGCG ~ EC > EGC, reflecting the retention times of these 
catechins in reverse-phase HPLC (Amarowicz and Shahidi 1995). These findings lend 
further support to the antioxidant "polar paradox" theory, which also states that nonpolar 
antioxidants are more effective than polar ones in emulsions, indicating an opposite trend 
from that in bulk oil. In the oil-in-water emulsion systems, hydrophilic antioxidants such 
as EGCG tend to move to the water phase and hence providing less protection to the oil. 
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Table 4-1. Inhibitory effect of EGCG and its derivatives against P-carotene bleaching and 
TBARS formation in cooked pork. 
Inhibition(%) EGCG Compound 1 Compound 2 Compound 3 BHA 
{J-carotene bleaching 1 
7.90 ± 0.64 c 16.8 ± 4.19 b 28.0 ± 0.17 a 32.1 ± 4.48 a 
TBARS formation in cooked pork 2 
71.9 ± 1.56 d 86.3 ± 2.1 0 a 80.5 ± 0.80 be 78.4 ± 1.62 c 83.3 ± 2.34 ab 
Values (mean± SD of three replicates) in the same row with different letters were significantly different at 
P < 0.05. Compounds 1, 2 and 3 are EGCG tetraesters of SA, EPA and DHA, respectively 
1 inhibition (%) calculated at the end of incubation (1 05 min); 
2 inhibition(%) calculated at the end of storage (day 14). 
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Figure 4-2. P-Carotene bleaching as affected by EGCG and its derivatives (compounds 1, 
2 and 3 are EGCG tetraesters of SA, EPA and DHA, respectively). 
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The lipophilic derivatives of EGCG, in contrast, are more soluble in the oil phase, or 
oriented in the oil-water interface due to the presence of both hydrophobic aliphatic side 
chains and hydrophilic hydroxyl groups in their molecules, thus showing higher 
antioxidant activity than their hydrophilic counterpart EGCG. However, the test 
compounds demonstrated different antioxidant kinetics in the last 60 min of the assay. 
Compound 1 exhibited a lower inhibitory effect against P-carotene bleaching than 
compounds 2 and 3 after 45 min, possibly due to their depletion or the fact that compound 
1 plays a better protective role in the early as compared to the later stages of oxidation. 
All derivatives possessed a superior antioxidant effectiveness than their parent EGCG 
molecule at all time intervals (0-1 05 min), thus suggesting their greater potential as 
antioxidants in emulsion systems of most foods, cosmetics and biological environments. 
Antioxidant activity in muscle food. Lipids are not only important components of bulk 
oils such as cooking oil and emulsions such as salad dressings and margarines, they are 
also incorporated into processed whole tissue foods such as in many fast foods and are 
responsible to a large extent for their quality deterioration. The lipids in processed whole 
tissue foods are characterized by a high surface-to-volume ratio and are usually 
considered a very polar medium (Porter 1993). These foods generally require larger 
amount and different types of antioxidants due to their predisposition to oxidation during 
precooking and long storage time under high surface-to-volume conditions (Porter 1993). 
Cooked ground muscle foods provide an excellent model for assessing effectiveness of 
antioxidants in thermally processed whole or modified tissue foods, where heating causes 
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rapid oxidation of lipid and meat flavor deterioration as well as development of "warmed-
over flavor" (Rubin and Shahidi 1988). 
Antioxidant activity of EGCG and other tea catechins has been evaluated in muscle food 
model systems. EGCG inhibited lipid oxidation in cooked fish (mackerel) meat with a 
higher efficacy than that of the other catechins and TBHQ (tert-butylhydroquinone), a 
commonly used synthetic antioxidant (He and Shahidi 1997). In a cooked pork model 
system, EGCG showed antioxidant activity higher than other catechins and typical food 
antioxidants BHT (butylated hydroxytoluene) and a-tocopherol (Shahidi and Alexander 
1998). 
In this work, the antioxidant activity of EGCG and its derivatives was determined in a 
cooked pork model system by monitoring the formation of secondary oxidation products 
as represented by TBARS values and as affected by test compounds and a reference 
antioxidant BHA (butylated hydroxyanisole). During cold storage (4°C), all meat samples 
showed increasing concentrations of TBARS with time as a result of lipid oxidation 
(Figure 4-3). The groups with added EGCG and its derivatives had significantly lower 
TBARS values than the control over the entire storage period. The antioxidants added to 
fresh meat exerted inhibitory effects against oxidation during cooking of the meat prior to 
storage, which explains the higher TBARS value in control at day 0. From day 0-5, test 
compounds did not differ significantly in their antioxidant activity. However, varied 
antioxidant potencies were observed for EGCG and its derivatives during day 5-14. The 
inhibition of TBARS formation by test compounds and BHA in cooked meat after a 14-
day storage period is given in Table 4-1. Compound 1 was most effective in inhibiting the 
production of TBARS followed by compounds 2 and 3, while all lipophilic derivatives 
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Figure 4-3 . TBARS in cooked pork as affected by EGCG and its derivatives. 
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exhibited greater antioxidant efficacy than their parent EGCG molecule. This trend is in 
accordance with that obtained from P-carotene bleaching assay (first 45 min), which 
correlated well with the lipophilicity of the compounds. Lipophilicty of antioxidants 
appeared to be positively associated with their activity in cooked muscle food, as in oil-
in-water emulsions. Two of the derivatives (compounds 1 and 2) possessed antioxidant 
activity comparable to that of BHA, a commonly used antioxidant in foods. The results 
suggest that lipophilic EGCG derivatives with enhanced antioxidant activity may serve as 
potential antioxidants in cooked muscle foods for better oxidative stability and longer 
shelf life of the products. 
Conclusions 
The lipophilic ester derivatives of EGCG exhibited great antioxidant potential in 
inhibiting lipid oxidation in bulk oil, emulsion and muscle food model systems. The 
antioxidant activity of EGCG derivatives was similar or superior to that of the parent 
EGCG molecule, suggesting their potential for possible use in food formulations. 
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CHAPTERS 
Lipophilized epigallocatechin gallate (EGCG) derivatives and their antioxidant 
potential in biological systems 
Introduction 
Oxidative changes m biological systems mediated by reactive oxygen species (ROS) 
render a destructive cellular effect in vivo and has been implicated in the pathogenesis of 
numerous chronic diseases and health conditions. Lipids in living organisms undergo 
oxidation reaction during normal aerobic metabolism (Beckman and Ames 1998). 
Approximately 2-5% oxygen consumed by a cell is converted to oxygen radicals, the 
important intermediates in oxidation chain reaction (Floyd and Hensley 2002). 
Polyunsaturated fatty acids (PUF A) in triacylglycerols (as well as mono- and 
diacyglycerols) and membrane phospholipids are generally the major reactants affected 
by such reactions. However, the substrates may be extended, in principle, to all cellular 
and extracellular components, including cholesterol, proteins, enzymes, lipoproteins and 
DNA, causing damage to cells and tissues. Antioxidant defense systems by endogenous 
and exogenous antioxidant substances provide protection against oxidative damage in 
vivo. Antioxidant strategy has been employed in preventing/treating oxidative stress-
associated diseases, including cardiovascular disease, cancers, hypertension, diabetes, 
inflammation, and other autoimmune disorders. 
Epigallocatechin gallate (EGCG), the most predominant polyphenol in tea, has been 
shown to possess antioxidant activity, among other bioactivities, and has been proposed 
as a potential health-promoting agent. Inhibitory effects of EGCG against LDL-
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cholesterol oxidation, DNA sc1sswn and liposome oxidation have been reported by 
various in vitro and in vivo studies (Huang and Frankel 1997; Ishikawa et al. 1997; Hu 
and Kitts 2001). However, its antioxidant effectiveness in vitro may not necessarily 
correlate with that in vivo, due to its low bioavailability. EGCG is hydrophilic with poor 
solubility in lipid, which, at least partially, accounts for its low cellular absorption in vivo. 
It is advantageous to increase the lipophilicity of EGCG for improved cellular uptake and 
affinity to lipid particles and membrane and other oxidation-susceptible sites. For this 
purpose, the water-soluble EGCG was structurally modified by esterification with long-
chain saturated or polyunsaturated fatty acids, and three ester derivatives (compounds 1-3, 
Figure 2-2) with enhanced lipophilicity were produced (Chapter 2). These partially 
substituted EGCG esters with retained/improved/novel bioactivities may serve as 
potential lipophilic alternatives to EGCG for diverse areas of application and in different 
media. The antioxidant activities of the lipophilic EGCG derivatives in different chemical 
assays and food model systems as well as their antiviral activities were previously studied, 
and found to be similar or superior to that of the original EGCG (Chapters 3 and 4). Their 
affinity to lipid membranes and effectiveness as antioxidants to protect against oxidation 
in biological systems are presented in this chapter. 
Materials and methods 
Materials. EGCG was supplied by Dr. Yu Shao of GlaxoSmithKline Consumer 
Healthcare (Parsippany, NJ, USA). Stearoyl chloride were purchased from Nu-chek Prep 
Inc. (Elysian, MN, USA). Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) 
were prepared as described in Chapter 2 from oils provided by Fuso Pharmaceutical 
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Industries, Ltd. (Osaka, Japan) and Martek Bioscience Corporation (Columbia, MD, 
USA), respectively. Egg yolk phosphatidylcholine (PC), human LDL and supercoiled 
plasmid pBR322 DNA were purchased from Sigma-Aldrich Canada Ltd. (Oakville, ON), 
and SYBR safe gel stain from Invitrogen Corporation (Carlsbad, CA, USA). Other 
chemicals were purchased from Sigma-Aldrich Canada Ltd. All solvents used were 
obtained from Fisher Scientific Ltd. (Ottawa, ON). The solvents employed were of 
reagent or HPLC grade. 
Preparation of lipophilic EGCG derivatives. Ester derivatives of EGCG were prepared 
as described in Chapter 2. Briefly, EGCG was allowed to react with acyl chlorides of 
stearic acid (SA), EPA and DHA. The crude product containing a mixture of EGCG 
polyesters (at different degrees of substitution) was then fractionated by flash column 
chromatography. The predominant fraction was identified by HPLC-MS, 1H NMR and 
13C NMR and subjected to subsequent antioxidant analysis in selected biological systems. 
Incorporation into liposomes. The incorporation of EGCG and its derivatives into 
liposomes through lipid bilayers was measured in order to estimate their affinities for cell 
membranes and cellular uptake. The experiment was carried out using 
phosphotidylcholine (PC) liposome multilamellar vesicles (ML V) as model membranes, 
according to Hashimoto et al. (1999) with modifications. PC (25 mg) was dissolved in a 
small amount of chloroform in a round bottom flask, followed by evaporation of the 
solvent using a rotary evaporator to obtain a thin layer film on the inner surface of the 
flask. Traces of solvent were removed by nitrogen flush. An aqueous glucose solution 
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(300mM, 5 ml) was added to the flask, and the content was thoroughly vmiexed and 
sonicated in an ultrosonicator, followed by four freeze-thaw cycles. The liposomal 
solution was diluted with 45 ml of phosphate buffer saline (PBS, 50mM, pH7.4) and 
transferred into a centrifuge tube. The content was centrifuged at 13000 g for 5 min to 
remove the untrapped glucose. The sediment was re-suspended in 25 ml of PBS to obtain 
a final liposomal MLV. An aliquot (0.9 ml) of the above MLV was transferred to an 
Eppendorf tube containing 0.1 ml of test compounds (500 ~-tM in ethanol) or ethanol blank. 
The content was mixed by vortexing and incubated for 20 min at 37°C. After incubation 
the mixture was centrifuged at 13000 g for 5 min, and the sediment was washed with 1 ml 
of 10% ethanol (in PBS), followed by a second centrifugation. The supernatants were 
combined and their absorbance read at 280 nrn. A series of standard solutions in 10% 
ethanol at different concentrations was prepared for each test compound and their 
absorbance measured at 280 nrn to construct a standard curve (absorbance vs. 
concentration). The un-incorporated test compounds in the supernatant were quantified 
using their corresponding standard curves. Percentage incorporation of each compound 
into the liposomes was calculated according to the following equation: 
% incorporation = 
100 x (1 -amount un-incorporated I amount added)= 100 x (1- C x 2 I 50) 
where, C is the concentration of test compounds read from the standard curve. 
Inhibition against copper-induced LDL-cholesterol oxidation. The inhibitory activity 
of EGCG and its derivatives against copper-induced LDL-cholesterol oxidation was 
determined as described by Lebeau et a!. 2000. Human LDL solution was dialyzed 
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overnight in PBS (lOmM, 0.15M NaCl, pH 7.4) at 4°C under a nitrogen blanket prior to 
the test. Sample solutions were prepared by dissolving the test compounds in ethanol (500 
f.!M). Aliquots (1 0 f.!l) of sample solutions were transferred into a set of Eppendorf tubes, 
and the solvent was evaporated to dryness under a stream of nitrogen. To each tube 0.1 ml 
of PBS was added, followed by vortexing for 1 min. An aliquot (0.8 ml) of the dialyzed 
and diluted LDL solution (0.125mg/ml) was added to each tube, and the contents were 
mixed well and incubated at 37°C for 15 min. The reaction was initiated by the addition 
of 0.1 ml of CuS04 (20f.!M, previously incubated at 37°C). A blank containing only 
sample without LDL or CuS04 was prepared for each test compound. After incubation of 
the reaction mixture at 37°C for 22 hours, the conjugated dienes formed as a result of 
oxidation were measured spectrophotometrically at 234 run. Antioxidant activities of test 
compounds were expressed as percentage inhibition of conjugated diene formation, which 
was calculated as follows: 
% inhibition = 100 X (Abs.control- AbS.sample) I (Abs.control- Abs.native LDL) 
where, control had LDL and CuS04 without antioxidants, and native LDL contained LDL 
only. All absorbances for samples were blank-corrected. 
Inhibition against DNA scission. Antioxidant activity of EGCG and its derivatives 
against DNA scission was determined as described by Hiramoto et al. (1996) with some 
modifications. DNA strand breaking was induced by hydroxyl and peroxyl radicals and 
monitored by gel-electrophoresis. For hydroxyl radical-induced DNA oxidation, 2 fll of 
test compounds dissolved in ethanol were added into an Eppendorf tube and the solvent 
was evaporated under a stream of nitrogen. To the tube 2 fll of distilled water were added, 
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followed by thorough vortexing for 1 min. The following reagents were then added to the 
tube in the order stated: 2 I-ll of PBS (pH? .4), 2 I-ll of supercoiled pBR322 DNA, 2 I-ll of 
H202 and 2 j.ll of Fe2S04• The mixture (1 0 1-!1) containing 1 1-!M test compounds, 0.1 M 
PBS, 10 j.lg/ml DNA, 0.2 mM H20 2 and 0.1 mM Fe2S04 (final concentration/assay) was 
incubated at 37°C for 1 hour. For peroxyl radical-induced DNA oxidation, a higher 
concentration of samples were used, and H20 2 and Fe2S04 were replaced with 4 j.ll of 
AAPH (2,2'-azobis (2-aminopropane) dihydrochloride]. The reaction mixture contained 
10 1-!M test compounds, 0.1 M PBS, 10 j.lg/ml DNA and 9 mM AAPH. A blank (DNA 
only) and a control (DNA + free radicals) were also prepared for both assays. 
After incubation, l I-ll of loading dye (0.25% bromophenol blue/0.25% xylene cyanol/50% 
glycerol) was added, and the whole mixture was loaded onto an agarose gel. The agarose 
gel was prepared by dissolving 0.7% (w/v) agarose in Tris-acetic acid-EDTA 
( ethylenediaminetetraacetic acid) buffer (T AE, pH 8.5) and stained with SYBR safe gel 
stain. Gel electrophoresis was performed at 80V for 90 min in T AE buffer using a 
horizontal submarine gel electrophoresis apparatus. The bands were visualized under UV 
light and the images were photographed by a GelDoc apparatus equipped with a Sony 
digital camera. The images were analyzed using AlphaEase stand-alone software (Alpha 
Innotech Co., San Leandro, CA, USA) and the intensity or density of the bands (obtained 
from densitometer) was used as an indicator of the concentration of the native 
(supercoiled) and nicked DNA fractions. Antioxidant activity was calculated as DNA 
retention according to the following equation: 
%retention= 100 X (native DNAsample I native DNAblank) 
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where, DNAsample and DNAblank are n01malized concentrations of native supercoiled DNA 
in total DNA for sample groups and blank, respectively. 
Inhibition against UV-induced liposome oxidation. Antioxidant activity of EGCG and 
its derivatives in inhibiting UV -induced liposome oxidation was measured. To prepare 
liposome ML V, 10 mg of egg yolk PC were dissolved in a small amount of chloroform in 
a round bottom flask and the solvent was removed using a rotary evaporator followed by 
nitrogen flush. The thin film on the inner surface of the flask was suspended in 10 ml of 
PBS (lOmM, pH7.4, 150mM NaCl) by vOiiexing and sonication, and the emulsion was 
then frozen and thawed four times. The liposomal ML V obtained were diluted with 90 ml 
of PBS, and an aliquot (750 !ll) was transferred into an Eppendorf tube containing 10 Ill 
of the test compounds dissolved in ethanol and 240 Ill of PBS. The content was mixed 
well and incubated at 3 7°C for 15 min. After incubation, the mixture was exposed to UV 
irradiation (254 nm) for 45 min. The oxidation was detected by measuring conjugated 
dienes (CD) spectrophotometically at 234 nm against a blank without liposome (test 
compounds + PBS). Conjugated diene values were calculated as follows using blank-
corrected absorbances: 
CD (mol/g of PC)= Abs./cLC , 
where E is the absorptivity constant (29500 M-'cm-1), Lis the length of the cuvette (1 em) 
and C is the final concentration of PC (g/L). Antioxidant activity was then obtained as 
percentage inhibition of conjugated diene formation according to the following equation. 
% inhibition = 100 X (CD control- CD sample) I CD control 
where control had only liposome and PBS without test compounds. 
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Statistical Analysis. One-way analysis of variance (ANOVA) with pairwise comparisons 
(Tukey's HSD) was performed at a P < 0.05 level using Sigmastat for Windows version 
2.0 (Jande! Corp., San Rafael, CA) to determine the significant differences. 
Results and discussion 
Incorporation into liposomes lipid bilayers. The biological activities of tea catechins 
and other plant polyphenols have been examined by various in vitro assays for prediction 
of their ability to prevent diseases and promote health. However, their activities found in 
in vitro experiments may not necessarily reflect their protective effectiveness in living 
organisms, mostly due to their low cellular absorption. The structure- activity 
relationships have revealed that the dose-dependency of polyphenol bioactives in vivo is 
largely governed by the amount incorporated into the cells. Since no transporter specific 
to plant polyphenols has been found in mammalian cells, it is supposed that most 
polyphenols are incorporated into the cells by passive transport and the amount 
incorporated is related to their affinity for the cell membranes (Nakayama et al. 2006). 
In this study, the cell membrane affinity and cellular uptake of EGCG and its ester 
derivatives were estimated using liposome ML V as model membranes. Separation of 
liposomes by centrifugation was facilitated by trapping a dense solution of glucose, as 
proposed by Hashimoto et al. (1999). The amount of test compounds incorporated into 
the core and/or lipid bilayers of the liposomes was quantified by subtracting the amount 
un-incorporated from the total amount added. The rates of incorporation into the liposome 
MLV ranged from 65 .2 to 91.2% for EGCG and its derivatives (Table 5-1). The highest 
incorporation was found for compound 1 (91.2%), followed by compound 3 (80.9%) and 
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Table 5-l. Incorporation(%) ofEGCG and its derivatives into liposomes. 
EGCG Compound 1 Compound 2 Compound 3 
% incorporation 65.2 ± 0.41 91.2 ± 1.89 a 71.8 ± 0.33 c 80.9 ± 1.43 
Values (mean± SD of three replicates) with different letters were significantly different at P < 0.05. 
Compounds 1, 2 and 3 are EGCG tetraesters of SA, EPA and DHA, respectively. 
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2 (71.8%); while EGCG (65.2%) showed the poorest liposome incorporation. The trend 
for incorporation of test compounds was well correlated with that of their lipophilicity, 
which was in the order of compound 1 > 3 2: 2 > EGCG (measured as octanol-water 
partition coefficient, data shown in Chapter 2). 
Studies on interaction of tea catechins with liposome have revealed that the affinity of 
catechins for lipid membrane bilayers was governed by their lipophilicity and 
stereochemical structure (Hashimoto et al. 1999; Kajiya et al. 2002). The authors 
demonstrated that the amount of tea catechins incorporated into liposome lipid bilayers 
followed the same order of their partition coeffecients in an octanol-PBS system, i.e. 
epicatechin gallate (ECG) with the highest lipophilicity had the highest incorporation rate 
among all. It was also suggested that conformational features affect the membrane 
affinity of catechins (e.g. EGCG > gallocatechin gallate). The ester derivatives of EGCG 
with enhanced lipophilicity in this study exhibited significantly (P < 0.05) improved 
affinity to membrane phospholipids compared with EGCG. However, the effect of steric 
changes caused by acylation on membrane affinity remains to be unraveled. The results 
suggest that the lipophilic derivatives of EGCG with greater cell membrane incorporation 
may have better cellular absorption in vivo than the parent EGCG, leading to improved 
bioavailability and bioefficiency when ingested orally. Moreover, the liposome-water 
partition coefficient is an important parameter for evaluation of drug delivery in 
pharmaceuticals. Lipophilic EGCG derivatives may be superior to EGCG in terms of 
compatibility in the liposome drug delivery systems. Further research investigating the 
specific incorporation location of these derivatives in the liposome ML V and their 
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interaction with the lipid bilayers may help shed light on the absorption and antioxidant 
mechanisms of action of EGCG derivatives at cellular levels. 
Inhibition against LDL-cholesterol oxidation. Catechins from tea have been shown to 
render cardioprotective effects, mostly through their interaction with LDL-cholesterol, 
including reducing LDL uptake by macrophages, inhibiting LDL oxidation, and 
decreasing the susceptibility of LDL to aggregation (Scalbert et al. 2005). A large body of 
literature has shown that EGCG and other tea catechins can inhibit oxidative modification 
of LDL-cholesterol (Yamanaka et al. 1997; Ishikawa et al. 1997; Nakagawa et al. 1999; 
Trevisanato and Kim 2000; Gomikawa and Ishikawa 2002), which plays a key role in the 
pathogenesis of atherosclerosis and heart disease (Sajilata et al. 2008). The mechanisms 
proposed for catechins and other polyphenol antioxidants to inhibit LDL oxidation 
include scavenging free radicals and other ROS, chelating prooxidant metals, and binding 
with the ape-lipoprotein B, which promotes the access of antioxidant to the lipids and 
prevents approaching of oxidation catalysts (Satue-Gracia et al. 1997). 
In this study, the antioxidant activity of EGCG and its derivatives in inhibiting Cu2+-
induced LDL-cholesterol oxidation was evaluated and the results are given in Table 5-2. 
After 22 hours incubation LDL was oxidized to varying extents depending on the 
presence and the type of antioxidants employed. Both EGCG and its derivatives were able 
to inhibit LDL oxidation, possibly through chelation of copper ions and scavenging free 
radicals generated. Among them, compounds 1 and 2 were significantly more effective 
than the parent EGCG molecule in inhibiting the formation of conjugated dienes. 
Compound 3 had a slightly higher effect than EGCG although statistically insignificant 
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Table 5-2. Inhibition (%) of EGCG and its derivatives against copper-induced LDL-
cholesterol oxidation. 
EGCG Compound 1 Compound 2 Compound 3 
%inhibition 6.53 ± 0.92 c 16.33 ± 1.07 a 11.80 ± 2.26 a 8.18 ± 2.90 c 
Values (mean ± SD of three replicates) with different letters were significantly different at P < 0.05. 
Compounds 1, 2 and 3 are EGCG tetraesters of SA, EPA and DHA, respectively. 
5-12 
(P>0.05). The improved inhibitory activity of the derivatives against LDL oxidation may 
be due to their greater lipophilicity, hence greater affinity to the phospholipids which are 
the major components of the surface region of LDL. Moreover, introduction of 
hydrophobic fatty acid side chains into the water soluble EGCG may improve its 
amphiphilic nature, thus allowing the derivatives to exert their antioxidant activities 
within the LDL particle and/or on the surface or extraparticle environment of LDL. In 
addition to lipophilicity, the steric features could influence the interaction between the 
antioxidants and LDL particles, which may be responsible for the lower efficacy of 
compound 3. It is also possible that the highly unsaturated EPA and DHA side chains in 
compounds 2 and 3, respectively, contributed to conjugated dienes formation, slightly 
counteracting its inhibition against oxidation as compared to compound 1 with saturated 
side chains. The overall results suggest that the lipophilic derivatives of EGCG were 
superior or similar to their parent EGCG in inhibiting LDL-cholesterol oxidation and may 
be used as potential anti-atherogenic agents in cardiovascular diseases risk reduction. 
Inhibition against DNA scission. Oxidative stress in cells caused by ROS such as 
hydroxyl and peroxyl radicals also leads to DNA damage, which is implicated m 
mutagenesis and carcinogenesis, among other pathological processes. Oxidative damage 
to the DNA may occur at both the phosphate backbone and the nucleotide bases, resulting 
in a wide variety of modifications, including strand scission, sister chromatid exchange, 
DNA-DNA and DNA-protein cross-links as well as base modification (Davies 1995). 
Hydroxyl radical, generated under physiological conditions from hydrogen peroxide 
(product of superoxide anion dismutation) in the presence of transition metals (known as 
5-13 
Fenton reaction), is considered a major source of biologically relevant ROS responsible 
for oxidative damage of DNA, especially mitochondrial DNA (Perron et al. 2008). 
Peroxyl radicals have also been shown to be involved in inducing DNA strand breakage 
and base modification (Rodriguez et al. 1999). A number of polyphenols have been 
studied for their effects on DNA oxidation, and both antioxidant and prooxidant activities 
have been reported. EGCG, for example, has shown both inhibiting and stimulating 
effects on DNA scission (Hiramoto et al. 1996). The dual action of EGCG (inhibitor or 
stimulator) on DNA oxidation has been found to be concentration dependent (Hiramoto et 
al. 1996; Ohashi et al. 2002), and may render either protective or harmful effects to living 
organisms. EGCG as a prooxidant may have mutagenic effects on normal cells, but may 
also be beneficial because of its cytotoxic and apoptotic effects on tumor cells (Chen et al. 
1998; Hadi et al. 2000). 
In this study, the effects of EGCG and its derivatives on hydroxyl and peroxyl radicals 
induced DNA strand scission was evaluated. As shown in Figures 5-1 and 5-2 (lane 2), 
the supercoiled plasmid DNA was converted into nicked open circular forms through 
single strand cleavage in the presence of hydroxyl and peroxyl radicals. The linear form 
was not observed, suggesting the absence of double strand breakage under the test 
conditions. Hydroxyl radical as oxidizing agent was generated from hydrogen peroxide in 
the presence of Fe2+, which was then converted into Fe3+. EGCG and its derivatives 
exhibited inhibitory effects against hydroxyl radical induced DNA scission, possibly 
through a combination of radical scavenging and ferrous ion chelation. As shown in Table 
5-3, the lowest DNA retention was observed for the control (no test compounds added), 
and presence of EGCG and its derivatives enhanced the retention of native supercoiled 
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2 3 4 5 6 
Open circular form 
Supercoiled form 
Figure 5-1. Hydroxyl radical induced DNA scission (lane 1: DNA only; lane 2: DNA + 
FeS04 + H202; lane 3: DNA+ FeS04 + H202 + EGCG; lane 4: DNA+ FeS04 
+ H20 2 +compound 1; lane 5: DNA+ FeS04 + H20 2 +compound 2; lane 6: 
DNA + FeS04 + H20 2 + compound 3;· Compounds 1, 2 and 3 are EGCG 
tetraesters of SA, EPA and DHA, respectively). 
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1 2 3 4 5 6 
Open circular form 
Supercoiled form 
Figure 5-2. Peroxyl radical induced DNA scission (lane 1: DNA only; lane 2: DNA + 
AAPH; lane 3: DNA+ AAPH + EGCG; lane 4: DNA + AAPH + compound 
1; lane 5: DNA+ AAPH +compound 2; lane 6: DNA + AAPH + compound 
3; Compounds 1, 2 and 3 are EGCG tetraesters of SA, EPA and DHA, 
respectively). 
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Table 5-3. DNA retention(%) in hydroxyl and peroxyl radical induced oxidative scission. 
DNA retention(%) Hydroxyl radical induced Peroxyl radical induced 
Control 30.15 23.53 
EGCG 35.37 ± 0.77 c 90.02 ± 0.18 a 
Compound 1 48.19 ± 0.56 b 82.84 ± 0.49 b 
Compound 2 53.37 ± 1.15 a 50.75 ± 1.02 d 
Compound 3 47.44 ± 0.91 b 56.25 ± 0.89 c 
Values (mean± SD of three replicates) in the same row with different letters were significantly different at 
P < 0.05. Compounds 1, 2 and 3 are EGCG tetraesters of SA, EPA and DHA, respectively. 
* Control contained DNA and free radicals only. 
5-17 
DNA to various extents. The ester derivatives of EGCG were more effective than EGCG 
in protecting against DNA scission, with the EPA ester (compound 2) being the most 
potent antioxidant among all. This may be due to cumulative factors of lipophilicity, 
steric features (DNA binding affinity), hydroxyl radical scavenging and metal chelation 
capacity, all of which could play a role in the overall antioxidant efficacy of the test 
compounds. The greater antioxidant efficacy of compound 2 may largely be attributed to 
its higher metal chelation capacity (results shown in Chapter 3). The reducing power of 
EGCG and its derivatives may also be involved, in a negative manner, as reported for 
many other polyphenols (Hu and Kitts 2001; Azam et al. 2004). EGCG with the highest 
reducing power among all test compounds (results shown in chapter 3) may reduce Fe3+ 
produced in the Fenton reaction to its more reactive ferrous form, thus stimulating the 
generation of hydroxyl radical and compromising its overall protection against DNA 
scission. EGCG at certain concentrations, where its stimulating effect dominates over 
scavenging effect on hydroxyl radical, have been reported to accelerate oxidative damage 
of DNA (Hiramoto et al. 1996). This may partially explain the low antioxidant efficacy of 
EGCG compared to that of its ester derivatives. 
Incubation of supercoiled DNA with peroxyl radical (generated from AAPH) also 
resulted in single strand breakage of the DNA (Figure 5-2). Addition of EGCG and its 
derivatives significantly improved the oxidative stability and retention of native DNA, 
which ranged from 50.75 to 90.02% (Table 5-3). However, the test compounds showed a 
nearly opposite trend of antioxidant efficacy to that in hydroxyl radical induced DNA 
scission. The ester derivatives were less effective in inhibiting DNA scission than their 
parent EGCG molecule. The EPA ester (compound 2), while being the most potent 
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antioxidant against hydroxyl radical induced DNA scission, was the least effective among 
all in inhibiting peroxyl radical induced DNA damage. The degree of DNA oxidation 
varied depending on the nature of the catalysts/prooxidents involved (e.g. free radical 
species, presence of metal ions), leading to different and distinct antioxidant mechanisms 
and activity of the test compounds in inhibiting DNA scission. The ester derivatives, 
although less potent than EGCG at the concentrations tested, showed excellent protection 
(50.75-82.84% DNA retention) against peroxyl radical induced DNA scission. This and 
their superior antioxidant activities against hydroxyl radical induced DNA scission 
suggest that lipophilic derivatives of EGCG may be good candidates as antimutagenic 
agents. 
Inhibition against UV -induced liposome oxidation. UV radiation, as an oxidizing agent, 
is generally considered harmful to biological organisms by initiating photooxidation and 
causing oxidative damage in cells and tissues. Repeated exposure to UV radiation may 
overwhelm the body's natural antioxidant defense mechanisms, leading to oxidative 
stress and development of related pathogenesis including carcinogenesis. The effect of 
UV radiation on multicellular organisms is localized on the skin as the outermost tissue, 
which is constantly exposed to solar UV radiation. The cutaneous damage induced has 
been linked to increased risk of numerous skin disorders, including phototoxicity, 
photoallergy, photosenescence, photoaging and photocarcinogenesis (Guercio-Hauer et al. 
1994). Antioxidants such as tea catechins topically or orally administrated are known to 
provide protection against UV -induced oxidation (Bonina et al. 1996; Cabrielska et al. 
2005). The in vitro and in vivo animal and human studies have reported that EGCG acts 
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as a photoprotective agent against UV -induced oxidative stress (Katiyar 2003; Morley et 
al. 2005). 
UV radiation can induce lipid oxidation in biological membranes, causing structural and 
functional changes that eventually lead to oxidation of cellular components of the skin 
and other cells. Hence, many studies on the effects of UV radiation and antioxidant 
protection have focused on lipid oxidation in cell membranes and related models thereof 
(liposomes). In this study, the ability of EGCG and its derivatives to inhibit UV -induced 
liposome oxidation was investigated. 
As shown in Table 5-4, all test compounds exhibited inhibitory effects against lipid 
oxidation in the liposomes, ranging from 3.47% for compound 2 to 47.6% for compound 
1. The antioxidant activities of EGCG and its derivatives may be attributed to their ability 
for scavenging free radicals (e.g. superoxide anion, hydroxyl, peroxyl radicals, etc.), 
quenching singlet oxygen and absorbing UV radiation, among others. Their antioxidant 
efficacy increased in the order of compound 2 < EGCG < 3 < 1, which did not correlate 
well with their incorporation rates into lipsomes (Table 5-l ). Compounds 1 and 3 
exhibited significantly higher antioxidant activity than EGCG, as expected, based on their 
greater liposome affinity. However, compound 2 had greater liposome incorporation than 
EGCG but lower antioxidant effectiveness. The observed variations may be caused by the 
existing differences in their interaction with the liposome lipid bilayers, i.e. their location 
and effects on membrane structure. Polyphenols are incoroporated into liposomes 
differently, depending on the lipophilicity, stereochemical structure and concentration of 
the molecules. Some polyphenols are absorbed on the membrane surface, while others 
may permeate deeper into the hydrophobic region of the lipid bilayers, as observed for 
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Table 5-4. Inhibition (%) of EGCG and its derivatives against UV -induced liposome 
oxidation. 
EGCG Compound 1 Compound 2 Compound 3 
% inhibition 9.53 ± 1.61 c 47.6 ± 0.963 3.47 ± 0.53 16.2±3.53 
Values (mean ± SD of three replicates) with different letters were significantly different at P < 0.05. 
Compounds 1, 2 and 3 are EGCG tetraesters of SA, EPA and DHA, respectively. 
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different catechins (Hashimoto et al. 1999; Kubota et al. 2007). Antioxidants at different 
locations of the liposomes may render different efficacies in inhibiting oxidation. It has 
been suggested that antioxidants absorbed on the membrane surface or those (interface 
antioxidants) located in the polar region of the bilayer near the hydrophobic-hydrophilic 
border are effective in protecting the membranes against oxidation (Gabrielska et al. 
2006). It is possible that compound 2 was distributed in a lower proportion on the 
liposome surface compared to other compounds, or it was preferentially located in the 
hydrophobic core of the lipid bilayers, hence being less effective as an antioxidant. 
Moreover, it is worth noting that some polyphenols including EGCG at higher 
concentrations may enter into the lipid bilayer and broaden or even perturb the membrane, 
leading to compromised protection or even prooxidant effect (Kajiya et al. 2002; Kubota 
et al. 2007), which may also account for lower antioxidant efficacy of compound 2. 
Further investigation is required to better understand the mechanism(s) of the interaction 
between the EGCG derivatives and membrane lipid bilayers. 
Conclusions 
Ester derivatives of EGCG with improved lipophilicity were readily incorporated into the 
model membrane (liposome ML V) and exhibited better or comparable antioxidant 
activities to that of the parent EGCG molecule in biological model systems. The 
derivatives had higher liposome incorporation than EGCG, suggesting their higher 
cellular absorption in vivo and greater potential in liposome drug delivery. LDL-
cholesterol oxidation was inhibited by EGCG derivatives to a greater extent than by 
EGCG, which indicates their greater potency as anti-atherogenic and cardioprotective 
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agents. The derivatives were also able to inhibit hydroxyl and peroxyl radical-induced 
DNA scission, and may be used as potential inhibitors for mutagenesis and 
carcinogenesis. The derivatives exhibited inhibitory effect on UV -induced oxidation of 
liposome, which supports their potential use in skin care and cosmetic products. 
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CHAPTER6 
Anti-inflammatory activity of lipophilic epigallocatechin gallate (EGCG) derivatives 
in LPS-stimulated murine macrophages 
Introduction 
Inflammation is a normal physiological response of the immune system to counteract 
pathological states such as irritation/infection caused by chemicals, microbial pathogens 
and/or wounding. However, unbalanced or prolonged inflammation leads to progressive 
tissue damage and has been implicated in the development of many chronic diseases such 
as cancer and neurodegenerative disorders as well as diabetes and cardiovascular disease. 
Inflammation is characterized by recruitment of a wide range of immune cells (e.g. 
neutrophils, macrophages and monocytes, etc.) to the inflamed sites and the release of 
various pro-inflammatory cytokines and reactive oxygen/nitrogen species (ROS/RNS). 
Oxidative stress through continuous overproduction of ROS/RNS by . activated 
phagocytes constitutes the major tissue-destructive force in vivo, and in turn promotes 
inflammation by stimulating production of inflammatory mediators and cytokines 
(Shahidi and Zhong 2009). Evidence has shown that ROS/RNS are involved in the 
activation of a variety of kinases and transcription factors, whose regulation is dependent 
on the redox changes. The transcription factors nuclear factor-kappa B (NF-KB) and 
activator protein (AP)-1, for example, are redox -sensitive and become activated under 
oxidative/nitrosative stress. Once activated, NF -KB and AP-1 translocate from the 
cytoplasm to the nucleus, leading to the up-regulation of numerous inflammatory genes, 
such as those coding for inducible nitric oxide synthase (iNOS) and cyclooxygenase 
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(COX)-2, among others (Kamata and Hirata 1999). Hence, ROS/RNS and pro-
inflammatory cytokines work in a synergistic manner through a ROS/RNS-cytokine-
transcription factor regulatory loop, thereby augmenting the inflammatory response and 
tissue damage (Fiocchi, 1998). The production of NO and prostaglandins by iN OS and 
COX-2, respectively, are considered to be the most prominent molecular mechanisms in 
the inflammatory processes (Moncada 1999; Turini and DuBois 2002), and are also 
involved in the multistage carcinogenesis, especially the promotion stage (Pan and Ho 
2008). Excessive and prolonged NO generation caused by overexpression of iNOS has 
also been implicated in inflammational tumorigenesis; while COX-2-mediated 
prostaglandin production stimulates cell proliferation, invasion and angiogenesis in 
cancer development (Mann et al. 2005). 
Anti-inflammatory agents can block the ROS/RNS and cytokine-involved inflammatory 
cascade. Compared to steroidal or non-steroidal chemical drugs for treating inflammation, 
naturally derived substances are readily available at lower costs while having limited side 
effects and intolerance. Polyphenols found abundantly in plant foods have been studied 
for their anti-inflammatory activities in suppressing tl1e synthesis (gene expression) and 
action (enzyme activity) of many pro-inflammatory mediators. Tea catechins, especially 
epigallocatechin gallate (EGCG), have been reported to exhibit anti-inflammatory activity 
through their ability to scavenge NO, peroxynitrite (ONOO-) and other ROS/RNS, to 
inhibit the translocation ofNF-KB and AP-1 from cytoplasm to nucleus, and to inhibit the 
activity of iNOS and COX-2 (Paquay et al., 2000; Nagai et al., 2002; Tedeschi et al., 
2004). EGCG is found abundantly in green tea as a major polyphenol with a variety of 
health benefits. However, the molecule is hydrophilic with poor solubility in lipid systems, 
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which, at least partially, accounts for its low absorption by the cells and limited efficacy 
in the cellular environment. Moreover, cell line studies have suggested that EGCG and 
other tea catechins are subject to active efflux by multidrug resistance-related proteins, 
leading to restricted bioefficiency in vivo (Hong et a!. 2003). In such cases, prodrug 
strategies may be employed. Ester-based prodrugs are known to provide improved 
bioavailability and reduced toxicity by occlusion of polar side chains, increasing 
hydrophobicity and making the hydroxyl groups unavailable for phase II 
biotransformation or oxidative degradation (Lambert et al. 2006). 
In this work, EGCG was structurally modified by esterification with different fatty acids 
to produce lipophilic ester derivatives with enhanced cellular absorption and bioefficiency 
in vivo. EGCG was esterified with docosapentaenoic acid (DPA) and the crude product 
(EGCG-DPA ester mixture containing mainly tetra- and pentaesters, Figure 6-1) was 
evaluated for its anti-inflammatory activities in terms of inhibition against NO and 
prostaglandin E2 (PGE2) production as well as iNOS and COX-2 gene expression in 
murine macrophages. Three isolated EGCG ester compounds (1, tetrastearate; 2, 
tetraeicosapentaenoate; 3, tetradocosahexaenoate) were also examined for their effect on 
NO production and iNOS and COX-2 expression, in order to compare the anti-
inflammatory efficacy of the esters with that of the original EGCG on a molar basis. 
Materials and methods 
Materials. EGCG was supplied by Dr. Yu Shao of GlaxoSmithKline Consumer 
Healthcare (Parsippany, NJ, USA). Stearoyl chloride was purchased from Nu-chek Prep 
Inc. (Elysian, MN, USA). Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) 
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Figure 6-1. Chemical structures ofEGCG and EGCG-DPA esters. 
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were prepared as described in Chapter 2 from oils provided by Fuso Pharmaceutical 
Industries, Ltd. (Osaka, Japan) and Martek Bioscience Corporation (Columbia, MD,USA), 
respectively. DPA was produced via a proprietary procedure from seal blubber oil. RAW 
264.7 cells, derived from murine macrophages, were purchased from the American Type 
Culture Collection (Rockville, MD, USA); cell culture medium from GIBCO (Grand 
Island, NY, USA); ACE ™ EIA kit from Cayman Chemical Co. (Ann Arbor, MI, USA); 
bicinchoninic acid assay (BCA) kit from Pierce (Rockford, IL, USA); PVDF membranes 
from Millipore Corporation (Bedford, MA, USA); iNOS and COX-2 monoclonal 
antibodies, anti-mouse and anti-rabbit IgG antibodies from BD Transduction Laboratories 
(Lexington, KY, USA); anti-P-actin monoclonal antibodies from Oncogene Science Inc. 
(Uniondale, NJ, USA); ECL western blotting detection agent from Arnersham 
Corporation (Arlington Heights, IL, USA); Trizol Reagent from Invitrogen Life 
Technologies (Carlsbad, CA, USA); and PCR Beads from Arnersham Pharmacia Biotech 
(Piscataway, NJ, USA). Other chemicals were purchased from Sigma-Aldrich Canada 
Ltd. (Oakville, ON). All solvents used were obtained from Fisher Scientific Ltd. (Ottawa, 
ON). The solvents employed were of reagent or HPLC grade. 
Preparation of EGCG ester derivatives. Ester derivatives of EGCG were prepared as 
previously described in Chapter 2. Briefly, EGCG was reacted with acyl chloride of DPA, 
stearic acid (SA), EPA or DHA. The crude product containing a mixture of EGCG-DPA 
polyesters (mainly tetra- and pentaesters) was used as such without further purification 
for subsequent anti-inflammation analyses. The SA, EPA and DHA esters were 
fractionated by flash column chromatography. The predominant fraction was identified 
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by HPLC-MS, 1H NMR and 13C NMR. These isolated pure compounds were evaluated 
on a molar basis for their effect on NO production and iNOS and COX-2 expression. 
Cell culture. RAW 264.7 cells were cultured in Roswell Park Memorial Institute (RPMI) 
1640 media (without phenol red) supplemented with 10% endotoxin-free, heat-inactivated 
fetal calf serum, 100 units/ml penicillin, and 100 ~-tg/ml streptomycin. When the cells 
reached a density of 2-3 x 106 cells/ml, they were activated by incubation in a medium 
containing E. coli LPS (1 00 ng/ml). Various concentrations of test compounds dissolved 
in dimethyl sulfoxide (DMSO) were added together with LPS. Cells were treated with 
0.05% DMSO as vehicle control. 
Nitrite assay. The LPS-induced NO production by the macrophages was determined as 
the nitrite concentration in the culture medium according to the Griess reaction (Kim et al. 
1995). The culture medium of control and treated cells was collected and centrifuged. An 
aliquot (1 00 ~-tL) of the supernatant was mixed with an equal volume of Griess reagent 
(1% sulfanilamide in 5% phosphoric acid and 0.1% naphthylethylenediamine 
dihydrochloride in water) . Absorbance of the mixture was read at 550 nm with an ELISA 
plate reader (Dynatech MR-7000, Dynatech Laboratories, Chantilly, VA, USA). 
Determination of PGE2 
The level of PGE2 released into the culture medium was quantified by a specific enzyme 
immunoassay (EIA) method using a ACE TM EIA kit according to the manufacturer's 
instructions. 
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Western Blotting. The stimulated murine macrophage cell line RAW 264.7 cells were 
washed with phosphate buffer solution (PBS) and lysed in an ice cold 
radioimmunoprecipitation assay (RIPA) buffer (Tris-HCl, pH 7.2, 25 mM; 0.1% sodium 
dodecyl sulfate (SDS); 1 mM ethylenediaminetetraacetic acid (EDT A); 1% Triton X -1 00; 
1% sodium deoxycholate; 0.15 M NaCl) containing 1 mM phenylmethyl sulfonyl fluoride 
(PMSF), 10 J..lg/mL aprotinin, 1 mM sodium orthovanadate, and 5 )..lg/mL leupeptin. 
Protein concentrations were determined using the bicinchoninic acid assay (BCA) kit. 
The samples (50 )..lg of protein) were mixed with 5-fold sample buffer containing 0.3 M 
Tris-HCl (pH 6.8), 25% 2-mercaptoethanol, 12% SDS, 25 mM EDTA, 20% glycerol, and 
0.1% bromophenol blue. The mixtures were boiled at 100 °C for 5 min, pre-run on a 
stacking gel, and then resolved by 12% SDS-polyacrylamide minigels at a constant 
current of 20 rnA. For western blot, proteins on the gel were electro-transferred onto a 45 
J..Lm immobile polyvinylidene fluoride (PVDF) membrane with a transfer buffer composed 
of25 mM Tris-HCl (pH 8.9), 192 mM glycine, and 20% methanol, as described by Pan et 
al. (2000). Membrane blocking was then carried out at room temperature for 1 h in 
blocking solution (20 mM Tris-HCl pH 7.4, 125 mM NaCl, 0.2% Tween 20, 1% bovine 
serum albumin, and 0.1% sodium azide). The membrane was incubated with the primary 
antibody of iNOS and COX-2 at 4°C overnight. The membrane was subsequently probed 
with anti-mouse or anti-rabbit IgG antibody conjugated to horseradish peroxidase and 
visualized using enhanced chemiluminescence. The densities of the bands were 
quantitated with a computer densitometer (Alphalmager 2200 System, Alpha Innotech 
Corp., San Leandro, CA, USA). All the membranes were stripped and reprobed for ~­
actin as loading control. 
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Reverse transcriptase polymerase chain reaction (RT -PCR). Total RNA was isolated 
from mouse macrophage RA W264.7 cell using Trizol Reagent according to the 
manufacturer's instructions. Changes in the steady-state concentration of mRNA in iN OS, 
COX-2, and P-actin (control) were assessed by RT-PCR. Total RNA (2 )-lg) was 
converted to eDNA in a series of standard 10 )-ll reverse transcription reactions. DNA 
amplification was carried out in u Ready To Go" PCR Beads. The initial conditions 
were 95 °C for 5 min. Amplification 30 cycles of iNOS were 95 °C for 40 s, 65 oc for 60 
s, and 72 °C for 2 min, followed by a 1 0 min extension at 72 °C. The thermal cycle 
conditions of COX-2 were initiated at 95 °C for 60 min, then 30 cycles of amplification 
(94 °C for 45 s, 55 oc for 60s, and 72 °C for 2 min) were performed followed by 10 min 
extension at 72 °C. The PCR products were separated by electrophoresis on a 1% agarose 
gel and visualized by ethidium bromide staining. Amplification of P-actin served as a 
control for sample loading and integrity. PCR was performed on the eDNA using the 
following sense and antisence primer: iN OS, forward primer 5' -CCCTTCCGAAGTTTC-
TGGCAGCAGC-3' (2944-2968), reverse pnmer 5'-GGCTGTCAGAGCCTCG-
TGGCTTTGG-3' (3419-3443); COX-2, forward primer 5' -GGAGAGACTA TCAAGA-
TAGTGATC-3' (1094-1117), reverse primer 5'-ATGGTCAGTAGACTTTTACAGCTC-
3' (1931-1954); p-actin, forward primer 5'- AAGAGAGGCATCCTCACCCT-3 ', reverse 
primer 5 '-TACATGGCTGGGGTGTTGAA-3'. Confirmation of the correct amplicons 
was obtained by direct DNA sequencing of the PCR products. 
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Results and discussion 
Inhibition of LPS-induced nitrite production by EGCG-DPA esters. Nitric oxide (NO) 
is an impmiant oxidative and inflanunatory mediator produced by NOS under 
physiological and pathophysiological conditions. It is a lipid-soluble free radical with a 
considerably long life and capable of diffusing several cell diameters from its synthesis 
site (Kruidenier and Verspaget, 2002). NO itself at nanomolar concentrations is not 
particularly harmful and in some occasions may even exert beneficial effects (Kruidenier 
and Verspaget, 2002). However, it is the precursor of a more damaging RNS peroxynitrite 
anion (ONOO-), a stable and reactive oxidizing/nitrating agent that can damage a broad 
array of biomolecules in cells. Excessive and uncontrolled production of NO in activated 
immune cells during inflammation contributes to the major destructive force in tissue 
injury. NO production by immune cells has been used as an indicator of the presence and 
extent of inflammation as well as the effectiveness of anti-inflammatory agents. 
In this work, the ability of EGCG-DPA esters to inhibit NO production in murine RAW 
264.7 macro phages was evaluated and compared with that of their acyl donor DP A. The 
macrophages were activated by LPS, and NO production was measured as nitrite 
concentration in the culture medium. LPS is a cell wall component of gram-negative 
bacteria that is known to induce the activation of monocytes and macrophages and 
production of pro-inflammatory mediators and cytokines (Nicholas et al. 2007). As 
shown in Figure 6-2, LPS treatment resulted in a sharp increase in the nitrite level in the 
macrophages. Both DPA and EGCG-DPA were effective in alleviating the LPS-induced 
NO overproduction. Their inhibitory effect did not differ significantly within the 
concentration range of2.5-25 J.lg/ml, whereas a dramatic drop (~50%) in nitrite level was 
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Figure 6-2. Effect of DPA and EGCG-DPA on NO production in LPS-stimulated 
RA W264.7 macrophages (*, P<0.05; **, P<O.Ol; ***, P<O.OOl compared 
with the LPS treatment only; #' P<O.OOl compared with the control). 
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observed in macrophages treated with 50 1-lg/ml of EGCG-DPA but not for the DPA 
counterpart. This suggests that EGCG-DPA esters at certain concentrations may act as 
efficient anti-inflammatory agents by inhibiting production ofNO. 
Direct and indirect mechanisms have been reported for NO inhibition by EGCG and other 
tea catechins (Paquay et al. 2000). Similar mechanisms may be involved for EGCG ester 
derivatives with possible additional contribution from the fatty acid side chain. EGCG has 
been demonstrated to inhibit NO production by suppressing gene expression of iN OS, an 
enzyme catalyzing production of NO and an important target for anti-inflammatory drug 
search or design. EGCG-DPA may render a similar suppressing effect on iNOS 
biosynthesis. This hypothesis is supported by the effect of EGCG-DPA esters on iNOS 
gene expression, which was also investigated in this study (results in Figure 6-4). 
Moreover, EGCG-DPA esters may inhibit the activity of iNOS at the enzyme level 
through the polyphenol-protein binding, as observed for many polyphenols including 
EGCG. In addition to the inhibition of iN OS, the EGCG moiety in the ester may render a 
direct scavenging effect on NO, and the lipophilic DPA moiety may contribute to a higher 
affinity of the molecule to the lipid soluble free radical. 
Inhibition of LPS-induced PGE2 production by EGCG-DPA esters. Prostaglandins 
are a group of arachidonic acid (AA)-derived eicosanoids biosynthesized through a 
cyclooxygenase pathway. They are lipid mediators that coordinate a wide variety of 
physiologic and pathologic processes (Fitzpatrick and Soberman 2001). Prostaglandins 
under physiologic conditions play important roles in the cytoprotection of gastric mucosa, 
hemostasis, and renal homodynamic. However, their stimulated biosynthesis is implicated 
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in pathogenesis of various diseases including inflammation and cancer (Patrignani et al. 
2005). Enhanced prostaglandin production is observed in immune cells, due to the 
relatively high levels of AA as the precursor in the immune cell membrane phospholipids 
as well as the induction of COX-2 in response to cellular stimulation. PGE2 is the best 
characterized prostaglandin and a major target for anti-inflammation and anti-cancer 
research. 
As shown in Figure 6-3, PGE2 production in LPS-stimulated macrophages was inhibited 
by EGCG-DPA esters and DPA, especially at high concentrations (25 and 50 1-lg/ml). The 
inhibitory effect was found to be stronger by EGCG-DPA esters than by the fatty acid 
DP A. DPA as an omega-3 fatty acid may act as a competitive inhibitor against the 
omega-6 fatty acid AA for the COX enzymes. It has been well documented that 
incorporation of increased amounts of omega-3 fatty acids such as EPA and DHA into 
cell membranes results in decreased production of arachidonic acid-derived eicosanoid 
mediators such as PGE2 (Clifton 2009). Meanwhile, EGCG is able to inhibit both the gene 
expression and activity of COX-2, the enzyme that catalyses the conversion of AA into 
prostaglandins (Kundu et a/. 2003). The EGCG-DPA esters with improved lipophilicity 
and cellular absorption may take advantage of both the DP A and EGCG moieties as well 
as possible synergistic effects between them. It is worth noting that both NO and PGE2 
inhibitory effects of the test compounds were determined on a weight basis, and an even 
more distinctive effect may be expected for the ester derivatives than for DPA at 
equimolar levels, due to the much higher molecular weight of the esters. 
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Inhibition iNOS and COX-2 induction by EGCG-DPA esters. In order to further 
confirm that NO and PGE2 production was inhibited by the test compounds through, at 
least partially, down-regulation of iNOS and COX-2, the protein levels of the two 
inflammatory mediators were determined. NOS comprise a family of enzymes that 
catalyse the production of NO in vivo, and are commonly known in two forms: eNOS that 
is constituently present in several types of cells (e.g. neurons and endothelial cells), and 
iNOS whose expression is induced in response to pro-inflammatory cytokines and 
bacterial LPS (Pan et al. 2009). In addition to its pro-inflammatory role, iNOS has also 
been proposed to be a major factor involved in pathological vessel dilation and 
tumorigenesis (Biesalski 2007). COX-2 is an inducible enzyme catalyzing the conversion 
of AA to prostaglandins. Bioactive lipids produced by COX-2 such as PGE2, have been 
identified to be potent inflammatory mediators that can also promote tumor growth and 
metastasis (Mann et al. 2005). Suppression of induction and activities of iNOS and COX-
2 is an important approach to preventing inflammation and carcinogenesis. 
The effect ofEGCG-DPA esters on induction ofiNOS and COX-2 protein was evaluated 
in LPS-stimulated murine RAW 264.7 macrophages using P-actin as the control protein. 
According to the results from western blotting (Figure 6-4), LPS remarkably increased 
the protein level of both iNOS and COX-2, while EGCG-DPA esters and DPA were able 
to attenuate the increase caused by LPS to various extents. Both the esters and DP A 
showed a dose-dependent relationship in suppressing the production of iNOS and COX-2, 
and the inhibitory effect was greater for the EGCG-DPA esters than for DP A. The iN OS 
concentrations in macrophages treated with EGCG-DPA were reduced by >50% 
compared to those treated with LPS alone, and were even lower than the negative control, 
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Figure 6-4. Effect of DPA and EGCG-DPA on expression of iNOS and COX-2 proteins 
in LPS-stimulated RA W264.7 macrophages (C: negative control without LPS; 
+ : positive control with LPS). 
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i.e. in the absence ofLPS stimulator. COX-2 induction was also inhibited to a large extent 
by EGCG-DPA esters, while only a slight inhibition was observed for DP A. These results 
correlated well with their inhibition against NO and PGE2 production, suggesting that 
suppression of iNOS and COX-2 induction plays a major role in the anti-inflammatory 
mechanism ofEGCG-DPA esters. 
The inhibition of iNOS and COX-2 induction by EGCG-DPA esters may be due to the 
down-regulation of their gene expression at transcriptional level, as reported for EGCG 
and other tea catechins (Lin and Lin, 1997; Kim et al. 2007). Gene expression of iN OS 
and COX-2 is promoted by the transcription factor NF-KB and AP-1, which are redox-
sensitive and become activated under oxidative stress. This may explain why many 
antioxidants also possess anti-inflammatory activity. The EGCG-DPA esters with 
antioxidant potential (as reported for SA, EPA and DHA esters in chapters 2-5) may 
alleviate oxidative stress and inhibit activation and/or translocation of NF -KB and AP-1, 
thus down-regulating the expression of the iNOS and COX-2 genes. 
Inhibition of iNOS and COX-2 mRNA expression by EGCG-DPA esters. The 
decrease in the concentration of iNOS and COX-2 in EGCG-DPA treated macrophages 
could be due to inhibited synthesis or promoted degradation of the proteins. The mRNA 
expression of the two inflammatory mediators was monitored in order to test the 
involvement of transcriptional events during their biosynthesis. Changes in the steady-
state concentration of mRNA for iNOS and COX-2 were assessed by RT-PCR using ~­
actin as the control gene. 
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As shown in Figure 6-5, mRNA expression of iNOS and COX-2 was markedly enhanced 
by LPS, while EGCG-DPA esters effectively inhibited the LPS-induced up-regulation of 
the their mRNA. The level of iN OS mRNA was reduced by >50% in EGCG-DPA treated 
macrophages, and a greater inhibition was achieved at the lower concentration (25 J..Lg/ml). 
The mRNA expression for COX-2 was also inhibited, albeit to a lesser extent (<50%), by 
EGCG-DPA esters. The effect ofDPA on mRNA expression, however, was inconsistent 
between the two inflammatory mediators. DPA-treated macrophages showed a mild 
decrease in iNOS mRNA level, while the mRNA for COX-2 was slightly up-regulated by 
DP A at 50 J..Lg/ml. 
The results from RT-PCR on the iNOS and COX-2 mRNA expression as affected by 
EGCG-DPA suggest involvement of a pretranslational or transcriptional mechanism in 
the inhibition of iNOS and COX-2 protein production. As discussed earlier, the down-
regulation effect of EGCG-DPA esters on the two inflammatory mediators may arise 
from their EGCG moiety, which has been demonstrated to inhibit the activation of 
transcription factors NF -KB and AP-I through various mechanisms (Surh 2006). The 
DPA, according to Figure 6-5, exerted an insignificant effect on transcription of the iN OS 
and COX-2 genes. However, its incorporation into the EGCG molecule may lead to 
improved cell membrane affinity and enhanced cellular absorption of the esters into the 
macrophages, and hence improved bioefficiency. The DPA moiety of the esters after 
absorption may then contribute to the anti-inflammatory activity through other 
mechanisms. 
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Figure 6-5. Effect ofDPA and EGCG-DPA on expression ofiNOS and COX-2 mRNA in 
LPS-stimulated RA W264.7 macrophages (C: negative control without LPS; 
+ : positive control with LPS). 
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Anti-inflammatory activity of EGCG and its individual ester derivatives. In addition 
to the DP A ester mixture, three isolated EGCG esters (SA, EPA and DHA tetraesters, 
structure shown in Figure 2-2 of Chapter 2) were also investigated on a molar basis for 
their inhibitory effect against NO production and iNOS and COX-2 expression. 
All test compounds (including EGCG and its esters) inhibited NO production in LPS-
stimulated macro phages in a dose dependent manner. The IC5o value (concentration to 
achieve 50% inhibition) obtained for each compound (Figure 6-6) indicated the highest 
IC50 (103.3 f.!M) for EGCG, and hence the lowest efficiency in inhibiting NO production. 
The ester derivatives showed greater inhibitory effects than the EGCG molecule itself, 
with low IC50 ranging from 29.8 to 40.7 f.!M. The derivatives were estimated to have 
higher cellular absorption than EGCG due to their higher lipophilicity and cell membrane 
affinity (Chapter 5), suggesting larger amounts of the compounds incorporated into the 
macrophage cells that are available to render their anti-inflammatory effect. Among the 
derivatives, compounds 2 and 3 with polyunsaturated side chains had slightly lower ICso 
than compound 1 with saturated side chain. The steric characteristics of the derivatives, 
especially those of compounds 2 and 3 with bending fatty acid side chains, may favor 
iN OS binding and account for greater inhibition of the enzyme activity than that exerted 
byEGCG. 
The EGCG derivatives exhibited down-regulation effects on iNOS and COX-2 
biosynthesis. All test compounds inhibited the LPS-induced iNOS expression in the 
macrophages in a dose-dependent manner (Figure 6-7). Compound 3 was the most potent 
inhibitor, followed by EGCG. Compounds 1 and 2 were less effective, except for 
compound 2 at a higher concentration ( 40 f.!M). This trend did not correlate with that of 
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Figure 6-6. Inhibitory effect of EGCG and its derivatives on nitrite production in LPS-
stimulated RA W264. 7 macrophages (compounds 1, 2 and 3 are EGCG 
tetraesters of SA, EPA and DHA, respectively). 
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6-21 
their NO inhibition capability, where the derivatives (compounds 1-3) showed a higher 
potency than EGCG. The variation may be attributed to the contribution of other possible 
mechanisms to NO inhibition, such as inhibition of the iNOS activity and NO radical 
scavenging, as discussed earlier. 
Macrophages treated with EGCG and its derivatives showed altered protein levels of 
COX-2 compared to those treated with LPS alone (Figure 6-7). All test compounds 
inhibited COX-2 induction at 20 JlM, while compound 3 at 40 JlM resulted in slightly 
increased level of COX-2. The inhibitory effect of compounds tested decreased in the 
order of Compound 1 > 2 > EGCG > 3, which is opposite to that observed for iNOS 
inhibition. The difference in their inhibitory trend against iNOS and COX-2 expression 
may be due to other mechanisms involved in addition to blocking ofthe NF-KB and AP-1 
signalling pathways. EGCG and its derivatives may also suppress the production of the 
two inflammatory mediators by breaking down the protein and mRNA of iNOS and 
COX-2 to various degrees, which requires fwther investigation. 
Conclusions 
Ester derivatives of EGCG with improved lipophilicity exhibited anti-inflammatory 
activities in LPS-stimulated murine macrophages, possibly through enhanced cellular 
absorption and contribution from both EGCG and the fatty acid moieties. The EGCG 
esters showed inhibition against LPS-induced production of NO and PGE2 in the 
macrophages. The inhibitory effect is largely related to their ability to down-regulate the 
inflammatory mediators (iNOS and COX-2) biosynthesis at transcriptional level, while 
other mechanisms may also be operative, such as direct inhibition of the enzyme activity 
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and scavenging of NO by EGCG, and substrate competition of the omega-3 fatty acids 
with arachidonic acid, the precursor for pro-inflammatory prostaglandins. These findings 
suggest that the EGCG ester derivatives may serve as lipophilic alternatives to EGCG in 
preventing/treating inflammation-mediated diseases. 
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CHAPTER 7 
Protective effects of epigallocatechin gallate (EGCG) derivatives on azoxymethane-
induced colonic tumorigenesis in mice 
Introduction 
Colorectal cancer (CRC) is the second most often diagnosed cancer and a significant 
cause of mortality in the western countries (Stevens et al. 2007). Both hereditary and 
environmental factors (through ingestion of genotoxins and carcinogens in alimentation) 
contribute to the development of CRC (Yuan et al. 2008). The pathogenesis of CRC 
involves sequential and multistep progression of epithelial cells initiated to a cancerous 
state with defined precancerous intermediaries (Raju 2008). Colonic aberrant crypt foci 
(ACF) are identified as intermediate precancerous lesions and precursors of adenoma and 
cancer, and may serve as predictive biomarkers of CRC. ACF are both morphological and 
genetic abnormalities in single crypts during the development of colonic mucosal 
preneoplasia with potential for progression, and are often used to identify modulators of 
colon carcinogensis, including carcinogens and anticarcinogens (Stevens et al. 2007). In 
the rat model, the ACF was enhanced by cancer promoters such as azoxymethane (AOM) 
and suppressed by chemopreventive agents (Y akayama et a!. 1998). The ACF were 
observed in rat colon a few weeks after treatment with a colon-specific carcinogen and 
grew larger with time with more marked nuclear dysplasia (McLellan et al. 1991 ). It has 
been widely accepted that the incidence of ACF in rodents correlates strongly with the 
final tumor outcome. In humans, significant correlation has also been established between 
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the number of ACF, the size of the foci, the presence of dysplastic foci and the number of 
adenomas (Y akayama et al. 1998). 
Epigallocatechin gallate (EGCG), the major bioactive polyphenolic compound in tea, has 
been known to possess anticancer potential, which is thought to be attributed to its 
antioxidant activity, induction of phase II enzymes, inhibition against cell proliferation, 
and induction of apoptosis, among others (Pham-Huy et al. 2008). EGCG and other tea 
polyphenols have been shown to inhibit tumorigenesis in different animal models, 
including those with induced cancers of the skin, lung, oral cavity, esophagus, stomach, 
small intestine, colon, bladder, liver pan crease, prostate and mammary glands (Yang et al. 
2008). Inhibitory effects of tea and tea polyphenols on intestinal tumorigenesis have been 
reported in mice (Yin et al. 1994; Suganuma et al. 2001). Xiao et al. (2008) demonstrated 
that dietary tea polyphenols (containing 65% EGCG) significantly and dose-dependently 
inhibited the colonic ACF formation, especially the high-grade dysplastic ACF in AOM-
treated F344 rats. The inhibition was proposed to be associated with the capability of 
EGCG and other polyphenols to promote apoptosis, prevent aberrant nuclear P-catenin 
accumulation, decrease cyclin D 1 level and maintain RXRa expression. 
In this work, the EGCG molecule was structurally modified by esterification with 
selected fatty acids to yield ester derivatives in order to take advantage of the ester-based 
prodrugs, including improved lipophilicity and bioavailability in vivo as well as additional 
benefits or synergism arising from the fatty acid moiety, in this case, docosahexaenoic 
acid (DHA) and butyric acid. A EGCG-DHA mixture (54.7% tetraester and 3.1% 
pentaester and 42.2% unreacted EGCG) and perbutyrated EGCG (EGCG octabutyrate) 
(Figure 7-1) were evaluated for their effect on colon tumorigenesis in AOM-treated mice 
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EGCG-octabutyrate: R=CO(CH2) 2CH3 
EGCG-DHA: R= CO(CH2MCH=CHCH2) 6CH3 at some positions, and =Hat others 
Figure 7-1. Chemical structures of EGCG and its derivatives. 
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by monitoring the ACF formation and expression of two tumor-promoting enzymes 
inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). 
Materials and methods 
Materials. EGCG was supplied by Dr. Yu Shao of GlaxoSmithKline Consumer 
Healthcare (Parsippany, NJ, USA). Butyroyl chloride was purchased from Nu-chek Prep 
Inc. (Elysian, MN, USA). DHA was prepared as described in Chapter 2 from DHASCO 
(Martek Bioscience Corporation, Columbia, MD, USA). Polyvinylidene fluoride (PVDF) 
membranes were purchased from Millipore Corp. (Bedford, MA, USA); iNOS and COX-
2 monoclonal antibodies, anti-mouse and anti-rabbit IgG antibodies from BD 
Transduction Laboratories (Lexington, KY, USA); ECL western blotting detection agent 
from Amersham Corp. (Arlington Heights, IL, USA). Other chemicals were purchased 
from Sigma-Aldrich Canada Ltd. (Oakville, ON). All solvents used were obtained from 
Fisher Scientific Ltd. (Ottawa, ON). The solvents employed were of reagent or HPLC 
grade. 
Preparation of EGCG esters. Ester derivatives of EGCG were prepared as described in 
Chapter 2. Briefly, EGCG was acylated with DHA through its acyl chloride, and the 
composition of the crude products containing a mixture of EGCG polyesters was 
determined by HPLC-MS. EGCG octabutyrate was prepared by reacting EGCG with an 
excess of butyroyl chloride and its identity was confirmed with HPLC-MS. The EGCG-
DHA crude mixture (54.7% tetraester, 3.1% pentaester and 42.2% unreacted EGCG 
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according to HPLC) and EGCG octabutyrate were evaluated for their protective effect 
against AOM-induced colon tumorigenesis in mice. 
Animals. Male ICR (Institute of Cancer Research) miCe at 5 weeks of age were 
purchased from the BioLASCO Experimental Animal Center (Taipei, Taiwan). After 1 
week of acclimation, the animals were randomly distributed into the control and 
experimental groups (12 mice in each group, Figure 7-2). Groups 1 and 2 were given a 
basal diet, whereas groups 3 through 6 were given a diet supplemented with different 
concentrations (0.25 and 0.50%) of EGCG derivatives. Mice in groups 2 though 6 were 
injected with AOM (5 mg/kg body weight) twice a week for two weeks. All mice were 
housed in a controlled atmosphere (25 ± 1 °C, 50 % relative humidity, and 12-hour 
light/12-hour dark cycle) with free access to food and water at all times. Food containers 
were replenished with fresh diet every day. At the termination of the study (after 5 weeks), 
the animals were sacrificed with C02 asphyxiation and dissected, and the weights of their 
whole body and selected tissues, including the liver, kidney and spleen, were recorded. 
Identification of colonic ACF. The formalin-fixed colonic tissues were cut into proximal 
(1-2 em from the cecum), middle (3-4 em) and distal (1-2 em from anus) segments and 
stained in a 0.2 % methylene blue solution for 10 min. Aberrant crypts (AC) were 
identified under a microscope (x 40) as large thick crypts that are more darkly stained 
than normal crypts. The stained AC in each focus were counted and the location (distance 
from anus), number and size (number of AC) of ACF were recorded. 
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Figure 7-2. Experimental treatment of mice with AOM and EGCG derivatives. 
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Western blot analysis for iNOS and COX-2 expression. For protein analyses, total 
scraped colon mucosa was homogenized on ice for 15 s with a Polytron tissue 
homogenizer and lysed in 0.5 mL ice-cold lysis buffer (50 mM Tris-HCl, pH 7.4, 1 mM 
NaF, 150 mM NaCl, 1 mM ethylenediaminetetraacetic acid (EDTA), 1 mM 
phenylmethane-sulfonyl fluoride, 1% NP-40, and 10 mg/mL leupeptin) on ice for 30 min, 
followed by centrifugation at 1 O,OOOg for 30 min at 4 °C. The samples (50 )lg of protein) 
were mixed with 5x sample buffer containing 0.3 M Tris-HCl (pH 6.8), 25% 2-
mercaptoethanol, 12% sodium dodecyl sulfate (SDS), 25 mM EDTA, 20% glycerol, and 
0.1% bromophenol blue. The mixtures were boiled at 100 oc for 5 min and were 
subjected to gel electrophoresis with 12% SDS-polyacrylamide minigels at a constant 
current of 20 rnA. For Western blot analysis, proteins on the gel were electrotransferred 
onto the 45 micron immobile membrane (PVDF) with transfer buffer containing 25 mM 
Tris-HCl (pH 8.9), 192 mM glycine, and 20% methanol. The membranes were blocked 
with blocking solution (20 mM Tris-HCl pH 7.4, 0.2% Tween 20, 1% bovine serum 
albumin, and 0.1% sodium azide). The membrane was further incubated with respective 
specific antibodies, at appropriate dilution (1: 1 000) using blocking solution with the 
primary antibody of iNOS, COX-2 monoclonal antibodies overnight at 4°C. The 
membranes were subsequently probed with anti-mouse or anti-rabbit lgG antibody 
conjugated to horseradish peroxidise and visualized using enhanced chemiluminescence. 
The densities of the bands were quantified with a computer densitometer (Alphalmager 
TM 2200 System, Alpha Innotech Corporation, San Leandro, CA, USA). All the 
membranes were stripped and reprobed for ~-actin as loading control. 
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Results and discussion 
General observations. Figure 7-3 shows the body and selected tissue weights of the mice 
at the termination of the experiment, including the vehicle (negative control) and AOM-
treated (positive control) mice as well as those administered with different concentrations 
of EGCG esters. No significant variations were observed for the body and tissue weight 
among the groups. Injection of the colon-specific carcinogen AOM did not result in 
abnormal weight gain or loss of the mice in a short term (5 weeks). The tissue weight of 
liver, kidney and spleen did not seem to be affected by AOM injection or EGCG ester 
administration. Similar results have been reported in AOM and green tea polyphenols-
treated rats, which did not show any significant difference in their body and spleen 
weights (Xiao et al. 2008). However, Shimizu et al. (2008) demonstrated that AOM 
treatment resulted in reduced weight gain in mice with obese and diabetic mellitus. The 
authors also stated that this may be due to greater susceptibility of the diabetic mice to 
AOM toxicity. 
Inhibition of AOM-induced ACF in mouse colon. After 5 weeks of dietary treatment 
with EGCG derivatives, all mice were killed and the entire colon harvested for analysis of 
ACF, the reliable intermediate biomarkers for colon carcinogenesis. Colonic ACF were 
identified after methylene blue staining and their location, number and size recorded. 
Figure 7-4 shows the morphology of the colon crypts as affected by treatment with AOM 
and EGCG derivatives. Compared to normal crypts, AC were more darkly stained with 
thicker epithelial linings and increased pericryptal space and often had irregular lumens, 
e.g. oval or slit-shaped lumens. Distribution of ACF in the colon was not even. ACF, 
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Figure 7-3. Whole body and selected tissue weights of AOM-treated mice. 
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Normal 0.25% EGCG-octabutyrate 0.25% EGCG-DHA 
AOM alone 0. 50% EGCG-octabutvrate 0.50% EGCG-DHA 
Figure 7-4. Morphological observation of normal and aberrant crypts in the mice colon as 
affected by EGCG derivatives. 
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especially those larger than 7 AC/focus, occurred mostly in the distal and middle colon, 
while less detected in the proximal colon (Table 7-1 ). The prevalent localization of ACF 
in the distal and middle colon has been reported by other researchers, who suggested that 
ACF are not random lesions of the rodent colon treated with genotoxic colon carcinogens 
(Geng et al. 1998; Rodrigues et al. 2002). Among the different treatment groups, the mice 
receiving 0.25% EGCG derivatives had smaller number of large ACF (?:.7 AC/focus) in 
their distal colon. ACF containing more than seven AC were specifically investigated as 
they are believed to be more significant in identifying colonic carcinogenesis (Magnuson 
et al. 1993; Davies et al. 1998). 
The formation of ACF in the entire colon was stimulated by AOM injection, while dietary 
supplementation with EGCG derivatives inhibited the AOM-induced ACF formation to 
different extents (Figure 7-4). The inhibition was characterized by a decrease in total 
number of AC per mouse and number of AC per focus (Table 7-2). However, the total 
number of ACF per mouse was not affected significantly (P>0.05) by EGCG derivatives 
administration. Thus, treatment of EGCG esters appears to have a greater effect in 
reducing the size than the number of ACF in the mice colon. The esters were able to 
inhibit the formation of large ACF, i.e. foci with more than 7 AC/focus. EGCG-DHA 
esters in the diet remarkably decreased the number of ACF larger than 7 AC/focus, while 
EGCG-octabutyrate did not show any significant effect (Figure 7-5). Both the DHA esters 
and octabutyrate significantly decreased the number of ACF larger than 10 AC/focus. The 
EGCG derivatives were effective in inhibiting the intermediate precancerous lesions in 
the colon, thus exerting an anti-cancer activity in the sequential progression of colon 
turnorogensis. Tumors, defined as lesions with a crypt multiplicity of ?:.32 AC/lesion, 
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Table 7-1. ACF development (number of foci) in the colon of AOM-treated mice. 
Treatment 
Positive control 
0.25% EGCG-octabutyrate 
0.50% EGCG-octabutyrate 
0.25% EGCG-DHA 
0.50% EGCG-DHA 
Proximal 
<7 AC ?:.7 AC 
9.0 ± 2.6 5.0 ± 1.0 
7.0 ± 2.8 3.0 ± 2.8 
11.3 ± 3.5 10.3 ± 3.0 
10.0 ± 6.9 6.0 ± 2.0 
8.3±3.8 4.7±2.1 
Middle Distal 
<7 AC ?:.7 AC <7 AC ?:.7 AC 
6.3±2.3 11.5 ± 6.7 4.3 ± 3.0 19.3 ± 1.5 
8.3 ± 6.8 15.0 ± 8.5 3.0 ± 1.4 14.0 ± 1.4. 
7.3 ± 3.1 14.7 ± 8.5 14.3 ± 4.9 13 .7 ± 8.0 
9.0 ± 5.0 9.0 ± 5.3 17.3 ± 5.9 4.3 ± 1.2· 
9.3 ± 7.4 9.3 ± 2.1 15.7 ± 8.6 13.0 ± 6.6 
* Numbers are significantly different from the positive control (AOM only) at P<0.05. 
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Table 7-2. ACF formation (number and size) in the colon as affected by AOM and EGCG 
derivatives treatment. 
Treatment 
Positive control 
0.25% EGCG-octabutyrate 
0.50% EGCG-octabutyrate 
0.25% EGCG-DHA 
0.50% EGCG-DHA 
Total number of 
ACF/mouse 
61.0 ± 7.9 
52.0 ± 24.0 
72.3 ± 25.4 
57.0 ± 23.3 
59.7 ± 8.5 
Total number of 
AC/mouse 
511.7±31.8 
488.5 ± 16.8 
461.0 ± 24.2 
398.5 ± 11.2* 
366.0 ± 7.4. 
* Numbers are significantly different from the positive control (AOM alone) at P<0.05. 
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Figure 7-5. Number of ACF and tumor in the mice colon. 
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were detected in the colon of the mice treated with AOM except for the groups 
supplemented with EGCG-DHA esters, which exhibited a 100% inhibition against tumor 
formation (Figure 7-5). The octabutyrate, although less potent than the DHA esters, also 
significantly (P<0.03) decreased the number of tumors in the mouse colon in a dose-
dependent manner. 
ACF formation is known as a putative indicator of colon tumorigenesis and efficacy of 
anticarcinogenic agents. ACF were first reported in a rodent model by Bird (1987), and 
are now recognized as the earliest identifiable lesions on the pathway to CRC in humans. 
Formation of ACF has been related to a number of neoplastic alterations of the colon 
epithelial cells, such as increased proliferation, nuclear and cytoplasmic P-catenin 
expression, K-RAS and APC mutations as well as microsatellite instability (Augenlicht et 
al. 1996; Takayama et al. 2001 ). More recently, it has been suggested that ACF 
containing P-catenin accumulated crypts with dysplasia in nature are more relevant and 
informative preneoplastic lesions for chemical carcinogen-induced colon cancer (Femia et 
al. 2007). 
The colon is considered a promising site for chemoprevention with polyphenols, as it is 
exposed to considerable levels of polyphenols from dietary sources that have low 
systemic bioavailability (Yang et al. 2008). EGCG from green tea, for example, has only 
limited systemic bioavailability after oral ingestion, and even the absorbed EGCG is 
excreted mostly into the intestine through the bile (Yang et al. 2008). EGCG has been 
reported to inhibit the formation of colonic ACF and the growth and metastasis of cancer 
cells, mostly via inhibiting cell proliferation and/or inducing apoptosis in colon cancer 
(Carter et al. 2007). The exact mechanism of EGCG in the inhibition of colon 
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tumorigenesis IS not yet fully unravelled, but is suggested to involve its roles in 
preventing aberrant nuclear P-catenin accumulation, decreasing cyclin D 1 level, 
maintaining RXRa expression as well as activating Nr£2-UGTs (nuclear factor E2-related 
factor 2-uridine 5' -diphosphate glucuronosyltransferase, a phase II metabolism) 
signalling pathway, among others (Xiao et al. 2008; Yuan et a!. 2008). Esterification of 
EGCG with fatty acids employed in this study might have led to improved lipophilicity 
and membrane affinity (data shown for EGCG-DHA tetraester in Chapters 2 and 5), and 
presumably enhanced absorption through the intestine. The absorbed compounds with 
less free hydroxyl groups might lead to decreased conjugation (glucuronidation, sulfation 
and methylation, etc.) during metabolism and reduced rate of urinary excretion, in other 
words, increased deposition in the colon through the bile. In addition, the fatty acid 
moiety in the derivatives may also contribute to the anti-carcinogenic effect of these 
compounds, possibly in a synergistic manner with EGCG. Both DHA and butyrate have 
been reported to induce apoptosis in colorectal tumor cells (Johnson 2002). DHA not only 
inhibited AOM-induced ACF formation, but also reduced the incidence of spontaneous 
ACF in rats without carcinogen treatment (Takahashi et al. 1994 ). The mechanisms of the 
protective effect of the EGCG ester derivatives needs to be further clarified in future 
investigations. 
Inhibition against expression of pro-tumorigenic inflammatory mediators. There has 
been a causal relationship between tumorigenesis (including cellular transformation, 
promotion, proliferation and metastasis steps) and chronic inflammation, characterized by 
increased expression of many pro-inflammatory mediators. Some pro-inflammatory 
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mediators such as iNOS and COX-2 are known to act as promoters of carcinogenesis, 
whose expressions in the colonic mucosa are altered during CRC development (Cheng 
and Lai 2003). iNOS belongs to the family of enzymes that catalyse the production of 
nitric oxide (NO) in vivo. It is induced in response to inflammation and the excessive and 
prolonged iNOS-mediated NO production has been linked to promotion of tumorigenesis. 
COX-2 is an inducible enzyme catalyzing the conversion of arachidonic acid to 
prostaglandins. Recent studies have suggested that increased levels of prostaglandins and 
COX-2 activity may play important roles in many epithelial cancers including colon 
carcinoma (Dubois et al. 1998). Therefore, suppression of gene expression of iNOS and 
COX-2 may serve as an important approach to inhibiting CRC development and a useful 
indicator for assessing chemopreventive efficacy of novel anticarcinogens. Inhibitory 
effects of EGCG on iN OS and COX-2 expression have been reported (Lin and Lin 1997; 
Kundu et al. 2003). EGCG and other tea polyphenols are believed to down-regulate iNOS 
and COX-2 expression at the transcriptional level through inhibiting the activation and/or 
translocation of the transcription factor NF (nuclear factor)-KB and AP (activator 
protein)-1 (Surh 2006). 
The ester derivatives of EGCG used in this study with the improved lipophilicity were 
evaluated for their efficacy in inhibiting colon mucosal expression of the tumor-
promoting enzymes iNOS and COX-2. As shown in Figure 7-6, AOM treatment (positive 
control) had a stimulating effect on the protein expression of both iNOS and COX-2 in 
the mice colon. Oral administration of EGCG derivatives was able to alleviate the 
carcinogen-induced overexpression of the two enzymes. EGCG-DHA esters significantly 
suppressed the expression ofiNOS and COX-2 in a dose-dependent manner. Mice treated 
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AOM (5 mg/kg) 
EGCG-octabutyrate EGCG-DHA 
c + 0.25 0.50 0.25 0.50 (%) 
I~ iNOS (130 kDa) 
2.3 0.5 
I~ COX-2 (72 kDa) 
1.0 41.5 10.8 12.9 1.4 0.6 
I~ P-actin (43 kDa) 
Figure 7-6. Mucosal expression ofiNOS and COX-2 in the mice colon (C: negative 
control; +: positive control, AOM only). 
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with 0.5% of EGCG-DHA showed even lower levels of iNOS and COX-2 proteins in 
their colon mucosa compared to those fed a standard diet without AOM injection 
(negative control). EGCG-octabutyrate, although less effective than the DHA esters, also 
exhibited a remarkable inhibitory effect against AOM-induced expression of the two 
tumor-promoting enzymes, and the effect was found to be greater at a lower concentration 
(0.25%). The excellent suppressing activity of the EGCG derivatives on the pro-
tumorigenic enzymes may be attributed to both EGCG and the fatty acids, as 
compartments in the ester molecules or in their free form after hydrolysis, as well as 
possible synergism between the two moieties. DHA and other long-chain omega 3 PUF A 
have been demonstrated to possess anti-inflammatory effects (Bouwens et a/. 2009). 
Moreover, a synergistic effect has been reported for DHA and the polyphenol curcumin in 
suppressing the pro-inflammatory and tumor-promoting enzymes iNOS and COX-2 (Saw 
eta/. 2010). The short chain butyric acid, resulting from colonic fermentation of dietary 
fiber, was found to act as an efficient anti-inflammatory agent and be responsible for the 
protective role of dietary fiber against colon cancer (Salimath et a/. 1999). 
Conclusions 
Esterification of the green tea polyphenol EGCG with butyric acid and DHA provides a 
novel approach to search for anti-cancer agents. The ester derivatives with improved 
lipophilicity may have altered metabolism and elimination in the body from that of the 
parent EGCG, and therefore varied bioactivity in vivo. In mice treated with a colon-
specific carcinogen (AOM), oral administration of the EGCG derivatives significantly 
inhibited the colon tumorgenesis. Formation of ACF was significantly inhibited by the 
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derivatives, observed as the decrease in the total number of AC and size of the foci. 
Supplementation of the EGCG derivatives, especially the DHA esters, showed a striking 
effect in reducing the total number of colon tumors in mice. The expression of the tumor-
promoting enzymes iNOS and COX-2 was also suppressed to great extents by the 
derivatives. The findings suggest that EGCG ester derivatives with chemopreventive 
potential may serve as anticarcinogenic agents in preventing and/or treating colon cancers. 
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CHAPTERS 
Summary and recommendations for future research 
This study investigated the lipophilization of the water-soluble epigallocatechin gallate 
(EGCG) for its expanded application and improved bioefficiency in food and natural 
health products. EGCG was esterified with fatty acids of different chain lengths and 
degrees of unsaturation, including stearic (SA, C 18 :0), eicosapentaenoic (EPA, C20: 5) 
and dososahexaenoic acids (DHA, C22:6). Under selected reaction conditions, tetraesters 
were dominant in the crude products which contained a mixture of EGCG esters with 
different degrees of substitution. The structures of the isolated tetraesters were identified 
by MS, 1H and 13C NMR as EGCG-3' ,5' ,3" ,5"-0-tetrastearate (compound 1), EGCG-
3 ',5' ,3 ",5" -0-tetraeicosapentaenoate (compound 2), and EGCG-3 ' ,5' ,3 ",5" -0-
tetradocosahexaenoate (compound 3). These ester derivatives showed enhanced 
lipophilicity and liposome incorporation (indicator of cellular uptake), as expected, and 
were evaluated for their bioactivities using a number of in vitro, ex vivo and in vivo tests. 
The bioactivities examined included antioxidant activity determinations using chemical 
assays, food and biological model systems, antiviral activity in inhibiting different 
virulent enzymes, anti-inflammatory activity in lipopolysaccharides (LPS)-stimulated 
murine macrophages, and anticancer activity in a carcinogen-induced mouse colon cancer 
model. In addition to the three isolated tetraesters (compounds 1-3), a crude product of 
EGCG-DPA (docosapentaenoic acid, C22:5) ester mixture and perbutyrated EGCG 
(EGCG-octabutyrate) were also prepared and subjected to selected bioactivity tests. 
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The EGCG derivatives (compounds 1-3) exhibited excellent antioxidant activity in 
various in vitro chemical assays, including the oxygen radical absorbance capacity 
(ORAC), 1, 1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity, reducing 
power, and metal ion chelation capability. The antioxidant activity of EGCG and its 
derivatives varied depending on the system environment involved and EGCG derivatives 
had generally similar or superior antioxidant activity when compared to the original 
EGCG. In order to evaluate the potential of EGCG derivatives as food preservatives, their 
antioxidant activity in several food model systems were investigated. EGCG derivatives 
effectively inhibited lipid oxidation in a bulk oil (stripped corn oil), an emulsion (~­
carotene/linoleate emulsion) and a muscle food (pork) model system. Again, the 
derivatives tested exhibited antioxidant activities similar or superior to that of the EGCG. 
The ester derivatives, as potential health-promoting agents, were assessed in several 
biological systems for their antioxidant activity. LDL-cholesterol oxidation was inhibited 
by the derivatives to a greater extent than by EGCG, suggesting their anti-atherogenic 
effect and hence cardioprotective potency. The derivatives also inhibited hydroxyl and 
peroxyl radical-induced DNA scission, the free radical-mediated oxidative damage 
involved in mutagenesis and carcinogenesis. The derivatives were able to render 
protective effects against UV -induced oxidation in a liposome model. Thus, it is 
suggested that the lipophilic derivatives of EGCG be considered for use as potential skin 
care agents. 
The antiviral activity of EGCG derivatives, including the tetraesters (compounds 1-3) and 
the perbutyrate (EGCG-octabutyrate ), was studied in order to explore the potential role of 
8-2 
these compounds in protecting against virus-initiated infections or diseases. The 
derivatives showed great potential in inhibiting NS3/4A protease, an important enzyme 
required for the maturation of hepatitis C virus (HCV), and a-glucosidase, the enzyme 
essential for HIV infectivity, while the effect was not observed for the parent compound 
EGCG. It was also noted that the HCV protease inhibitory activities of the EGCG-PUF A 
(polyunsaturated fatty acids) esters (compounds 2 and 3) were about 1700-fold greater 
than that of the positive control embelin. 
The anti-inflammatory activity of EGCG derivatives, including the tetraesters 
(compounds 1-3) and the EGCG-DPA ester mixture, was evaluated in LPS-stimulated 
murine macrophages. The derivatives were effective in inhibiting LPS-induced nitric 
oxide (NO) and prostaglandin E2 (PGE2) production and the effectiveness was attributed 
to their ability to down-regulate the gene expression of inducible NO synthase (iNOS) 
and cyclooxygenase (COX)-2 at the transcriptional level. 
The anti-cancer activity of selected EGCG derivatives (EGCG-octabutyrate and crude 
EGCG-DHA mixture) was evaluated using a mouse model of colon carcinogenesis 
induced by azoxymethane (AOM). Oral administration of the EGCG derivatives 
significantly inhibited the AOM-induced colon tumorigenesis, observed as decreased 
number of aberrant crypts (AC) and total number of tumors as well as suppressed iNOS 
and COX-2 expression in the mice colon. The DHA esters of EGCG, in particular, were 
able to totally eliminate tumorogenesis in the limited number of animals used. These 
findings suggest that EGCG ester derivatives possess chemopreventive potential against 
colon cancer. 
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Overall, the results from this study suggest that esterification with long-chain fatty acids 
can serve as a useful tool to enhance the lipophilicity of EGCG, and that EGCG ester 
derivatives can be used as lipophilic alternatives to the bioactive EGCG with expanded 
applications and improved bioefficacy. Moreover, improved bioavailability can be 
expected as a result of increased liposome membrane affinity and hence enhanced cellular 
absorption in vivo. Thus, the use of EGCG esters as functional food ingredients and 
pharmaceuticals for health promotion and disease risk reduction may be suggested. 
However, further investigations need to be carried out on bioactivities of the EGCG 
derivatives ex vivo and in vivo using cell line and animal models, followed by human 
clinical studies. Meanwhile, scale-up production of ester derivatives of EGCG and other 
green tea catechins as well as crude tea extracts and evaluation of the economy of the 
process must be explored. Use of other omega-3 fatty acids such as stearidonic and a-
linolenic acids as well as selected omega-6 fatty acids can also be considered for their 
potential health benefits. 
8-4 
